JP5864589B2 - 細菌トポイソメラーゼii阻害性2−エチルカルバモイルアミノ−1,3−ベンゾチアゾール−5−イル類 - Google Patents
細菌トポイソメラーゼii阻害性2−エチルカルバモイルアミノ−1,3−ベンゾチアゾール−5−イル類 Download PDFInfo
- Publication number
- JP5864589B2 JP5864589B2 JP2013532015A JP2013532015A JP5864589B2 JP 5864589 B2 JP5864589 B2 JP 5864589B2 JP 2013532015 A JP2013532015 A JP 2013532015A JP 2013532015 A JP2013532015 A JP 2013532015A JP 5864589 B2 JP5864589 B2 JP 5864589B2
- Authority
- JP
- Japan
- Prior art keywords
- ethylcarbamoylamino
- benzothiazol
- piperidine
- pyrimidin
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 230000001580 bacterial effect Effects 0.000 title claims description 17
- 102000007537 Type II DNA Topoisomerases Human genes 0.000 title 1
- 108010046308 Type II DNA Topoisomerases Proteins 0.000 title 1
- 230000002401 inhibitory effect Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 claims description 249
- 150000001875 compounds Chemical class 0.000 claims description 224
- 125000000217 alkyl group Chemical group 0.000 claims description 202
- 229910052739 hydrogen Inorganic materials 0.000 claims description 186
- 229920006395 saturated elastomer Polymers 0.000 claims description 107
- -1 Ethylcarbamoylamino Chemical group 0.000 claims description 84
- 239000002243 precursor Substances 0.000 claims description 71
- 150000003839 salts Chemical class 0.000 claims description 60
- 125000000623 heterocyclic group Chemical group 0.000 claims description 58
- 125000005843 halogen group Chemical group 0.000 claims description 51
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 44
- 125000003545 alkoxy group Chemical group 0.000 claims description 43
- 125000002619 bicyclic group Chemical group 0.000 claims description 40
- 229910052757 nitrogen Inorganic materials 0.000 claims description 40
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 claims description 35
- 125000000246 pyrimidin-2-yl group Chemical group [H]C1=NC(*)=NC([H])=C1[H] 0.000 claims description 33
- 125000003118 aryl group Chemical group 0.000 claims description 32
- 239000002253 acid Substances 0.000 claims description 30
- 229910052799 carbon Inorganic materials 0.000 claims description 30
- 238000000034 method Methods 0.000 claims description 29
- 125000001475 halogen functional group Chemical group 0.000 claims description 27
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 26
- 230000008878 coupling Effects 0.000 claims description 22
- 238000010168 coupling process Methods 0.000 claims description 22
- 238000005859 coupling reaction Methods 0.000 claims description 22
- 125000002950 monocyclic group Chemical group 0.000 claims description 22
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims description 19
- 229910052760 oxygen Inorganic materials 0.000 claims description 19
- 125000001072 heteroaryl group Chemical group 0.000 claims description 15
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 15
- 125000001313 C5-C10 heteroaryl group Chemical group 0.000 claims description 14
- ZADPBFCGQRWHPN-UHFFFAOYSA-N boronic acid Chemical compound OBO ZADPBFCGQRWHPN-UHFFFAOYSA-N 0.000 claims description 14
- 125000001424 substituent group Chemical group 0.000 claims description 14
- 125000003342 alkenyl group Chemical group 0.000 claims description 13
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims description 11
- 239000003242 anti bacterial agent Substances 0.000 claims description 11
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 claims description 10
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 claims description 10
- 208000035143 Bacterial infection Diseases 0.000 claims description 10
- 125000002947 alkylene group Chemical group 0.000 claims description 10
- 208000022362 bacterial infectious disease Diseases 0.000 claims description 10
- 125000004432 carbon atom Chemical group C* 0.000 claims description 10
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims description 10
- VWGVZRSKDSKOCX-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-pyridin-2-yl-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C1=CC=CC=N1 VWGVZRSKDSKOCX-UHFFFAOYSA-N 0.000 claims description 9
- 230000008569 process Effects 0.000 claims description 9
- 229910052717 sulfur Inorganic materials 0.000 claims description 9
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims description 8
- 125000004450 alkenylene group Chemical group 0.000 claims description 8
- 125000004419 alkynylene group Chemical group 0.000 claims description 8
- 150000007942 carboxylates Chemical class 0.000 claims description 8
- JSJORNVDZKDKSU-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-(4-methylpyridin-2-yl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C1=CC(C)=CC=N1 JSJORNVDZKDKSU-UHFFFAOYSA-N 0.000 claims description 7
- LEQHROIJVSVGKQ-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-(pyridine-2-carbonylamino)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1NC(=O)C1=CC=CC=N1 LEQHROIJVSVGKQ-UHFFFAOYSA-N 0.000 claims description 7
- JUYRPCDORFQPQJ-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-4-pyridin-2-yl-[1,3]thiazolo[5,4-c]pyridin-6-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=NC=1C1=CC=CC=N1 JUYRPCDORFQPQJ-UHFFFAOYSA-N 0.000 claims description 6
- LQPRFUISPJLHIA-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-(pyrimidine-2-carbonylamino)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1NC(=O)C1=NC=CC=N1 LQPRFUISPJLHIA-UHFFFAOYSA-N 0.000 claims description 6
- XHZIGBLECMTNGL-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-[2-(6-methoxypyridin-2-yl)ethynyl]-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C#CC1=CC=CC(OC)=N1 XHZIGBLECMTNGL-UHFFFAOYSA-N 0.000 claims description 6
- MTAJMFNBGICWOP-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-pyridin-2-yl-1,3-benzothiazol-5-yl]pyridazin-3-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=C(N=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C1=CC=CC=N1 MTAJMFNBGICWOP-UHFFFAOYSA-N 0.000 claims description 6
- HLKACKWVNDSHBX-UHFFFAOYSA-N 1-[5-[7-bromo-2-(ethylcarbamoylamino)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=1C(Br)=C2SC(NC(=O)NCC)=NC2=CC=1C(C=N1)=CN=C1N1CCC(C)(C(O)=O)CC1 HLKACKWVNDSHBX-UHFFFAOYSA-N 0.000 claims description 6
- SVJMHGIAIUBOET-UHFFFAOYSA-N 7-[2-(ethylcarbamoylamino)-7-pyridin-2-yl-1,3-benzothiazol-5-yl]-2-methyl-3-oxo-4h-pyrido[3,2-b][1,4]oxazine-2-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=C3OC(C)(C(=O)NC3=NC=2)C(O)=O)=CC=1C1=CC=CC=N1 SVJMHGIAIUBOET-UHFFFAOYSA-N 0.000 claims description 6
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 6
- 239000001301 oxygen Substances 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- OXEAADVCNBKSBS-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=1C=C2SC(NC(=O)NCC)=NC2=CC=1C(C=N1)=CN=C1N1CCC(C)(C(O)=O)CC1 OXEAADVCNBKSBS-UHFFFAOYSA-N 0.000 claims description 5
- OASNACIRCRZKGU-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-(2-methoxy-1,3-thiazol-4-yl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C1=CSC(OC)=N1 OASNACIRCRZKGU-UHFFFAOYSA-N 0.000 claims description 5
- RNPFNBDXZQGQRJ-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-(2-methoxyethoxymethyl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=1C(COCCOC)=C2SC(NC(=O)NCC)=NC2=CC=1C(C=N1)=CN=C1N1CCC(C)(C(O)=O)CC1 RNPFNBDXZQGQRJ-UHFFFAOYSA-N 0.000 claims description 5
- XUPBYGGPWQXYQB-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-[[methyl(pyrimidin-2-yl)amino]methyl]-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1CN(C)C1=NC=CC=N1 XUPBYGGPWQXYQB-UHFFFAOYSA-N 0.000 claims description 5
- DRMIPWIMPSKYAQ-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-methyl-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=1C(C)=C2SC(NC(=O)NCC)=NC2=CC=1C(C=N1)=CN=C1N1CCC(C)(C(O)=O)CC1 DRMIPWIMPSKYAQ-UHFFFAOYSA-N 0.000 claims description 5
- NDKAXLRYJQJEEE-UHFFFAOYSA-N 1-[5-[7-cyclohexyl-2-(ethylcarbamoylamino)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C1CCCCC1 NDKAXLRYJQJEEE-UHFFFAOYSA-N 0.000 claims description 5
- DTPGVCZIIMRXML-UHFFFAOYSA-N 1-[5-[7-ethyl-2-(ethylcarbamoylamino)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=1C(CC)=C2SC(NC(=O)NCC)=NC2=CC=1C(C=N1)=CN=C1N1CCC(C)(C(O)=O)CC1 DTPGVCZIIMRXML-UHFFFAOYSA-N 0.000 claims description 5
- 229910014033 C-OH Inorganic materials 0.000 claims description 5
- 229910014570 C—OH Inorganic materials 0.000 claims description 5
- 238000011109 contamination Methods 0.000 claims description 5
- FPXFVAZABUPWIT-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-(1-methyltriazol-4-yl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C1=CN(C)N=N1 FPXFVAZABUPWIT-UHFFFAOYSA-N 0.000 claims description 4
- ICMDMPKJQUFPDF-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-(1-phenyltriazol-4-yl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C(N=N1)=CN1C1=CC=CC=C1 ICMDMPKJQUFPDF-UHFFFAOYSA-N 0.000 claims description 4
- FWWLCZIDTDZESJ-AMVVHIIESA-N 1-[5-[2-(ethylcarbamoylamino)-7-[(e)-n-methoxy-c-methylcarbonimidoyl]-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=1C(\C(C)=N\OC)=C2SC(NC(=O)NCC)=NC2=CC=1C(C=N1)=CN=C1N1CCC(C)(C(O)=O)CC1 FWWLCZIDTDZESJ-AMVVHIIESA-N 0.000 claims description 4
- KLDMGBMNAIRONS-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-hydroxy-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=1C(O)=C2SC(NC(=O)NCC)=NC2=CC=1C(C=N1)=CN=C1N1CCC(C)(C(O)=O)CC1 KLDMGBMNAIRONS-UHFFFAOYSA-N 0.000 claims description 4
- LZPWAYBEOJRFAX-UHFFFAOYSA-N 4,4,5,5-tetramethyl-1,3,2$l^{2}-dioxaborolane Chemical compound CC1(C)O[B]OC1(C)C LZPWAYBEOJRFAX-UHFFFAOYSA-N 0.000 claims description 4
- QVGBSVRQPUQXSZ-IBBHUPRXSA-N 4-ethyl-1-[5-[2-(ethylcarbamoylamino)-7-[(e)-n-methoxy-c-methylcarbonimidoyl]-1,3-benzothiazol-5-yl]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound C=1C(\C(C)=N\OC)=C2SC(NC(=O)NCC)=NC2=CC=1C(C=N1)=CN=C1N1CCC(CC)(C(O)=O)CC1 QVGBSVRQPUQXSZ-IBBHUPRXSA-N 0.000 claims description 4
- 125000004429 atom Chemical group 0.000 claims description 4
- 150000001768 cations Chemical class 0.000 claims description 4
- XUVJOQRNPJNTHG-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-4-fluoro-7-pyridin-2-yl-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=C(F)C(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C1=CC=CC=N1 XUVJOQRNPJNTHG-UHFFFAOYSA-N 0.000 claims description 3
- XYEMQUWUUXZULS-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-ethynyl-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=1C(C#C)=C2SC(NC(=O)NCC)=NC2=CC=1C(C=N1)=CN=C1N1CCC(C)(C(O)=O)CC1 XYEMQUWUUXZULS-UHFFFAOYSA-N 0.000 claims description 3
- GVQIMNOYLDVOJX-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-pyrazin-2-yl-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-prop-2-enylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(CC=C)(CC2)C(O)=O)=CC=1C1=CN=CC=N1 GVQIMNOYLDVOJX-UHFFFAOYSA-N 0.000 claims description 3
- VMIAHALRMSSYGZ-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-pyridin-2-yl-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-(trifluoromethyl)piperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(CC2)(C(O)=O)C(F)(F)F)=CC=1C1=CC=CC=N1 VMIAHALRMSSYGZ-UHFFFAOYSA-N 0.000 claims description 3
- CFECMZNVTSKBMB-UHFFFAOYSA-N 1-[5-[7-(4,5-dihydro-1,2-oxazol-3-yl)-2-(ethylcarbamoylamino)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-ethylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(CC)(CC2)C(O)=O)=CC=1C1=NOCC1 CFECMZNVTSKBMB-UHFFFAOYSA-N 0.000 claims description 3
- QBIZSRFTNZRMDT-UHFFFAOYSA-N 1-[5-[7-(ethylcarbamoyl)-2-(ethylcarbamoylamino)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=1C(C(=O)NCC)=C2SC(NC(=O)NCC)=NC2=CC=1C(C=N1)=CN=C1N1CCC(C)(C(O)=O)CC1 QBIZSRFTNZRMDT-UHFFFAOYSA-N 0.000 claims description 3
- XTCZNJQRUBTOSI-UHFFFAOYSA-N 1-[5-[7-cyclopropyl-2-(ethylcarbamoylamino)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C1CC1 XTCZNJQRUBTOSI-UHFFFAOYSA-N 0.000 claims description 3
- QUYTUENFVFMKJF-UHFFFAOYSA-N 4-ethyl-1-[5-[2-(ethylcarbamoylamino)-7-formyl-1,3-benzothiazol-5-yl]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound C=1C(C=O)=C2SC(NC(=O)NCC)=NC2=CC=1C(C=N1)=CN=C1N1CCC(CC)(C(O)=O)CC1 QUYTUENFVFMKJF-UHFFFAOYSA-N 0.000 claims description 3
- 239000005973 Carvone Substances 0.000 claims description 3
- 229910052796 boron Inorganic materials 0.000 claims description 3
- UEAGFZUKGBQFSG-UHFFFAOYSA-N ethyl 1-[5-[2-(ethylcarbamoylamino)-7-(oxan-4-yl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylate Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(=O)OCC)=CC=1C1CCOCC1 UEAGFZUKGBQFSG-UHFFFAOYSA-N 0.000 claims description 3
- 239000002271 gyrase inhibitor Substances 0.000 claims description 3
- 125000003003 spiro group Chemical group 0.000 claims description 3
- VZRLKPOBDKXHEN-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-(1,3-thiazol-2-ylcarbamoyl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C(=O)NC1=NC=CS1 VZRLKPOBDKXHEN-UHFFFAOYSA-N 0.000 claims description 2
- KOLVVJOFVJGNBD-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-(methoxymethyl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=1C(COC)=C2SC(NC(=O)NCC)=NC2=CC=1C(C=N1)=CN=C1N1CCC(C)(C(O)=O)CC1 KOLVVJOFVJGNBD-UHFFFAOYSA-N 0.000 claims description 2
- DYVMIAODNIPPKX-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-(morpholin-4-ylmethyl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1CN1CCOCC1 DYVMIAODNIPPKX-UHFFFAOYSA-N 0.000 claims description 2
- ZXJVTCXBSJRTAY-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-(morpholine-4-carbonyl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C(=O)N1CCOCC1 ZXJVTCXBSJRTAY-UHFFFAOYSA-N 0.000 claims description 2
- BCOKKZLVXVOUBR-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-[ethyl(methyl)carbamoyl]-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=1C(C(=O)N(C)CC)=C2SC(NC(=O)NCC)=NC2=CC=1C(C=N1)=CN=C1N1CCC(C)(C(O)=O)CC1 BCOKKZLVXVOUBR-UHFFFAOYSA-N 0.000 claims description 2
- HOHICCCLUXQFKL-UHFFFAOYSA-N 1-[5-[7-(1-acetylpiperidin-4-yl)-2-(ethylcarbamoylamino)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C1CCN(C(C)=O)CC1 HOHICCCLUXQFKL-UHFFFAOYSA-N 0.000 claims description 2
- XXYZRWMRILLPBR-UHFFFAOYSA-N 1-[5-[7-carbamoyl-2-(ethylcarbamoylamino)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-ethylpiperidine-4-carboxylic acid Chemical compound C=1C(C(N)=O)=C2SC(NC(=O)NCC)=NC2=CC=1C(C=N1)=CN=C1N1CCC(CC)(C(O)=O)CC1 XXYZRWMRILLPBR-UHFFFAOYSA-N 0.000 claims description 2
- FAWKRDYMJYUEKB-UHFFFAOYSA-N 4-ethyl-1-[5-[2-(ethylcarbamoylamino)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound C=1C=C2SC(NC(=O)NCC)=NC2=CC=1C(C=N1)=CN=C1N1CCC(CC)(C(O)=O)CC1 FAWKRDYMJYUEKB-UHFFFAOYSA-N 0.000 claims description 2
- VYLKCVDNRCETDL-UHFFFAOYSA-N 4-ethyl-1-[5-[2-(ethylcarbamoylamino)-7-morpholin-4-yl-1,3-benzothiazol-5-yl]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(CC)(CC2)C(O)=O)=CC=1N1CCOCC1 VYLKCVDNRCETDL-UHFFFAOYSA-N 0.000 claims description 2
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 claims description 2
- HNYOPLTXPVRDBG-UHFFFAOYSA-N barbituric acid Chemical compound O=C1CC(=O)NC(=O)N1 HNYOPLTXPVRDBG-UHFFFAOYSA-N 0.000 claims description 2
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 claims description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 2
- AFWWNXOSDUHYFQ-UHFFFAOYSA-N 1,3-dioxane-2-carboxylic acid Chemical compound OC(=O)C1OCCCO1 AFWWNXOSDUHYFQ-UHFFFAOYSA-N 0.000 claims 1
- ZDUQPQAZIGLDOX-UHFFFAOYSA-N 1-[4-[2-(ethylcarbamoylamino)-7-pyridin-2-yl-1,3-benzothiazol-5-yl]pyridin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=C(N=CC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C1=CC=CC=N1 ZDUQPQAZIGLDOX-UHFFFAOYSA-N 0.000 claims 1
- VDQBFVNLOKHTEL-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-5-pyrazol-1-yl-[1,2,4]triazolo[1,5-a]pyridin-7-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound N12N=C(NC(=O)NCC)N=C2C=C(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)C=C1N1C=CC=N1 VDQBFVNLOKHTEL-UHFFFAOYSA-N 0.000 claims 1
- QPNYUROAFAKJGR-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-5-pyrazol-1-ylimidazo[1,2-a]pyridin-7-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=1C2=NC(NC(=O)NCC)=CN2C(N2N=CC=C2)=CC=1C(C=N1)=CN=C1N1CCC(C)(C(O)=O)CC1 QPNYUROAFAKJGR-UHFFFAOYSA-N 0.000 claims 1
- SBOXALOUCSXAEY-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-6-methoxy-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound COC=1C=C2SC(NC(=O)NCC)=NC2=CC=1C(C=N1)=CN=C1N1CCC(C)(C(O)=O)CC1 SBOXALOUCSXAEY-UHFFFAOYSA-N 0.000 claims 1
- HRZPPODWLOBXDJ-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-(1,3-oxazol-2-yl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C1=NC=CO1 HRZPPODWLOBXDJ-UHFFFAOYSA-N 0.000 claims 1
- OBVVAQMYRWVXJH-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-(1,3-thiazol-4-yl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C1=CSC=N1 OBVVAQMYRWVXJH-UHFFFAOYSA-N 0.000 claims 1
- YDYDPEKDUOINGU-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-(1,3-thiazol-5-yl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C1=CN=CS1 YDYDPEKDUOINGU-UHFFFAOYSA-N 0.000 claims 1
- UUFGLKGSUOBNSA-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-(1-methyl-2-oxopyridin-4-yl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C=1C=CN(C)C(=O)C=1 UUFGLKGSUOBNSA-UHFFFAOYSA-N 0.000 claims 1
- JSBMZEZVRKQZLV-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-(1-methylpyrrol-2-yl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C1=CC=CN1C JSBMZEZVRKQZLV-UHFFFAOYSA-N 0.000 claims 1
- OVHSCXCBFSZSNG-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-(1h-pyrazol-4-yl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C=1C=NNC=1 OVHSCXCBFSZSNG-UHFFFAOYSA-N 0.000 claims 1
- QBQCASRBYYVDRF-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-(2-ethyl-1,3-thiazol-5-yl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C1=CN=C(CC)S1 QBQCASRBYYVDRF-UHFFFAOYSA-N 0.000 claims 1
- YVTUROXWRQKRSE-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-(2-methoxypyrimidin-4-yl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C1=CC=NC(OC)=N1 YVTUROXWRQKRSE-UHFFFAOYSA-N 0.000 claims 1
- VXDFZZQXRYBOHG-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-(2-methylpyrimidin-4-yl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C1=CC=NC(C)=N1 VXDFZZQXRYBOHG-UHFFFAOYSA-N 0.000 claims 1
- QJRZJUOAYABAMS-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-(2-morpholin-4-yl-1,3-thiazol-5-yl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C(S1)=CN=C1N1CCOCC1 QJRZJUOAYABAMS-UHFFFAOYSA-N 0.000 claims 1
- MEEZWPCKGHOMRD-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-(2-pyrazin-2-ylethynyl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C#CC1=CN=CC=N1 MEEZWPCKGHOMRD-UHFFFAOYSA-N 0.000 claims 1
- TZUHMJOMWDKWPD-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-(2-pyridin-3-ylethynyl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C#CC1=CC=CN=C1 TZUHMJOMWDKWPD-UHFFFAOYSA-N 0.000 claims 1
- BGZGXALJMXKQON-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-(2-pyridin-4-ylethynyl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C#CC1=CC=NC=C1 BGZGXALJMXKQON-UHFFFAOYSA-N 0.000 claims 1
- QVNJEAQVVHJSID-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-(2-pyrimidin-2-ylethynyl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C#CC1=NC=CC=N1 QVNJEAQVVHJSID-UHFFFAOYSA-N 0.000 claims 1
- YASIJTBDSUKURQ-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-(2-pyrimidin-4-ylethynyl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C#CC1=CC=NC=N1 YASIJTBDSUKURQ-UHFFFAOYSA-N 0.000 claims 1
- AFTLKGYVTIOXTL-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-(3-fluoro-4-methoxypyridin-2-yl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C1=NC=CC(OC)=C1F AFTLKGYVTIOXTL-UHFFFAOYSA-N 0.000 claims 1
- GQKBXCHOLJDRBG-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-(3-fluoro-5-methylpyridin-2-yl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C1=NC=C(C)C=C1F GQKBXCHOLJDRBG-UHFFFAOYSA-N 0.000 claims 1
- VDKYTVIOWRBCRJ-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-(3-fluoropyridin-2-yl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C1=NC=CC=C1F VDKYTVIOWRBCRJ-UHFFFAOYSA-N 0.000 claims 1
- IYQYDKQIMUJUGT-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-(3-methoxy-6-methylpyridin-2-yl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C1=NC(C)=CC=C1OC IYQYDKQIMUJUGT-UHFFFAOYSA-N 0.000 claims 1
- HUSFGNCUFNDVTL-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-(3-methoxypyrazin-2-yl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C1=NC=CN=C1OC HUSFGNCUFNDVTL-UHFFFAOYSA-N 0.000 claims 1
- MAXPDCBPDUUJPC-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-(3-methoxypyridin-2-yl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C1=NC=CC=C1OC MAXPDCBPDUUJPC-UHFFFAOYSA-N 0.000 claims 1
- SKDCWESIRXHJJF-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-(3-methylpyrazin-2-yl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C1=NC=CN=C1C SKDCWESIRXHJJF-UHFFFAOYSA-N 0.000 claims 1
- FDKIGQXXNBPAPC-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-(4-fluoropyridin-2-yl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C1=CC(F)=CC=N1 FDKIGQXXNBPAPC-UHFFFAOYSA-N 0.000 claims 1
- NKYQSSLUCZYICX-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-(4-methoxypyridin-2-yl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C1=CC(OC)=CC=N1 NKYQSSLUCZYICX-UHFFFAOYSA-N 0.000 claims 1
- LJVUHQUMARIXOV-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-(4-methoxypyridin-2-yl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-propylpiperidine-4-carboxylic acid Chemical compound C1CC(CCC)(C(O)=O)CCN1C1=NC=C(C=2C=C3N=C(NC(=O)NCC)SC3=C(C=3N=CC=C(OC)C=3)C=2)C=N1 LJVUHQUMARIXOV-UHFFFAOYSA-N 0.000 claims 1
- SIBLNETVBOYCNW-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-(4-methoxypyrimidin-2-yl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C1=NC=CC(OC)=N1 SIBLNETVBOYCNW-UHFFFAOYSA-N 0.000 claims 1
- YRAGCRNFBQJOOL-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-(4-methoxypyrimidin-2-yl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-propylpiperidine-4-carboxylic acid Chemical compound C1CC(CCC)(C(O)=O)CCN1C1=NC=C(C=2C=C3N=C(NC(=O)NCC)SC3=C(C=3N=C(OC)C=CN=3)C=2)C=N1 YRAGCRNFBQJOOL-UHFFFAOYSA-N 0.000 claims 1
- OOEDBAUVFRBDGB-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-(4-methylpyrimidin-2-yl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C1=NC=CC(C)=N1 OOEDBAUVFRBDGB-UHFFFAOYSA-N 0.000 claims 1
- SCYCINRBSVGEHS-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-(5-ethylpyrazin-2-yl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C1=CN=C(CC)C=N1 SCYCINRBSVGEHS-UHFFFAOYSA-N 0.000 claims 1
- KMMKXBJQJRJNMJ-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-(5-ethylpyrimidin-2-yl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C1=NC=C(CC)C=N1 KMMKXBJQJRJNMJ-UHFFFAOYSA-N 0.000 claims 1
- ZPPQMMLXEXSHAN-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-(5-fluoro-4-methylpyridin-2-yl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C1=CC(C)=C(F)C=N1 ZPPQMMLXEXSHAN-UHFFFAOYSA-N 0.000 claims 1
- GPFVDNKQKJAXJD-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-(5-fluoro-6-methylpyridin-2-yl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C1=CC=C(F)C(C)=N1 GPFVDNKQKJAXJD-UHFFFAOYSA-N 0.000 claims 1
- MGUYYOXVTXRBSM-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-(5-fluoropyrimidin-2-yl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C1=NC=C(F)C=N1 MGUYYOXVTXRBSM-UHFFFAOYSA-N 0.000 claims 1
- LGQMXKZELLAQEN-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-(5-methoxypyrazin-2-yl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C1=CN=C(OC)C=N1 LGQMXKZELLAQEN-UHFFFAOYSA-N 0.000 claims 1
- SHGFDGWSFRDIGT-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-(5-methoxypyrimidin-2-yl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C1=NC=C(OC)C=N1 SHGFDGWSFRDIGT-UHFFFAOYSA-N 0.000 claims 1
- OCUHSSUTRYHEEE-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-(5-methyl-1,2,4-oxadiazol-3-yl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C1=NOC(C)=N1 OCUHSSUTRYHEEE-UHFFFAOYSA-N 0.000 claims 1
- IEYHJOZEAWWKPF-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-(5-methylpyrazin-2-yl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C1=CN=C(C)C=N1 IEYHJOZEAWWKPF-UHFFFAOYSA-N 0.000 claims 1
- NSVBZGBQGWZJPC-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-(5-methylpyridin-2-yl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C1=CC=C(C)C=N1 NSVBZGBQGWZJPC-UHFFFAOYSA-N 0.000 claims 1
- RQYYLZJLVWKJJP-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-(5-methylpyrimidin-2-yl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C1=NC=C(C)C=N1 RQYYLZJLVWKJJP-UHFFFAOYSA-N 0.000 claims 1
- GAESENQYNKARLM-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-(6-methoxypyrazin-2-yl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C1=CN=CC(OC)=N1 GAESENQYNKARLM-UHFFFAOYSA-N 0.000 claims 1
- JLVZTRLDVATONH-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-(6-methoxypyridin-2-yl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C1=CC=CC(OC)=N1 JLVZTRLDVATONH-UHFFFAOYSA-N 0.000 claims 1
- IBQZOCHIVKQRFE-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-(6-methoxypyrimidin-4-yl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C1=CC(OC)=NC=N1 IBQZOCHIVKQRFE-UHFFFAOYSA-N 0.000 claims 1
- OHBGLTWHKIAONR-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-(6-methoxypyrimidin-4-yl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-propylpiperidine-4-carboxylic acid Chemical compound C1CC(CCC)(C(O)=O)CCN1C1=NC=C(C=2C=C3N=C(NC(=O)NCC)SC3=C(C=3N=CN=C(OC)C=3)C=2)C=N1 OHBGLTWHKIAONR-UHFFFAOYSA-N 0.000 claims 1
- CHNMYRMMWYWYEV-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-(6-methylpyrimidin-4-yl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C1=CC(C)=NC=N1 CHNMYRMMWYWYEV-UHFFFAOYSA-N 0.000 claims 1
- KONROZWBHHWXPE-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-(6-oxo-1-propan-2-ylpyrimidin-4-yl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C1=CC(=O)N(C(C)C)C=N1 KONROZWBHHWXPE-UHFFFAOYSA-N 0.000 claims 1
- SHGQPWMQVRIHLW-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-(6-propan-2-yloxypyrimidin-4-yl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C1=CC(OC(C)C)=NC=N1 SHGQPWMQVRIHLW-UHFFFAOYSA-N 0.000 claims 1
- ZUCHLHNWYFNLHD-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-propylpiperidine-4-carboxylic acid Chemical compound C1CC(CCC)(C(O)=O)CCN1C1=NC=C(C=2C=C3N=C(NC(=O)NCC)SC3=C(C=3C=4C=CNC=4N=CN=3)C=2)C=N1 ZUCHLHNWYFNLHD-UHFFFAOYSA-N 0.000 claims 1
- KQNCAVRPKGDCKS-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-(oxan-4-yl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C1CCOCC1 KQNCAVRPKGDCKS-UHFFFAOYSA-N 0.000 claims 1
- ZDDJFBYGXKZOOI-HBHSWBPBSA-N 1-[5-[2-(ethylcarbamoylamino)-7-[(e)-c-methyl-n-(2,2,2-trifluoroethoxy)carbonimidoyl]-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=1C(\C(C)=N\OCC(F)(F)F)=C2SC(NC(=O)NCC)=NC2=CC=1C(C=N1)=CN=C1N1CCC(C)(C(O)=O)CC1 ZDDJFBYGXKZOOI-HBHSWBPBSA-N 0.000 claims 1
- GLGVXISUDYLTMU-IBBHUPRXSA-N 1-[5-[2-(ethylcarbamoylamino)-7-[(e)-n-(2-hydroxyethoxy)-c-methylcarbonimidoyl]-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=1C(\C(C)=N\OCCO)=C2SC(NC(=O)NCC)=NC2=CC=1C(C=N1)=CN=C1N1CCC(C)(C(O)=O)CC1 GLGVXISUDYLTMU-IBBHUPRXSA-N 0.000 claims 1
- PIXMQGNEPRYBGJ-KPGMTVGESA-N 1-[5-[2-(ethylcarbamoylamino)-7-[(e)-n-(2-methoxyethoxy)-c-methylcarbonimidoyl]-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=1C(\C(C)=N\OCCOC)=C2SC(NC(=O)NCC)=NC2=CC=1C(C=N1)=CN=C1N1CCC(C)(C(O)=O)CC1 PIXMQGNEPRYBGJ-KPGMTVGESA-N 0.000 claims 1
- GUNCNAJMPJRGCP-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-[1-(2-methoxyethyl)-6-oxopyrimidin-4-yl]-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C1=CC(=O)N(CCOC)C=N1 GUNCNAJMPJRGCP-UHFFFAOYSA-N 0.000 claims 1
- KWQOGTFVUKXYNZ-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-[2-(1,3-thiazol-2-yl)ethynyl]-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C#CC1=NC=CS1 KWQOGTFVUKXYNZ-UHFFFAOYSA-N 0.000 claims 1
- NVVGRGWUINPVHT-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-[2-(5-methyl-1,3,4-thiadiazol-2-yl)ethynyl]-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C#CC1=NN=C(C)S1 NVVGRGWUINPVHT-UHFFFAOYSA-N 0.000 claims 1
- HTTWSINFWVCFJS-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-[4-(hydroxymethyl)-1,3-thiazol-2-yl]-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C1=NC(CO)=CS1 HTTWSINFWVCFJS-UHFFFAOYSA-N 0.000 claims 1
- BLEDCLFQGPCGQI-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-[5-(morpholin-4-ylmethyl)pyridin-2-yl]-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C(N=C1)=CC=C1CN1CCOCC1 BLEDCLFQGPCGQI-UHFFFAOYSA-N 0.000 claims 1
- SWDROYBZLHRPJQ-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-[5-(trifluoromethyl)pyridin-2-yl]-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C1=CC=C(C(F)(F)F)C=N1 SWDROYBZLHRPJQ-UHFFFAOYSA-N 0.000 claims 1
- SFAJEYKXUYHKHG-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-[6-[(2-methylpropan-2-yl)oxy]pyrazin-2-yl]-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C1=CN=CC(OC(C)(C)C)=N1 SFAJEYKXUYHKHG-UHFFFAOYSA-N 0.000 claims 1
- OSIZFJHESNPNRM-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-furo[3,2-c]pyridin-4-yl-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=1C(C=2C=3C=COC=3C=CN=2)=C2SC(NC(=O)NCC)=NC2=CC=1C(C=N1)=CN=C1N1CCC(C)(C(O)=O)CC1 OSIZFJHESNPNRM-UHFFFAOYSA-N 0.000 claims 1
- YCNBLPNWRAXMJC-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-hex-1-ynyl-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=1C=2N=C(NC(=O)NCC)SC=2C(C#CCCCC)=CC=1C(C=N1)=CN=C1N1CCC(C)(C(O)=O)CC1 YCNBLPNWRAXMJC-UHFFFAOYSA-N 0.000 claims 1
- KHEJZFZUKOSVCN-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-imidazol-1-yl-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1N1C=CN=C1 KHEJZFZUKOSVCN-UHFFFAOYSA-N 0.000 claims 1
- LJFMHMRHZQAHGU-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-methoxy-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=1C(OC)=C2SC(NC(=O)NCC)=NC2=CC=1C(C=N1)=CN=C1N1CCC(C)(C(O)=O)CC1 LJFMHMRHZQAHGU-UHFFFAOYSA-N 0.000 claims 1
- VWDJHIIDPMAYAT-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-pyrazin-2-yl-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C1=CN=CC=N1 VWDJHIIDPMAYAT-UHFFFAOYSA-N 0.000 claims 1
- KEVFMPICOSXSNM-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-pyrazin-2-yl-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-propylpiperidine-4-carboxylic acid Chemical compound C1CC(CCC)(C(O)=O)CCN1C1=NC=C(C=2C=C3N=C(NC(=O)NCC)SC3=C(C=3N=CC=NC=3)C=2)C=N1 KEVFMPICOSXSNM-UHFFFAOYSA-N 0.000 claims 1
- NRQCOVTWTHVDHH-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-pyrazol-1-yl-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1N1C=CC=N1 NRQCOVTWTHVDHH-UHFFFAOYSA-N 0.000 claims 1
- XVIKDVDCYZJEQZ-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-pyridin-2-yl-1,3-benzothiazol-5-yl]-1,2,4-thiadiazol-3-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2SN=C(N=2)N2CCC(C)(CC2)C(O)=O)=CC=1C1=CC=CC=N1 XVIKDVDCYZJEQZ-UHFFFAOYSA-N 0.000 claims 1
- VTDLMMPOXPXBEX-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-pyridin-2-yl-1,3-benzothiazol-5-yl]-3-fluoropyridin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=C(F)C(N3CCC(C)(CC3)C(O)=O)=NC=2)=CC=1C1=CC=CC=N1 VTDLMMPOXPXBEX-UHFFFAOYSA-N 0.000 claims 1
- WTPJBVVUWARAKX-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-pyridin-2-yl-1,3-benzothiazol-5-yl]-3-methylpyridin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=C(C)C(N3CCC(C)(CC3)C(O)=O)=NC=2)=CC=1C1=CC=CC=N1 WTPJBVVUWARAKX-UHFFFAOYSA-N 0.000 claims 1
- UGAQROKNUXZONK-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-pyridin-2-yl-1,3-benzothiazol-5-yl]-4-methoxypyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C(=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)OC)=CC=1C1=CC=CC=N1 UGAQROKNUXZONK-UHFFFAOYSA-N 0.000 claims 1
- HJXQDUZLFXATDX-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-pyridin-2-yl-1,3-benzothiazol-5-yl]-4-methylpyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C(=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)C)=CC=1C1=CC=CC=N1 HJXQDUZLFXATDX-UHFFFAOYSA-N 0.000 claims 1
- BQMMRFSCMNFZSU-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-pyridin-2-yl-1,3-benzothiazol-5-yl]pyrazin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2N=CC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C1=CC=CC=N1 BQMMRFSCMNFZSU-UHFFFAOYSA-N 0.000 claims 1
- KDEJGQOKCYEPLC-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-pyridin-2-yl-1,3-benzothiazol-5-yl]pyridin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=CC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C1=CC=CC=N1 KDEJGQOKCYEPLC-UHFFFAOYSA-N 0.000 claims 1
- LURIJXSAKDBXEA-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-pyridin-2-yl-1,3-benzothiazol-5-yl]pyridin-3-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=C(C=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C1=CC=CC=N1 LURIJXSAKDBXEA-UHFFFAOYSA-N 0.000 claims 1
- XQUQYOUBYNTAGV-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-pyridin-2-yl-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-2-methylpiperidine-2-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2C(CCCC2)(C)C(O)=O)=CC=1C1=CC=CC=N1 XQUQYOUBYNTAGV-UHFFFAOYSA-N 0.000 claims 1
- XAKBUJMSYHVSRP-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-pyridin-2-yl-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-2-methylpyrrolidine-2-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2C(CCC2)(C)C(O)=O)=CC=1C1=CC=CC=N1 XAKBUJMSYHVSRP-UHFFFAOYSA-N 0.000 claims 1
- BSAZQPNUYCMTJT-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-pyridin-2-yl-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-3,4-dimethylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CC(C)C(C)(CC2)C(O)=O)=CC=1C1=CC=CC=N1 BSAZQPNUYCMTJT-UHFFFAOYSA-N 0.000 claims 1
- HECGYFDHCWIYHM-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-pyridin-2-yl-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-3-(trifluoromethyl)pyrrolidine-3-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CC(CC2)(C(O)=O)C(F)(F)F)=CC=1C1=CC=CC=N1 HECGYFDHCWIYHM-UHFFFAOYSA-N 0.000 claims 1
- HQJKRWSBBBIPJK-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-pyridin-2-yl-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-3-methylpyrrolidine-3-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CC(C)(CC2)C(O)=O)=CC=1C1=CC=CC=N1 HQJKRWSBBBIPJK-UHFFFAOYSA-N 0.000 claims 1
- DQFPWWTXWBMINF-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-pyridin-2-yl-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-(2,2,2-trifluoroethyl)piperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(CC(F)(F)F)(CC2)C(O)=O)=CC=1C1=CC=CC=N1 DQFPWWTXWBMINF-UHFFFAOYSA-N 0.000 claims 1
- OMKSSHCEHGMQCM-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-pyridin-2-yl-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-(methoxymethyl)piperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(COC)(CC2)C(O)=O)=CC=1C1=CC=CC=N1 OMKSSHCEHGMQCM-UHFFFAOYSA-N 0.000 claims 1
- NJNXSCUBTYHSGN-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-pyridin-2-yl-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-fluoropiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(F)(CC2)C(O)=O)=CC=1C1=CC=CC=N1 NJNXSCUBTYHSGN-UHFFFAOYSA-N 0.000 claims 1
- CIVMGLPXLKVJJI-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-pyridin-2-yl-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-hydroxy-3-methylpiperidine-3-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CC(C)(C(O)CC2)C(O)=O)=CC=1C1=CC=CC=N1 CIVMGLPXLKVJJI-UHFFFAOYSA-N 0.000 claims 1
- ZDIKOLMINUXGSX-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-pyridin-2-yl-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-hydroxypiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(O)(CC2)C(O)=O)=CC=1C1=CC=CC=N1 ZDIKOLMINUXGSX-UHFFFAOYSA-N 0.000 claims 1
- NEDZEUWJEDFTFG-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-pyridin-2-yl-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methoxypiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(CC2)(OC)C(O)=O)=CC=1C1=CC=CC=N1 NEDZEUWJEDFTFG-UHFFFAOYSA-N 0.000 claims 1
- RYGYAXOTBRTNEK-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-pyridin-2-yl-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methyl-n-methylsulfonylpiperidine-4-carboxamide Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(=O)NS(C)(=O)=O)=CC=1C1=CC=CC=N1 RYGYAXOTBRTNEK-UHFFFAOYSA-N 0.000 claims 1
- DVHHHIADFLWGRF-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-pyridin-2-yl-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylazepane-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CCC2)C(O)=O)=CC=1C1=CC=CC=N1 DVHHHIADFLWGRF-UHFFFAOYSA-N 0.000 claims 1
- MIBVQVWSUZXFCA-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-pyridin-2-yl-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylsulfanylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(CC2)(SC)C(O)=O)=CC=1C1=CC=CC=N1 MIBVQVWSUZXFCA-UHFFFAOYSA-N 0.000 claims 1
- JMDUFIAKFPSXMZ-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-pyridin-2-yl-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylsulfonylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(CC2)(C(O)=O)S(C)(=O)=O)=CC=1C1=CC=CC=N1 JMDUFIAKFPSXMZ-UHFFFAOYSA-N 0.000 claims 1
- JCAYVDPDWCOPOX-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-pyridin-2-yl-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-phenylpiperidine-4-carboxamide Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(CC2)(C(N)=O)C=2C=CC=CC=2)=CC=1C1=CC=CC=N1 JCAYVDPDWCOPOX-UHFFFAOYSA-N 0.000 claims 1
- PCQLZNPLABVNRW-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-pyridin-2-yl-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-phenylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(CC2)(C(O)=O)C=2C=CC=CC=2)=CC=1C1=CC=CC=N1 PCQLZNPLABVNRW-UHFFFAOYSA-N 0.000 claims 1
- COGPNSRZKKKKBG-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-pyridin-2-yl-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-propan-2-ylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(CC2)(C(C)C)C(O)=O)=CC=1C1=CC=CC=N1 COGPNSRZKKKKBG-UHFFFAOYSA-N 0.000 claims 1
- XWZGNAXIFOXKJQ-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-pyridin-2-yl-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-propylpiperidine-4-carboxylic acid Chemical compound C1CC(CCC)(C(O)=O)CCN1C1=NC=C(C=2C=C3N=C(NC(=O)NCC)SC3=C(C=3N=CC=CC=3)C=2)C=N1 XWZGNAXIFOXKJQ-UHFFFAOYSA-N 0.000 claims 1
- YVQWIPHRMCUJNH-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-pyridin-4-yl-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C1=CC=NC=C1 YVQWIPHRMCUJNH-UHFFFAOYSA-N 0.000 claims 1
- MRGDQBIMOXGTEQ-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-pyrimidin-4-yl-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C1=CC=NC=N1 MRGDQBIMOXGTEQ-UHFFFAOYSA-N 0.000 claims 1
- NXOQMYUAZNPIOZ-UHFFFAOYSA-N 1-[5-[7-(2-cyanopyrimidin-4-yl)-2-(ethylcarbamoylamino)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C1=CC=NC(C#N)=N1 NXOQMYUAZNPIOZ-UHFFFAOYSA-N 0.000 claims 1
- FNSXITYKZZQJOW-UHFFFAOYSA-N 1-[5-[7-(2-cyclopentylethynyl)-2-(ethylcarbamoylamino)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C#CC1CCCC1 FNSXITYKZZQJOW-UHFFFAOYSA-N 0.000 claims 1
- MAPUQKJLTBPMPM-UHFFFAOYSA-N 1-[5-[7-(2-ethoxy-1,3-thiazol-5-yl)-2-(ethylcarbamoylamino)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C1=CN=C(OCC)S1 MAPUQKJLTBPMPM-UHFFFAOYSA-N 0.000 claims 1
- FNJXYMRQKGDTNM-UHFFFAOYSA-N 1-[5-[7-(3,5-difluoropyridin-2-yl)-2-(ethylcarbamoylamino)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C1=NC=C(F)C=C1F FNJXYMRQKGDTNM-UHFFFAOYSA-N 0.000 claims 1
- FUPVDXFSCLQKSB-UHFFFAOYSA-N 1-[5-[7-(3-amino-6-methoxypyridin-2-yl)-2-(ethylcarbamoylamino)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C1=NC(OC)=CC=C1N FUPVDXFSCLQKSB-UHFFFAOYSA-N 0.000 claims 1
- VRYIQUFCLHGKHD-UHFFFAOYSA-N 1-[5-[7-(3-cyano-4-methoxypyridin-2-yl)-2-(ethylcarbamoylamino)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C1=NC=CC(OC)=C1C#N VRYIQUFCLHGKHD-UHFFFAOYSA-N 0.000 claims 1
- NLQBPUHUQWDMLD-UHFFFAOYSA-N 1-[5-[7-(3-cyano-5-methylpyridin-2-yl)-2-(ethylcarbamoylamino)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C1=NC=C(C)C=C1C#N NLQBPUHUQWDMLD-UHFFFAOYSA-N 0.000 claims 1
- MNIRKDMYPAYHSX-UHFFFAOYSA-N 1-[5-[7-(3-cyanopyridin-2-yl)-2-(ethylcarbamoylamino)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-ethylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(CC)(CC2)C(O)=O)=CC=1C1=NC=CC=C1C#N MNIRKDMYPAYHSX-UHFFFAOYSA-N 0.000 claims 1
- UWRPXNHHUCKZMS-UHFFFAOYSA-N 1-[5-[7-(3-cyanopyridin-2-yl)-2-(ethylcarbamoylamino)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C1=NC=CC=C1C#N UWRPXNHHUCKZMS-UHFFFAOYSA-N 0.000 claims 1
- SWXYBOOMFRYRSI-UHFFFAOYSA-N 1-[5-[7-(3-cyanopyridin-2-yl)-2-(ethylcarbamoylamino)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-propylpiperidine-4-carboxylic acid Chemical compound C1CC(CCC)(C(O)=O)CCN1C1=NC=C(C=2C=C3N=C(NC(=O)NCC)SC3=C(C=3C(=CC=CN=3)C#N)C=2)C=N1 SWXYBOOMFRYRSI-UHFFFAOYSA-N 0.000 claims 1
- MJGPWHINCULELK-UHFFFAOYSA-N 1-[5-[7-(4-cyanopyridin-2-yl)-2-(ethylcarbamoylamino)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-ethylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(CC)(CC2)C(O)=O)=CC=1C1=CC(C#N)=CC=N1 MJGPWHINCULELK-UHFFFAOYSA-N 0.000 claims 1
- DZXMLSFUXACTGU-UHFFFAOYSA-N 1-[5-[7-(4-cyanopyridin-2-yl)-2-(ethylcarbamoylamino)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C1=CC(C#N)=CC=N1 DZXMLSFUXACTGU-UHFFFAOYSA-N 0.000 claims 1
- HBZMUYLGMPNMTE-UHFFFAOYSA-N 1-[5-[7-(4-cyanopyridin-2-yl)-2-(ethylcarbamoylamino)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-propylpiperidine-4-carboxylic acid Chemical compound C1CC(CCC)(C(O)=O)CCN1C1=NC=C(C=2C=C3N=C(NC(=O)NCC)SC3=C(C=3N=CC=C(C=3)C#N)C=2)C=N1 HBZMUYLGMPNMTE-UHFFFAOYSA-N 0.000 claims 1
- BLXJFFXXCRADJW-UHFFFAOYSA-N 1-[5-[7-(4-ethoxypyridin-2-yl)-2-(ethylcarbamoylamino)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C1=CC(OCC)=CC=N1 BLXJFFXXCRADJW-UHFFFAOYSA-N 0.000 claims 1
- QBXWBHJJMQJOQT-UHFFFAOYSA-N 1-[5-[7-(5,6-dimethoxypyridin-2-yl)-2-(ethylcarbamoylamino)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C1=CC=C(OC)C(OC)=N1 QBXWBHJJMQJOQT-UHFFFAOYSA-N 0.000 claims 1
- SWFFQRRFNOHNQV-UHFFFAOYSA-N 1-[5-[7-(5-cyano-3-fluoropyridin-2-yl)-2-(ethylcarbamoylamino)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C1=NC=C(C#N)C=C1F SWFFQRRFNOHNQV-UHFFFAOYSA-N 0.000 claims 1
- MPKUAYUJKGMPEE-UHFFFAOYSA-N 1-[5-[7-(5-cyano-3-methylpyridin-2-yl)-2-(ethylcarbamoylamino)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C1=NC=C(C#N)C=C1C MPKUAYUJKGMPEE-UHFFFAOYSA-N 0.000 claims 1
- RYDIXDHIUHYJDA-UHFFFAOYSA-N 1-[5-[7-(5-cyano-4-methylpyridin-2-yl)-2-(ethylcarbamoylamino)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C1=CC(C)=C(C#N)C=N1 RYDIXDHIUHYJDA-UHFFFAOYSA-N 0.000 claims 1
- XRRYLOBTHKJYPK-UHFFFAOYSA-N 1-[5-[7-(5-cyano-6-methylpyridin-2-yl)-2-(ethylcarbamoylamino)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C1=CC=C(C#N)C(C)=N1 XRRYLOBTHKJYPK-UHFFFAOYSA-N 0.000 claims 1
- QRSBDLNCIPTQSS-UHFFFAOYSA-N 1-[5-[7-(5-cyanopyridin-2-yl)-2-(ethylcarbamoylamino)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-ethylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(CC)(CC2)C(O)=O)=CC=1C1=CC=C(C#N)C=N1 QRSBDLNCIPTQSS-UHFFFAOYSA-N 0.000 claims 1
- PFMFGYIDJIGMRL-UHFFFAOYSA-N 1-[5-[7-(5-cyanopyridin-2-yl)-2-(ethylcarbamoylamino)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C1=CC=C(C#N)C=N1 PFMFGYIDJIGMRL-UHFFFAOYSA-N 0.000 claims 1
- KEYRTJWCHQTBGV-UHFFFAOYSA-N 1-[5-[7-(5-cyanopyridin-2-yl)-2-(ethylcarbamoylamino)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-propylpiperidine-4-carboxylic acid Chemical compound C1CC(CCC)(C(O)=O)CCN1C1=NC=C(C=2C=C3N=C(NC(=O)NCC)SC3=C(C=3N=CC(=CC=3)C#N)C=2)C=N1 KEYRTJWCHQTBGV-UHFFFAOYSA-N 0.000 claims 1
- CKXZNDIIPJVGGS-UHFFFAOYSA-N 1-[5-[7-(6-cyanopyridin-2-yl)-2-(ethylcarbamoylamino)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C1=CC=CC(C#N)=N1 CKXZNDIIPJVGGS-UHFFFAOYSA-N 0.000 claims 1
- UEEZCMFSTYORBV-CCVNUDIWSA-N 1-[5-[7-[(e)-ethoxyiminomethyl]-2-(ethylcarbamoylamino)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=1C(\C=N\OCC)=C2SC(NC(=O)NCC)=NC2=CC=1C(C=N1)=CN=C1N1CCC(C)(C(O)=O)CC1 UEEZCMFSTYORBV-CCVNUDIWSA-N 0.000 claims 1
- XZTZEMVCXPLIBS-IBBHUPRXSA-N 1-[5-[7-[(e)-n-ethoxy-c-methylcarbonimidoyl]-2-(ethylcarbamoylamino)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=1C(\C(C)=N\OCC)=C2SC(NC(=O)NCC)=NC2=CC=1C(C=N1)=CN=C1N1CCC(C)(C(O)=O)CC1 XZTZEMVCXPLIBS-IBBHUPRXSA-N 0.000 claims 1
- AVBOTASALZZZPO-UHFFFAOYSA-N 1-[5-[7-[2-(dimethylamino)-1,3-thiazol-5-yl]-2-(ethylcarbamoylamino)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C1=CN=C(N(C)C)S1 AVBOTASALZZZPO-UHFFFAOYSA-N 0.000 claims 1
- CFSJTWQUOAZSJC-UHFFFAOYSA-N 1-[5-[7-[3-cyano-4-(dimethylamino)pyridin-2-yl]-2-(ethylcarbamoylamino)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C1=NC=CC(N(C)C)=C1C#N CFSJTWQUOAZSJC-UHFFFAOYSA-N 0.000 claims 1
- JACOZHYDYPGGBJ-UHFFFAOYSA-N 1-[5-[7-[5-(cyanomethyl)pyridin-2-yl]-2-(ethylcarbamoylamino)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C1=CC=C(CC#N)C=N1 JACOZHYDYPGGBJ-UHFFFAOYSA-N 0.000 claims 1
- RBGVTBWFDSOTBB-UHFFFAOYSA-N 1-[5-[7-bromo-2-(ethylcarbamoylamino)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-ethylpiperidine-4-carboxylic acid Chemical compound C=1C(Br)=C2SC(NC(=O)NCC)=NC2=CC=1C(C=N1)=CN=C1N1CCC(CC)(C(O)=O)CC1 RBGVTBWFDSOTBB-UHFFFAOYSA-N 0.000 claims 1
- MNCCWECZKRRJQC-UHFFFAOYSA-N 1-[5-[7-bromo-2-(ethylcarbamoylamino)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-propylpiperidine-4-carboxylic acid Chemical compound C1CC(CCC)(C(O)=O)CCN1C1=NC=C(C=2C=C3N=C(NC(=O)NCC)SC3=C(Br)C=2)C=N1 MNCCWECZKRRJQC-UHFFFAOYSA-N 0.000 claims 1
- AHOCXEKTJIDOMA-UHFFFAOYSA-N 1-[5-[7-bromo-2-(ethylcarbamoylamino)-6-methoxy-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound COC=1C(Br)=C2SC(NC(=O)NCC)=NC2=CC=1C(C=N1)=CN=C1N1CCC(C)(C(O)=O)CC1 AHOCXEKTJIDOMA-UHFFFAOYSA-N 0.000 claims 1
- GFGKTSGYEFSJPT-UHFFFAOYSA-N 1-[[5-[2-(ethylcarbamoylamino)-7-pyridin-2-yl-1,3-benzothiazol-5-yl]pyrimidin-2-yl]methyl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(CN3CCC(C)(CC3)C(O)=O)=NC=2)=CC=1C1=CC=CC=N1 GFGKTSGYEFSJPT-UHFFFAOYSA-N 0.000 claims 1
- RWSIQFBDFSBCMM-UHFFFAOYSA-N 2-[5-[2-(ethylcarbamoylamino)-7-pyridin-2-yl-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-1,3,4,5,6,6a-hexahydrocyclopenta[c]pyrrole-3a-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CC3(CCCC3C2)C(O)=O)=CC=1C1=CC=CC=N1 RWSIQFBDFSBCMM-UHFFFAOYSA-N 0.000 claims 1
- OYDOPICKYILOLX-UHFFFAOYSA-N 2-ethyl-7-[5-[2-(ethylcarbamoylamino)-7-pyridin-2-yl-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-7-azaspiro[3.5]nonane-2-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC3(CC(CC)(C3)C(O)=O)CC2)=CC=1C1=CC=CC=N1 OYDOPICKYILOLX-UHFFFAOYSA-N 0.000 claims 1
- JCCMEQDXFMFWSY-UHFFFAOYSA-N 3-[5-[2-(ethylcarbamoylamino)-7-pyridin-2-yl-1,3-benzothiazol-5-yl]pyridin-2-yl]-5-methyl-4h-1,2-oxazole-5-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=CC=2)C=2CC(C)(ON=2)C(O)=O)=CC=1C1=CC=CC=N1 JCCMEQDXFMFWSY-UHFFFAOYSA-N 0.000 claims 1
- AICVCIFWLZLFMO-UHFFFAOYSA-N 4-[[5-[2-(ethylcarbamoylamino)-7-pyridin-2-yl-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-methylamino]-1-methylcyclohexane-1-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N(C)C2CCC(C)(CC2)C(O)=O)=CC=1C1=CC=CC=N1 AICVCIFWLZLFMO-UHFFFAOYSA-N 0.000 claims 1
- OLQZKASMDSLNHI-UHFFFAOYSA-N 4-[[5-[2-(ethylcarbamoylamino)-7-pyridin-2-yl-1,3-benzothiazol-5-yl]pyrimidin-2-yl]amino]-1-methylcyclohexane-1-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(NC3CCC(C)(CC3)C(O)=O)=NC=2)=CC=1C1=CC=CC=N1 OLQZKASMDSLNHI-UHFFFAOYSA-N 0.000 claims 1
- JAQPSBDKFLKJAF-UHFFFAOYSA-N 4-benzyl-1-[5-[2-(ethylcarbamoylamino)-7-pyridin-2-yl-1,3-benzothiazol-5-yl]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(CC=3C=CC=CC=3)(CC2)C(O)=O)=CC=1C1=CC=CC=N1 JAQPSBDKFLKJAF-UHFFFAOYSA-N 0.000 claims 1
- RERBMFQIXRURTK-UHFFFAOYSA-N 4-cyano-1-[5-[2-(ethylcarbamoylamino)-7-pyridin-2-yl-1,3-benzothiazol-5-yl]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(CC2)(C#N)C(O)=O)=CC=1C1=CC=CC=N1 RERBMFQIXRURTK-UHFFFAOYSA-N 0.000 claims 1
- XXNFHUQLHUKFJC-UHFFFAOYSA-N 4-cyclopropyl-1-[5-[2-(ethylcarbamoylamino)-7-pyridin-2-yl-1,3-benzothiazol-5-yl]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(CC2)(C2CC2)C(O)=O)=CC=1C1=CC=CC=N1 XXNFHUQLHUKFJC-UHFFFAOYSA-N 0.000 claims 1
- MLABYLQGVDSNEB-UHFFFAOYSA-N 4-ethoxy-1-[5-[2-(ethylcarbamoylamino)-7-pyridin-2-yl-1,3-benzothiazol-5-yl]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(CC2)(OCC)C(O)=O)=CC=1C1=CC=CC=N1 MLABYLQGVDSNEB-UHFFFAOYSA-N 0.000 claims 1
- ZWRJPAHTPARALH-UHFFFAOYSA-N 4-ethyl-1-[3-[2-(ethylcarbamoylamino)-7-pyridin-2-yl-1,3-benzothiazol-5-yl]-1,2,4-thiadiazol-5-yl]piperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2N=C(SN=2)N2CCC(CC)(CC2)C(O)=O)=CC=1C1=CC=CC=N1 ZWRJPAHTPARALH-UHFFFAOYSA-N 0.000 claims 1
- PMKIIDLYDLXPKN-UHFFFAOYSA-N 4-ethyl-1-[4-[2-(ethylcarbamoylamino)-7-pyridin-2-yl-1,3-benzothiazol-5-yl]-1,3-thiazol-2-yl]piperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2N=C(SC=2)N2CCC(CC)(CC2)C(O)=O)=CC=1C1=CC=CC=N1 PMKIIDLYDLXPKN-UHFFFAOYSA-N 0.000 claims 1
- WJDVHZMZOPTOIR-UHFFFAOYSA-N 4-ethyl-1-[5-[2-(ethylcarbamoylamino)-4-pyridin-2-yl-[1,3]thiazolo[5,4-c]pyridin-6-yl]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(CC)(CC2)C(O)=O)=NC=1C1=CC=CC=N1 WJDVHZMZOPTOIR-UHFFFAOYSA-N 0.000 claims 1
- YULATESOHQTMNQ-UHFFFAOYSA-N 4-ethyl-1-[5-[2-(ethylcarbamoylamino)-5-pyrazol-1-ylimidazo[1,2-a]pyridin-7-yl]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound C=1C2=NC(NC(=O)NCC)=CN2C(N2N=CC=C2)=CC=1C(C=N1)=CN=C1N1CCC(CC)(C(O)=O)CC1 YULATESOHQTMNQ-UHFFFAOYSA-N 0.000 claims 1
- PWBBQPMZYQRNQW-UHFFFAOYSA-N 4-ethyl-1-[5-[2-(ethylcarbamoylamino)-7-(4-fluorophenyl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(CC)(CC2)C(O)=O)=CC=1C1=CC=C(F)C=C1 PWBBQPMZYQRNQW-UHFFFAOYSA-N 0.000 claims 1
- HGEXZHKEFSHCLS-UHFFFAOYSA-N 4-ethyl-1-[5-[2-(ethylcarbamoylamino)-7-(4-methoxypyridin-2-yl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(CC)(CC2)C(O)=O)=CC=1C1=CC(OC)=CC=N1 HGEXZHKEFSHCLS-UHFFFAOYSA-N 0.000 claims 1
- YATUNNBRTDJPNO-UHFFFAOYSA-N 4-ethyl-1-[5-[2-(ethylcarbamoylamino)-7-(4-methoxypyrimidin-2-yl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(CC)(CC2)C(O)=O)=CC=1C1=NC=CC(OC)=N1 YATUNNBRTDJPNO-UHFFFAOYSA-N 0.000 claims 1
- BFZCYWDENDQLQG-UHFFFAOYSA-N 4-ethyl-1-[5-[2-(ethylcarbamoylamino)-7-(4-methylpyrimidin-2-yl)-1,3-benzothiazol-5-yl]pyrazin-2-yl]piperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2N=CC(=NC=2)N2CCC(CC)(CC2)C(O)=O)=CC=1C1=NC=CC(C)=N1 BFZCYWDENDQLQG-UHFFFAOYSA-N 0.000 claims 1
- ZYVCXNZAFYGWFH-UHFFFAOYSA-N 4-ethyl-1-[5-[2-(ethylcarbamoylamino)-7-(4-methylpyrimidin-2-yl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(CC)(CC2)C(O)=O)=CC=1C1=NC=CC(C)=N1 ZYVCXNZAFYGWFH-UHFFFAOYSA-N 0.000 claims 1
- BNKRGEZGEUGARE-UHFFFAOYSA-N 4-ethyl-1-[5-[2-(ethylcarbamoylamino)-7-(4-oxo-1h-pyrimidin-6-yl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(CC)(CC2)C(O)=O)=CC=1C1=CC(=O)NC=N1 BNKRGEZGEUGARE-UHFFFAOYSA-N 0.000 claims 1
- UEOTZTNEQXQQHC-UHFFFAOYSA-N 4-ethyl-1-[5-[2-(ethylcarbamoylamino)-7-(5-methylpyrimidin-2-yl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(CC)(CC2)C(O)=O)=CC=1C1=NC=C(C)C=N1 UEOTZTNEQXQQHC-UHFFFAOYSA-N 0.000 claims 1
- RYAIMKKRPXXRIP-UHFFFAOYSA-N 4-ethyl-1-[5-[2-(ethylcarbamoylamino)-7-(6-methoxypyrimidin-4-yl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(CC)(CC2)C(O)=O)=CC=1C1=CC(OC)=NC=N1 RYAIMKKRPXXRIP-UHFFFAOYSA-N 0.000 claims 1
- CNXYGMRWMNJHAM-UHFFFAOYSA-N 4-ethyl-1-[5-[2-(ethylcarbamoylamino)-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound C=1C(C=2C=3C=CNC=3N=CN=2)=C2SC(NC(=O)NCC)=NC2=CC=1C(C=N1)=CN=C1N1CCC(CC)(C(O)=O)CC1 CNXYGMRWMNJHAM-UHFFFAOYSA-N 0.000 claims 1
- QAQBBVBDUKDJTN-UHFFFAOYSA-N 4-ethyl-1-[5-[2-(ethylcarbamoylamino)-7-(C-ethyl-N-methoxycarbonimidoyl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound C=1C(C(CC)=NOC)=C2SC(NC(=O)NCC)=NC2=CC=1C(C=N1)=CN=C1N1CCC(CC)(C(O)=O)CC1 QAQBBVBDUKDJTN-UHFFFAOYSA-N 0.000 claims 1
- AUGCRZOOOOCFGR-UHFFFAOYSA-N 4-ethyl-1-[5-[2-(ethylcarbamoylamino)-7-(methoxymethyl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound C=1C(COC)=C2SC(NC(=O)NCC)=NC2=CC=1C(C=N1)=CN=C1N1CCC(CC)(C(O)=O)CC1 AUGCRZOOOOCFGR-UHFFFAOYSA-N 0.000 claims 1
- QAQBBVBDUKDJTN-BIZUNTBRSA-N 4-ethyl-1-[5-[2-(ethylcarbamoylamino)-7-[(e)-c-ethyl-n-methoxycarbonimidoyl]-1,3-benzothiazol-5-yl]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound C=1C(\C(CC)=N\OC)=C2SC(NC(=O)NCC)=NC2=CC=1C(C=N1)=CN=C1N1CCC(CC)(C(O)=O)CC1 QAQBBVBDUKDJTN-BIZUNTBRSA-N 0.000 claims 1
- QSSIULGDIOLINI-CCVNUDIWSA-N 4-ethyl-1-[5-[2-(ethylcarbamoylamino)-7-[(e)-methoxyiminomethyl]-1,3-benzothiazol-5-yl]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound C=1C(\C=N\OC)=C2SC(NC(=O)NCC)=NC2=CC=1C(C=N1)=CN=C1N1CCC(CC)(C(O)=O)CC1 QSSIULGDIOLINI-CCVNUDIWSA-N 0.000 claims 1
- QAQBBVBDUKDJTN-MZFJOGFUSA-N 4-ethyl-1-[5-[2-(ethylcarbamoylamino)-7-[(z)-c-ethyl-n-methoxycarbonimidoyl]-1,3-benzothiazol-5-yl]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound C=1C(\C(CC)=N/OC)=C2SC(NC(=O)NCC)=NC2=CC=1C(C=N1)=CN=C1N1CCC(CC)(C(O)=O)CC1 QAQBBVBDUKDJTN-MZFJOGFUSA-N 0.000 claims 1
- QSSIULGDIOLINI-MUXKCCDJSA-N 4-ethyl-1-[5-[2-(ethylcarbamoylamino)-7-[(z)-methoxyiminomethyl]-1,3-benzothiazol-5-yl]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound C=1C(\C=N/OC)=C2SC(NC(=O)NCC)=NC2=CC=1C(C=N1)=CN=C1N1CCC(CC)(C(O)=O)CC1 QSSIULGDIOLINI-MUXKCCDJSA-N 0.000 claims 1
- VSDAALGBJHRNCR-UHFFFAOYSA-N 4-ethyl-1-[5-[2-(ethylcarbamoylamino)-7-propanoyl-1,3-benzothiazol-5-yl]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound C=1C(C(=O)CC)=C2SC(NC(=O)NCC)=NC2=CC=1C(C=N1)=CN=C1N1CCC(CC)(C(O)=O)CC1 VSDAALGBJHRNCR-UHFFFAOYSA-N 0.000 claims 1
- PNZRDKVNWFGXIM-UHFFFAOYSA-N 4-ethyl-1-[5-[2-(ethylcarbamoylamino)-7-pyrazin-2-yl-1,3-benzothiazol-5-yl]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(CC)(CC2)C(O)=O)=CC=1C1=CN=CC=N1 PNZRDKVNWFGXIM-UHFFFAOYSA-N 0.000 claims 1
- DHRVPWANGFWADD-UHFFFAOYSA-N 4-ethyl-1-[5-[2-(ethylcarbamoylamino)-7-pyridin-2-yl-1,3-benzothiazol-5-yl]-1,3-thiazol-2-yl]piperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2SC(=NC=2)N2CCC(CC)(CC2)C(O)=O)=CC=1C1=CC=CC=N1 DHRVPWANGFWADD-UHFFFAOYSA-N 0.000 claims 1
- CEOBYTAJUWIVLD-UHFFFAOYSA-N 4-ethyl-1-[5-[2-(ethylcarbamoylamino)-7-pyridin-2-yl-1,3-benzothiazol-5-yl]pyrazin-2-yl]piperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2N=CC(=NC=2)N2CCC(CC)(CC2)C(O)=O)=CC=1C1=CC=CC=N1 CEOBYTAJUWIVLD-UHFFFAOYSA-N 0.000 claims 1
- GCWPCIHKHREHIS-UHFFFAOYSA-N 4-ethyl-1-[5-[2-(ethylcarbamoylamino)-7-pyridin-2-yl-1,3-benzothiazol-5-yl]pyridin-2-yl]piperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=CC=2)N2CCC(CC)(CC2)C(O)=O)=CC=1C1=CC=CC=N1 GCWPCIHKHREHIS-UHFFFAOYSA-N 0.000 claims 1
- BGDFGUILEKFYGA-UHFFFAOYSA-N 4-ethyl-1-[5-[2-(ethylcarbamoylamino)-7-pyridin-2-yl-1,3-benzothiazol-5-yl]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(CC)(CC2)C(O)=O)=CC=1C1=CC=CC=N1 BGDFGUILEKFYGA-UHFFFAOYSA-N 0.000 claims 1
- PMGZMASQWSAZQZ-UHFFFAOYSA-N 4-ethyl-1-[5-[2-(ethylcarbamoylamino)-7-pyridin-2-yl-3h-benzimidazol-5-yl]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound C=12NC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(CC)(CC2)C(O)=O)=CC=1C1=CC=CC=N1 PMGZMASQWSAZQZ-UHFFFAOYSA-N 0.000 claims 1
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- URRFLHQXSXTXQS-UHFFFAOYSA-N ethyl 1-[5-[2-(ethylcarbamoylamino)-6-methoxy-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylate Chemical compound COC=1C=C2SC(NC(=O)NCC)=NC2=CC=1C(C=N1)=CN=C1N1CCC(C)(C(=O)OCC)CC1 URRFLHQXSXTXQS-UHFFFAOYSA-N 0.000 claims 1
- MWJDLABAJOIWJU-UHFFFAOYSA-N ethyl 1-[5-[2-(ethylcarbamoylamino)-7-pyridin-2-yl-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylate Chemical class C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(=O)OCC)=CC=1C1=CC=CC=N1 MWJDLABAJOIWJU-UHFFFAOYSA-N 0.000 claims 1
- CLAQUKVMUVOGMZ-UHFFFAOYSA-N ethyl 1-[5-[2-(ethylcarbamoylamino)-7-pyridin-2-yl-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylsulfonylpiperidine-4-carboxylate Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(CC2)(C(=O)OCC)S(C)(=O)=O)=CC=1C1=CC=CC=N1 CLAQUKVMUVOGMZ-UHFFFAOYSA-N 0.000 claims 1
- SGWRIEGDMVMVEH-UHFFFAOYSA-N ethyl 1-[5-[7-(1-acetylpiperidin-4-yl)-2-(ethylcarbamoylamino)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylate Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(=O)OCC)=CC=1C1CCN(C(C)=O)CC1 SGWRIEGDMVMVEH-UHFFFAOYSA-N 0.000 claims 1
- HSWJFXXNRUQKQS-UHFFFAOYSA-N ethyl 3-[5-[2-(ethylcarbamoylamino)-7-pyridin-2-yl-1,3-benzothiazol-5-yl]pyridin-2-yl]-5-methyl-4h-1,2-oxazole-5-carboxylate Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=CC=2)C=2CC(C)(ON=2)C(=O)OCC)=CC=1C1=CC=CC=N1 HSWJFXXNRUQKQS-UHFFFAOYSA-N 0.000 claims 1
- LTWIXGSWLRJXFX-UHFFFAOYSA-N ethyl 5-[[5-[2-(ethylcarbamoylamino)-7-pyridin-2-yl-1,3-benzothiazol-5-yl]pyrimidin-2-yl]amino]-2-methyl-1,3-dioxane-2-carboxylate Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(NC3COC(C)(OC3)C(=O)OCC)=NC=2)=CC=1C1=CC=CC=N1 LTWIXGSWLRJXFX-UHFFFAOYSA-N 0.000 claims 1
- SRJOCJYGOFTFLH-UHFFFAOYSA-N isonipecotic acid Chemical compound OC(=O)C1CCNCC1 SRJOCJYGOFTFLH-UHFFFAOYSA-N 0.000 claims 1
- SHTRGQKBFCVOLF-UHFFFAOYSA-N methyl 1-[5-[2-(ethylcarbamoylamino)-7-pyridin-2-yl-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-3-methyl-4-oxopiperidine-3-carboxylate Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CC(C)(C(=O)CC2)C(=O)OC)=CC=1C1=CC=CC=N1 SHTRGQKBFCVOLF-UHFFFAOYSA-N 0.000 claims 1
- CMIGEQOTAHNYGK-UHFFFAOYSA-N methyl 1-[5-[2-(ethylcarbamoylamino)-7-pyridin-2-yl-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-hydroxy-3-methylpiperidine-3-carboxylate Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CC(C)(C(O)CC2)C(=O)OC)=CC=1C1=CC=CC=N1 CMIGEQOTAHNYGK-UHFFFAOYSA-N 0.000 claims 1
- LRIIHAFRFBCZMB-UHFFFAOYSA-N methyl 1-[5-[2-(ethylcarbamoylamino)-7-pyridin-2-yl-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-hydroxypiperidine-4-carboxylate Chemical class C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(O)(CC2)C(=O)OC)=CC=1C1=CC=CC=N1 LRIIHAFRFBCZMB-UHFFFAOYSA-N 0.000 claims 1
- GECJOBMLBYECOP-UHFFFAOYSA-N methyl 1-[5-[2-(ethylcarbamoylamino)-7-pyridin-2-yl-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methoxypiperidine-4-carboxylate Chemical class C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(CC2)(OC)C(=O)OC)=CC=1C1=CC=CC=N1 GECJOBMLBYECOP-UHFFFAOYSA-N 0.000 claims 1
- QVWDSJAIGUQZHX-UHFFFAOYSA-N methyl 1-[5-[2-(ethylcarbamoylamino)-7-pyridin-2-yl-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylate Chemical class C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(=O)OC)=CC=1C1=CC=CC=N1 QVWDSJAIGUQZHX-UHFFFAOYSA-N 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
- 125000006633 tert-butoxycarbonylamino group Chemical group 0.000 claims 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 432
- 239000000243 solution Substances 0.000 description 229
- 239000011541 reaction mixture Substances 0.000 description 225
- 235000019439 ethyl acetate Nutrition 0.000 description 215
- 239000007787 solid Substances 0.000 description 202
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 165
- 239000000047 product Substances 0.000 description 165
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 164
- 238000006243 chemical reaction Methods 0.000 description 153
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 147
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 141
- 230000002829 reductive effect Effects 0.000 description 137
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 120
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 117
- 238000004809 thin layer chromatography Methods 0.000 description 114
- 239000002904 solvent Substances 0.000 description 100
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 99
- 239000011734 sodium Substances 0.000 description 98
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 94
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 94
- 239000012267 brine Substances 0.000 description 89
- 239000000741 silica gel Substances 0.000 description 79
- 229910002027 silica gel Inorganic materials 0.000 description 79
- 238000005481 NMR spectroscopy Methods 0.000 description 75
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 72
- 239000012044 organic layer Substances 0.000 description 69
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 66
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 66
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 61
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 51
- 239000000543 intermediate Substances 0.000 description 50
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 45
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 42
- 238000003756 stirring Methods 0.000 description 42
- 238000000746 purification Methods 0.000 description 35
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 32
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 29
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 29
- 239000010410 layer Substances 0.000 description 29
- 239000000706 filtrate Substances 0.000 description 27
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 26
- 239000000460 chlorine Substances 0.000 description 25
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 25
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 25
- 238000001990 intravenous administration Methods 0.000 description 24
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 24
- 238000010926 purge Methods 0.000 description 24
- ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 description 22
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 22
- XPGIBDJXEVAVTO-UHFFFAOYSA-N 5-bromo-2-chloropyrimidine Chemical compound ClC1=NC=C(Br)C=N1 XPGIBDJXEVAVTO-UHFFFAOYSA-N 0.000 description 19
- NXQGGXCHGDYOHB-UHFFFAOYSA-L cyclopenta-1,4-dien-1-yl(diphenyl)phosphane;dichloropalladium;iron(2+) Chemical compound [Fe+2].Cl[Pd]Cl.[CH-]1C=CC(P(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1.[CH-]1C=CC(P(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 NXQGGXCHGDYOHB-UHFFFAOYSA-L 0.000 description 19
- 238000000605 extraction Methods 0.000 description 19
- 239000007788 liquid Substances 0.000 description 19
- 238000002953 preparative HPLC Methods 0.000 description 19
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 18
- 238000005160 1H NMR spectroscopy Methods 0.000 description 17
- 239000000463 material Substances 0.000 description 17
- 239000000725 suspension Substances 0.000 description 17
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical group [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 16
- 239000007858 starting material Substances 0.000 description 16
- 125000006570 (C5-C6) heteroaryl group Chemical group 0.000 description 15
- 238000003818 flash chromatography Methods 0.000 description 15
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 14
- 239000007864 aqueous solution Substances 0.000 description 14
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 13
- 230000015572 biosynthetic process Effects 0.000 description 13
- 238000004587 chromatography analysis Methods 0.000 description 13
- 239000013058 crude material Substances 0.000 description 13
- GROSTTZPZYYHEI-UHFFFAOYSA-N ethyl 1-[5-[7-bromo-2-(ethylcarbamoylamino)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylate Chemical compound C=1C(Br)=C2SC(NC(=O)NCC)=NC2=CC=1C(C=N1)=CN=C1N1CCC(C)(C(=O)OCC)CC1 GROSTTZPZYYHEI-UHFFFAOYSA-N 0.000 description 13
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 12
- 239000003921 oil Substances 0.000 description 12
- 235000019198 oils Nutrition 0.000 description 12
- 235000011056 potassium acetate Nutrition 0.000 description 12
- 239000002244 precipitate Substances 0.000 description 12
- 101710183280 Topoisomerase Proteins 0.000 description 11
- 238000001914 filtration Methods 0.000 description 11
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 11
- 239000011343 solid material Substances 0.000 description 11
- 238000003556 assay Methods 0.000 description 10
- 239000012298 atmosphere Substances 0.000 description 10
- 229910052794 bromium Inorganic materials 0.000 description 10
- WUDNUHPRLBTKOJ-UHFFFAOYSA-N ethyl isocyanate Chemical compound CCN=C=O WUDNUHPRLBTKOJ-UHFFFAOYSA-N 0.000 description 10
- KZPYGQFFRCFCPP-UHFFFAOYSA-N 1,1'-bis(diphenylphosphino)ferrocene Chemical compound [Fe+2].C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1 KZPYGQFFRCFCPP-UHFFFAOYSA-N 0.000 description 9
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 9
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 9
- 125000000714 pyrimidinyl group Chemical group 0.000 description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- 229910021595 Copper(I) iodide Inorganic materials 0.000 description 8
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 8
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 8
- 241000700159 Rattus Species 0.000 description 8
- 229910002091 carbon monoxide Inorganic materials 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 8
- 239000012299 nitrogen atmosphere Substances 0.000 description 8
- 239000008194 pharmaceutical composition Substances 0.000 description 8
- 125000004076 pyridyl group Chemical group 0.000 description 8
- 239000000377 silicon dioxide Substances 0.000 description 8
- CYPYTURSJDMMMP-WVCUSYJESA-N (1e,4e)-1,5-diphenylpenta-1,4-dien-3-one;palladium Chemical compound [Pd].[Pd].C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1 CYPYTURSJDMMMP-WVCUSYJESA-N 0.000 description 7
- WORJRXHJTUTINR-UHFFFAOYSA-N 1,4-dioxane;hydron;chloride Chemical compound Cl.C1COCCO1 WORJRXHJTUTINR-UHFFFAOYSA-N 0.000 description 7
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 7
- 229910052786 argon Inorganic materials 0.000 description 7
- 239000012043 crude product Substances 0.000 description 7
- SNRCKKQHDUIRIY-UHFFFAOYSA-L cyclopenta-1,4-dien-1-yl(diphenyl)phosphane;dichloromethane;dichloropalladium;iron(2+) Chemical compound [Fe+2].ClCCl.Cl[Pd]Cl.C1=C[CH-]C(P(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1.C1=C[CH-]C(P(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 SNRCKKQHDUIRIY-UHFFFAOYSA-L 0.000 description 7
- ZRVPAABDZYFQFB-UHFFFAOYSA-N ethyl 4-methylpiperidine-4-carboxylate;hydrochloride Chemical compound Cl.CCOC(=O)C1(C)CCNCC1 ZRVPAABDZYFQFB-UHFFFAOYSA-N 0.000 description 7
- 125000003386 piperidinyl group Chemical group 0.000 description 7
- 125000003373 pyrazinyl group Chemical group 0.000 description 7
- AFPNLFVPVQRYFL-UHFFFAOYSA-N 1-benzyl-4-hydroxypiperidin-1-ium-4-carboxylate Chemical compound C1CC(C(=O)O)(O)CCN1CC1=CC=CC=C1 AFPNLFVPVQRYFL-UHFFFAOYSA-N 0.000 description 6
- MYHJCTUTPIKNAT-UHFFFAOYSA-N 1-o-tert-butyl 4-o-ethyl piperidine-1,4-dicarboxylate Chemical compound CCOC(=O)C1CCN(C(=O)OC(C)(C)C)CC1 MYHJCTUTPIKNAT-UHFFFAOYSA-N 0.000 description 6
- AFABGHUZZDYHJO-UHFFFAOYSA-N 2-Methylpentane Chemical compound CCCC(C)C AFABGHUZZDYHJO-UHFFFAOYSA-N 0.000 description 6
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 6
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 6
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 6
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 6
- 241000699666 Mus <mouse, genus> Species 0.000 description 6
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 6
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 6
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 6
- SPQGDOFAPBNPMQ-UHFFFAOYSA-L [B+3].[B+3].CC(C)(C)CC(O)C([O-])=O.CC(C)(C)CC(O)C([O-])=O Chemical compound [B+3].[B+3].CC(C)(C)CC(O)C([O-])=O.CC(C)(C)CC(O)C([O-])=O SPQGDOFAPBNPMQ-UHFFFAOYSA-L 0.000 description 6
- 125000000304 alkynyl group Chemical group 0.000 description 6
- 235000019253 formic acid Nutrition 0.000 description 6
- 125000001188 haloalkyl group Chemical group 0.000 description 6
- 238000004128 high performance liquid chromatography Methods 0.000 description 6
- 229910052740 iodine Inorganic materials 0.000 description 6
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 6
- 229940098779 methanesulfonic acid Drugs 0.000 description 6
- OKKJLVBELUTLKV-VMNATFBRSA-N methanol-d1 Chemical compound [2H]OC OKKJLVBELUTLKV-VMNATFBRSA-N 0.000 description 6
- 239000012074 organic phase Substances 0.000 description 6
- SRJOCJYGOFTFLH-UHFFFAOYSA-M piperidine-4-carboxylate Chemical compound [O-]C(=O)C1CCNCC1 SRJOCJYGOFTFLH-UHFFFAOYSA-M 0.000 description 6
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 6
- 239000011591 potassium Substances 0.000 description 6
- 229910052700 potassium Inorganic materials 0.000 description 6
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 6
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 229940002612 prodrug Drugs 0.000 description 6
- 239000000651 prodrug Substances 0.000 description 6
- 229910000104 sodium hydride Inorganic materials 0.000 description 6
- 238000003786 synthesis reaction Methods 0.000 description 6
- DTQVDTLACAAQTR-UHFFFAOYSA-N trifluoroacetic acid Substances OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 6
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 6
- 125000004070 6 membered heterocyclic group Chemical group 0.000 description 5
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 5
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 5
- 229920000742 Cotton Polymers 0.000 description 5
- 108020004414 DNA Proteins 0.000 description 5
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 5
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 5
- 125000002877 alkyl aryl group Chemical group 0.000 description 5
- 150000001408 amides Chemical class 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 5
- 229940088710 antibiotic agent Drugs 0.000 description 5
- CPEKAXYCDKETEN-UHFFFAOYSA-N benzoyl isothiocyanate Chemical compound S=C=NC(=O)C1=CC=CC=C1 CPEKAXYCDKETEN-UHFFFAOYSA-N 0.000 description 5
- 230000005587 bubbling Effects 0.000 description 5
- 239000006071 cream Substances 0.000 description 5
- 239000003085 diluting agent Substances 0.000 description 5
- 239000006185 dispersion Substances 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 125000005842 heteroatom Chemical group 0.000 description 5
- 239000005457 ice water Substances 0.000 description 5
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 5
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 5
- 239000002480 mineral oil Substances 0.000 description 5
- 235000010446 mineral oil Nutrition 0.000 description 5
- 125000002757 morpholinyl group Chemical group 0.000 description 5
- NXJCBFBQEVOTOW-UHFFFAOYSA-L palladium(2+);dihydroxide Chemical compound O[Pd]O NXJCBFBQEVOTOW-UHFFFAOYSA-L 0.000 description 5
- 239000004810 polytetrafluoroethylene Substances 0.000 description 5
- 125000000335 thiazolyl group Chemical group 0.000 description 5
- DIOHEXPTUTVCNX-UHFFFAOYSA-N 1,1,1-trifluoro-n-phenyl-n-(trifluoromethylsulfonyl)methanesulfonamide Chemical compound FC(F)(F)S(=O)(=O)N(S(=O)(=O)C(F)(F)F)C1=CC=CC=C1 DIOHEXPTUTVCNX-UHFFFAOYSA-N 0.000 description 4
- DHWIKCKAGJHZIP-UHFFFAOYSA-N 1-(7-bromo-5-iodo-1,3-benzothiazol-2-yl)-3-ethylurea Chemical compound IC1=CC(Br)=C2SC(NC(=O)NCC)=NC2=C1 DHWIKCKAGJHZIP-UHFFFAOYSA-N 0.000 description 4
- MADXBQCAYGZHGN-UHFFFAOYSA-N 1-(7-bromo-5-phenylmethoxy-1,3-benzothiazol-2-yl)-3-ethylurea Chemical compound C=1C(Br)=C2SC(NC(=O)NCC)=NC2=CC=1OCC1=CC=CC=C1 MADXBQCAYGZHGN-UHFFFAOYSA-N 0.000 description 4
- CGBXIJUBUMBYPB-UVHMKAGCSA-N 1-[5-[2-(ethylcarbamoylamino)-7-[(e)-methoxyiminomethyl]-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=1C(\C=N\OC)=C2SC(NC(=O)NCC)=NC2=CC=1C(C=N1)=CN=C1N1CCC(C)(C(O)=O)CC1 CGBXIJUBUMBYPB-UVHMKAGCSA-N 0.000 description 4
- HCUGEMXYLZKDPO-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-[2-(3-methylimidazol-4-yl)ethynyl]-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C#CC1=CN=CN1C HCUGEMXYLZKDPO-UHFFFAOYSA-N 0.000 description 4
- YYLHYVKTWWQDHU-UHFFFAOYSA-N 1-[5-[7-(4,5-dihydro-1,3-thiazol-2-ylcarbamoyl)-2-(ethylcarbamoylamino)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(O)=O)=CC=1C(=O)NC1=NCCS1 YYLHYVKTWWQDHU-UHFFFAOYSA-N 0.000 description 4
- XPSFPOIHFGJCRK-UHFFFAOYSA-N 2,3,5-tribromo-4-methoxyaniline Chemical compound COC1=C(Br)C=C(N)C(Br)=C1Br XPSFPOIHFGJCRK-UHFFFAOYSA-N 0.000 description 4
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 4
- UKRJDZBIXJWPJM-UHFFFAOYSA-N 3,5-dibromo-4-methoxyaniline Chemical compound COC1=C(Br)C=C(N)C=C1Br UKRJDZBIXJWPJM-UHFFFAOYSA-N 0.000 description 4
- 125000002373 5 membered heterocyclic group Chemical group 0.000 description 4
- KDOPAZIWBAHVJB-UHFFFAOYSA-N 5h-pyrrolo[3,2-d]pyrimidine Chemical compound C1=NC=C2NC=CC2=N1 KDOPAZIWBAHVJB-UHFFFAOYSA-N 0.000 description 4
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 4
- KZMGYPLQYOPHEL-UHFFFAOYSA-N Boron trifluoride etherate Chemical compound FB(F)F.CCOCC KZMGYPLQYOPHEL-UHFFFAOYSA-N 0.000 description 4
- 241000283690 Bos taurus Species 0.000 description 4
- 241000282472 Canis lupus familiaris Species 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 4
- 108010054814 DNA Gyrase Proteins 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 241000283086 Equidae Species 0.000 description 4
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 4
- 241000282326 Felis catus Species 0.000 description 4
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 4
- 241001494479 Pecora Species 0.000 description 4
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 4
- FIHGXOKSXRJJEE-UHFFFAOYSA-N [2-(ethylcarbamoylamino)-7-pyridin-2-yl-1,3-benzothiazol-5-yl]boronic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(B(O)O)=CC=1C1=CC=CC=N1 FIHGXOKSXRJJEE-UHFFFAOYSA-N 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 4
- 229910000024 caesium carbonate Inorganic materials 0.000 description 4
- 238000004440 column chromatography Methods 0.000 description 4
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 4
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 239000003480 eluent Substances 0.000 description 4
- DOYPTJKSVFDMAW-UHFFFAOYSA-N ethyl 1-(5-bromopyrimidin-2-yl)-4-methylpiperidine-4-carboxylate Chemical compound C1CC(C(=O)OCC)(C)CCN1C1=NC=C(Br)C=N1 DOYPTJKSVFDMAW-UHFFFAOYSA-N 0.000 description 4
- QKGDDLXPSBUUIO-UHFFFAOYSA-N ethyl 1-[5-[7-bromo-2-(3-ethyl-5-methyl-2-oxo-1,3,5-triazinan-1-yl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylate Chemical compound C1CC(C(=O)OCC)(C)CCN1C1=NC=C(C=2C=C3N=C(SC3=C(Br)C=2)N2C(N(CC)CN(C)C2)=O)C=N1 QKGDDLXPSBUUIO-UHFFFAOYSA-N 0.000 description 4
- YRTCKZIKGWZNCU-UHFFFAOYSA-N furo[3,2-b]pyridine Chemical compound C1=CC=C2OC=CC2=N1 YRTCKZIKGWZNCU-UHFFFAOYSA-N 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 125000001183 hydrocarbyl group Chemical group 0.000 description 4
- 125000002883 imidazolyl group Chemical group 0.000 description 4
- 239000011630 iodine Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- AFJIZTKWUYPYNE-UHFFFAOYSA-N methyl 4-hydroxypiperidine-4-carboxylate Chemical compound COC(=O)C1(O)CCNCC1 AFJIZTKWUYPYNE-UHFFFAOYSA-N 0.000 description 4
- 125000002971 oxazolyl group Chemical group 0.000 description 4
- YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 description 4
- 239000000546 pharmaceutical excipient Substances 0.000 description 4
- 239000012071 phase Substances 0.000 description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 4
- NROKBHXJSPEDAR-UHFFFAOYSA-M potassium fluoride Chemical compound [F-].[K+] NROKBHXJSPEDAR-UHFFFAOYSA-M 0.000 description 4
- 125000006239 protecting group Chemical group 0.000 description 4
- 125000003226 pyrazolyl group Chemical group 0.000 description 4
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- 241000894007 species Species 0.000 description 4
- 239000012258 stirred mixture Substances 0.000 description 4
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 4
- AQRLNPVMDITEJU-UHFFFAOYSA-N triethylsilane Chemical compound CC[SiH](CC)CC AQRLNPVMDITEJU-UHFFFAOYSA-N 0.000 description 4
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 4
- OIIOPWHTJZYKIL-PMACEKPBSA-N (5S)-5-[[[5-[2-chloro-3-[2-chloro-3-[6-methoxy-5-[[[(2S)-5-oxopyrrolidin-2-yl]methylamino]methyl]pyrazin-2-yl]phenyl]phenyl]-3-methoxypyrazin-2-yl]methylamino]methyl]pyrrolidin-2-one Chemical compound C1(=C(N=C(C2=C(C(C3=CC=CC(=C3Cl)C3=NC(OC)=C(N=C3)CNC[C@H]3NC(=O)CC3)=CC=C2)Cl)C=N1)OC)CNC[C@H]1NC(=O)CC1 OIIOPWHTJZYKIL-PMACEKPBSA-N 0.000 description 3
- LVEYOSJUKRVCCF-UHFFFAOYSA-N 1,3-bis(diphenylphosphino)propane Chemical compound C=1C=CC=CC=1P(C=1C=CC=CC=1)CCCP(C=1C=CC=CC=1)C1=CC=CC=C1 LVEYOSJUKRVCCF-UHFFFAOYSA-N 0.000 description 3
- PAXUSHNWLIUWOV-UHFFFAOYSA-N 1-(4,6-dibromo-[1,3]thiazolo[5,4-c]pyridin-2-yl)-3-ethylurea Chemical compound BrC1=NC(Br)=C2SC(NC(=O)NCC)=NC2=C1 PAXUSHNWLIUWOV-UHFFFAOYSA-N 0.000 description 3
- YJHMRHGIFCLGHY-UHFFFAOYSA-N 1-(7-cyano-5-phenylmethoxy-1,3-benzothiazol-2-yl)-3-ethylurea Chemical compound C=1C(C#N)=C2SC(NC(=O)NCC)=NC2=CC=1OCC1=CC=CC=C1 YJHMRHGIFCLGHY-UHFFFAOYSA-N 0.000 description 3
- RDOXRKFBRSXZNU-UHFFFAOYSA-N 1-[5-(6-bromopyridazin-4-yl)-7-pyridin-2-yl-1,3-benzothiazol-2-yl]-3-ethylurea Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=C(Br)N=NC=2)=CC=1C1=CC=CC=N1 RDOXRKFBRSXZNU-UHFFFAOYSA-N 0.000 description 3
- XQRLXUYZKZXSBN-UHFFFAOYSA-N 1-benzyl-4-hydroxypiperidine-4-carbonitrile Chemical compound C1CC(O)(C#N)CCN1CC1=CC=CC=C1 XQRLXUYZKZXSBN-UHFFFAOYSA-N 0.000 description 3
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 3
- XASOHFCUIQARJT-UHFFFAOYSA-N 8-methoxy-6-[7-(2-morpholin-4-ylethoxy)imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one Chemical compound C(N1C(=O)C2=C(OC)C=C(C=3N4C(=NC=3)C=C(C=C4)OCCN3CCOCC3)C=C2CC1)C(F)(F)F XASOHFCUIQARJT-UHFFFAOYSA-N 0.000 description 3
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 3
- 108010041052 DNA Topoisomerase IV Proteins 0.000 description 3
- 241000400611 Eucalyptus deanei Species 0.000 description 3
- 239000007821 HATU Substances 0.000 description 3
- 241000124008 Mammalia Species 0.000 description 3
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 238000006069 Suzuki reaction reaction Methods 0.000 description 3
- DHXVGJBLRPWPCS-UHFFFAOYSA-N Tetrahydropyran Chemical compound C1CCOCC1 DHXVGJBLRPWPCS-UHFFFAOYSA-N 0.000 description 3
- FMHLZRHAVMRGDT-UHFFFAOYSA-N [2-(ethylcarbamoylamino)-7-pyridin-2-yl-1,3-benzothiazol-5-yl] trifluoromethanesulfonate Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(OS(=O)(=O)C(F)(F)F)=CC=1C1=CC=CC=N1 FMHLZRHAVMRGDT-UHFFFAOYSA-N 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 125000000539 amino acid group Chemical group 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 239000008346 aqueous phase Substances 0.000 description 3
- ZSIQJIWKELUFRJ-UHFFFAOYSA-N azepane Chemical compound C1CCCNCC1 ZSIQJIWKELUFRJ-UHFFFAOYSA-N 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 239000004202 carbamide Substances 0.000 description 3
- 125000002837 carbocyclic group Chemical group 0.000 description 3
- 239000000969 carrier Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 125000003963 dichloro group Chemical group Cl* 0.000 description 3
- WGLUMOCWFMKWIL-UHFFFAOYSA-N dichloromethane;methanol Chemical compound OC.ClCCl WGLUMOCWFMKWIL-UHFFFAOYSA-N 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- VWXIKDOADYUFTK-UHFFFAOYSA-N ethyl 1-(5-bromopyrimidin-2-yl)-4-prop-2-enylpiperidine-4-carboxylate Chemical compound C1CC(C(=O)OCC)(CC=C)CCN1C1=NC=C(Br)C=N1 VWXIKDOADYUFTK-UHFFFAOYSA-N 0.000 description 3
- VLEVNTMPDOAYJJ-UHFFFAOYSA-N ethyl 1-[5-[2-(ethylcarbamoylamino)-7-ethynyl-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylate Chemical compound C=1C(C#C)=C2SC(NC(=O)NCC)=NC2=CC=1C(C=N1)=CN=C1N1CCC(C)(C(=O)OCC)CC1 VLEVNTMPDOAYJJ-UHFFFAOYSA-N 0.000 description 3
- NXHZHDVVOZXSBB-UHFFFAOYSA-N ethyl 1-[5-[7-amino-2-(ethylcarbamoylamino)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylate Chemical compound C=1C(N)=C2SC(NC(=O)NCC)=NC2=CC=1C(C=N1)=CN=C1N1CCC(C)(C(=O)OCC)CC1 NXHZHDVVOZXSBB-UHFFFAOYSA-N 0.000 description 3
- PVAYYKRNIQMUNB-UHFFFAOYSA-N ethyl 4-(trifluoromethyl)piperidine-4-carboxylate;hydrochloride Chemical compound Cl.CCOC(=O)C1(C(F)(F)F)CCNCC1 PVAYYKRNIQMUNB-UHFFFAOYSA-N 0.000 description 3
- GMINGBPWJIXTOU-UHFFFAOYSA-N ethyl 4-[(5-bromopyrimidin-2-yl)amino]-1-methylcyclohexane-1-carboxylate Chemical compound C1CC(C(=O)OCC)(C)CCC1NC1=NC=C(Br)C=N1 GMINGBPWJIXTOU-UHFFFAOYSA-N 0.000 description 3
- SKWIXVUJYZWPSO-UHFFFAOYSA-N ethyl 4-ethylpiperidine-4-carboxylate;hydrochloride Chemical compound Cl.CCOC(=O)C1(CC)CCNCC1 SKWIXVUJYZWPSO-UHFFFAOYSA-N 0.000 description 3
- NBELYFILOKZYJZ-UHFFFAOYSA-N ethyl 5-[(5-bromopyrimidin-2-yl)amino]-2-methyl-1,3-dioxane-2-carboxylate Chemical compound C1OC(C(=O)OCC)(C)OCC1NC1=NC=C(Br)C=N1 NBELYFILOKZYJZ-UHFFFAOYSA-N 0.000 description 3
- ZTXJUYCMKVMHDE-UHFFFAOYSA-N ethyl n-[(2,3,5-tribromo-4-methoxyphenyl)carbamothioyl]carbamate Chemical compound CCOC(=O)NC(=S)NC1=CC(Br)=C(OC)C(Br)=C1Br ZTXJUYCMKVMHDE-UHFFFAOYSA-N 0.000 description 3
- 229910052731 fluorine Inorganic materials 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- XNXVOSBNFZWHBV-UHFFFAOYSA-N hydron;o-methylhydroxylamine;chloride Chemical compound Cl.CON XNXVOSBNFZWHBV-UHFFFAOYSA-N 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 239000003112 inhibitor Substances 0.000 description 3
- YNESATAKKCNGOF-UHFFFAOYSA-N lithium bis(trimethylsilyl)amide Chemical compound [Li+].C[Si](C)(C)[N-][Si](C)(C)C YNESATAKKCNGOF-UHFFFAOYSA-N 0.000 description 3
- KPQUYNPCHBZLQM-UHFFFAOYSA-N methyl 1-(5-bromopyrimidin-2-yl)-4-hydroxypiperidine-4-carboxylate Chemical compound C1CC(C(=O)OC)(O)CCN1C1=NC=C(Br)C=N1 KPQUYNPCHBZLQM-UHFFFAOYSA-N 0.000 description 3
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 3
- MUJIDPITZJWBSW-UHFFFAOYSA-N palladium(2+) Chemical compound [Pd+2] MUJIDPITZJWBSW-UHFFFAOYSA-N 0.000 description 3
- 239000003208 petroleum Substances 0.000 description 3
- 229910000027 potassium carbonate Inorganic materials 0.000 description 3
- 239000011698 potassium fluoride Substances 0.000 description 3
- 229910000160 potassium phosphate Inorganic materials 0.000 description 3
- 235000011009 potassium phosphates Nutrition 0.000 description 3
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 3
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 3
- 229940001584 sodium metabisulfite Drugs 0.000 description 3
- 235000010262 sodium metabisulphite Nutrition 0.000 description 3
- IOGXOCVLYRDXLW-UHFFFAOYSA-N tert-butyl nitrite Chemical compound CC(C)(C)ON=O IOGXOCVLYRDXLW-UHFFFAOYSA-N 0.000 description 3
- 125000001113 thiadiazolyl group Chemical group 0.000 description 3
- 125000001425 triazolyl group Chemical group 0.000 description 3
- WLPUWLXVBWGYMZ-UHFFFAOYSA-N tricyclohexylphosphine Chemical compound C1CCCCC1P(C1CCCCC1)C1CCCCC1 WLPUWLXVBWGYMZ-UHFFFAOYSA-N 0.000 description 3
- 239000003039 volatile agent Substances 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- ASGMFNBUXDJWJJ-JLCFBVMHSA-N (1R,3R)-3-[[3-bromo-1-[4-(5-methyl-1,3,4-thiadiazol-2-yl)phenyl]pyrazolo[3,4-d]pyrimidin-6-yl]amino]-N,1-dimethylcyclopentane-1-carboxamide Chemical compound BrC1=NN(C2=NC(=NC=C21)N[C@H]1C[C@@](CC1)(C(=O)NC)C)C1=CC=C(C=C1)C=1SC(=NN=1)C ASGMFNBUXDJWJJ-JLCFBVMHSA-N 0.000 description 2
- PAVKMURODQHTLD-UHFFFAOYSA-N (2,6-dibromopyridin-4-yl)thiourea Chemical compound NC(=S)NC1=CC(Br)=NC(Br)=C1 PAVKMURODQHTLD-UHFFFAOYSA-N 0.000 description 2
- PRNHAXOGIXNNAH-UHFFFAOYSA-N (2-bromo-4,6-dinitrophenyl) thiocyanate Chemical compound [O-][N+](=O)C1=CC(Br)=C(SC#N)C([N+]([O-])=O)=C1 PRNHAXOGIXNNAH-UHFFFAOYSA-N 0.000 description 2
- IUSARDYWEPUTPN-OZBXUNDUSA-N (2r)-n-[(2s,3r)-4-[[(4s)-6-(2,2-dimethylpropyl)spiro[3,4-dihydropyrano[2,3-b]pyridine-2,1'-cyclobutane]-4-yl]amino]-3-hydroxy-1-[3-(1,3-thiazol-2-yl)phenyl]butan-2-yl]-2-methoxypropanamide Chemical compound C([C@H](NC(=O)[C@@H](C)OC)[C@H](O)CN[C@@H]1C2=CC(CC(C)(C)C)=CN=C2OC2(CCC2)C1)C(C=1)=CC=CC=1C1=NC=CS1 IUSARDYWEPUTPN-OZBXUNDUSA-N 0.000 description 2
- ABGJNLNOERBQRI-UHFFFAOYSA-N (3-bromo-5-phenylmethoxyphenyl)thiourea Chemical compound NC(=S)NC1=CC(Br)=CC(OCC=2C=CC=CC=2)=C1 ABGJNLNOERBQRI-UHFFFAOYSA-N 0.000 description 2
- MPDDTAJMJCESGV-CTUHWIOQSA-M (3r,5r)-7-[2-(4-fluorophenyl)-5-[methyl-[(1r)-1-phenylethyl]carbamoyl]-4-propan-2-ylpyrazol-3-yl]-3,5-dihydroxyheptanoate Chemical compound C1([C@@H](C)N(C)C(=O)C2=NN(C(CC[C@@H](O)C[C@@H](O)CC([O-])=O)=C2C(C)C)C=2C=CC(F)=CC=2)=CC=CC=C1 MPDDTAJMJCESGV-CTUHWIOQSA-M 0.000 description 2
- YQOLEILXOBUDMU-KRWDZBQOSA-N (4R)-5-[(6-bromo-3-methyl-2-pyrrolidin-1-ylquinoline-4-carbonyl)amino]-4-(2-chlorophenyl)pentanoic acid Chemical compound CC1=C(C2=C(C=CC(=C2)Br)N=C1N3CCCC3)C(=O)NC[C@H](CCC(=O)O)C4=CC=CC=C4Cl YQOLEILXOBUDMU-KRWDZBQOSA-N 0.000 description 2
- 125000003161 (C1-C6) alkylene group Chemical group 0.000 description 2
- 125000006590 (C2-C6) alkenylene group Chemical group 0.000 description 2
- 125000006591 (C2-C6) alkynylene group Chemical group 0.000 description 2
- 125000006704 (C5-C6) cycloalkyl group Chemical group 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- OZSFGUGRXFXZNR-UHFFFAOYSA-N 1,2-dibromo-3,5-dinitrobenzene Chemical compound [O-][N+](=O)C1=CC(Br)=C(Br)C([N+]([O-])=O)=C1 OZSFGUGRXFXZNR-UHFFFAOYSA-N 0.000 description 2
- WTFAPFMYFQLHBO-UHFFFAOYSA-N 1-(5,7-dibromo-6-methoxy-1,3-benzothiazol-2-yl)-3-ethylurea Chemical compound BrC1=C(OC)C(Br)=C2SC(NC(=O)NCC)=NC2=C1 WTFAPFMYFQLHBO-UHFFFAOYSA-N 0.000 description 2
- IAVLPJBSBVKQNE-UHFFFAOYSA-N 1-(5-bromo-6-methoxy-1,3-benzothiazol-2-yl)-3-ethylurea Chemical compound BrC1=C(OC)C=C2SC(NC(=O)NCC)=NC2=C1 IAVLPJBSBVKQNE-UHFFFAOYSA-N 0.000 description 2
- SDVUVQRXKTYHOG-UHFFFAOYSA-N 1-(5-bromopyrimidin-2-yl)-2-methylpiperidine-2-carboxylic acid Chemical compound OC(=O)C1(C)CCCCN1C1=NC=C(Br)C=N1 SDVUVQRXKTYHOG-UHFFFAOYSA-N 0.000 description 2
- UTRRSBZHLYQGEZ-UHFFFAOYSA-N 1-(5-bromopyrimidin-2-yl)-4-[(2-methylpropan-2-yl)oxycarbonylamino]piperidine-4-carboxylic acid Chemical compound C1CC(NC(=O)OC(C)(C)C)(C(O)=O)CCN1C1=NC=C(Br)C=N1 UTRRSBZHLYQGEZ-UHFFFAOYSA-N 0.000 description 2
- UJDZSPJHFSTXFV-UHFFFAOYSA-N 1-(5-bromopyrimidin-2-yl)-4-methoxypiperidine-4-carboxylic acid Chemical compound C1CC(OC)(C(O)=O)CCN1C1=NC=C(Br)C=N1 UJDZSPJHFSTXFV-UHFFFAOYSA-N 0.000 description 2
- MYQISFOZUVNMFU-UHFFFAOYSA-N 1-(5-bromopyrimidin-2-yl)-4-methylpiperidine-4-carboxylic acid Chemical compound C1CC(C)(C(O)=O)CCN1C1=NC=C(Br)C=N1 MYQISFOZUVNMFU-UHFFFAOYSA-N 0.000 description 2
- JNMUIPOZZZFXFY-UHFFFAOYSA-N 1-(5-bromopyrimidin-2-yl)-4-phenylpiperidine-4-carbonitrile Chemical compound N1=CC(Br)=CN=C1N1CCC(C=2C=CC=CC=2)(C#N)CC1 JNMUIPOZZZFXFY-UHFFFAOYSA-N 0.000 description 2
- PMTOFJUSNIMRBS-UHFFFAOYSA-N 1-(5-bromopyrimidin-2-yl)-4-phenylpiperidine-4-carboxamide Chemical compound C1CC(C(=O)N)(C=2C=CC=CC=2)CCN1C1=NC=C(Br)C=N1 PMTOFJUSNIMRBS-UHFFFAOYSA-N 0.000 description 2
- QJYSSKKOFKIEHZ-UHFFFAOYSA-N 1-(5-bromopyrimidin-2-yl)-4-phenylpiperidine-4-carboxylic acid Chemical compound C1CC(C(=O)O)(C=2C=CC=CC=2)CCN1C1=NC=C(Br)C=N1 QJYSSKKOFKIEHZ-UHFFFAOYSA-N 0.000 description 2
- UFGWWRJBZVTZQO-UHFFFAOYSA-N 1-(6-bromo-4-pyridin-2-yl-[1,3]thiazolo[5,4-c]pyridin-2-yl)-3-ethylurea Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(Br)=NC=1C1=CC=CC=N1 UFGWWRJBZVTZQO-UHFFFAOYSA-N 0.000 description 2
- GVOSWQKMNMEMSI-UHFFFAOYSA-N 1-[5-(2-chloropyrimidin-5-yl)-7-pyridin-2-yl-1,3-benzothiazol-2-yl]-3-ethylurea Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(Cl)=NC=2)=CC=1C1=CC=CC=N1 GVOSWQKMNMEMSI-UHFFFAOYSA-N 0.000 description 2
- RQFQSJLSGLLQLT-UHFFFAOYSA-N 1-[7-(1-ethoxyethenyl)-5-phenylmethoxy-1,3-benzothiazol-2-yl]-3-ethylurea Chemical compound C=1C(C(=C)OCC)=C2SC(NC(=O)NCC)=NC2=CC=1OCC1=CC=CC=C1 RQFQSJLSGLLQLT-UHFFFAOYSA-N 0.000 description 2
- JKDQJTZCMWRKJA-UHFFFAOYSA-N 1-bromo-3-nitro-5-phenylmethoxybenzene Chemical compound [O-][N+](=O)C1=CC(Br)=CC(OCC=2C=CC=CC=2)=C1 JKDQJTZCMWRKJA-UHFFFAOYSA-N 0.000 description 2
- KIQHNLJETCYAGJ-UHFFFAOYSA-N 1-ethyl-3-(5-hydroxy-7-propanoyl-1,3-benzothiazol-2-yl)urea Chemical compound OC1=CC(C(=O)CC)=C2SC(NC(=O)NCC)=NC2=C1 KIQHNLJETCYAGJ-UHFFFAOYSA-N 0.000 description 2
- RWVCJLQRNVXWPH-UHFFFAOYSA-N 1-ethyl-3-(5-phenylmethoxy-7-propanoyl-1,3-benzothiazol-2-yl)urea Chemical compound C=1C(C(=O)CC)=C2SC(NC(=O)NCC)=NC2=CC=1OCC1=CC=CC=C1 RWVCJLQRNVXWPH-UHFFFAOYSA-N 0.000 description 2
- GWCLPHTXIBMKMS-UHFFFAOYSA-N 1-ethyl-3-(5-phenylmethoxy-7-pyridin-2-yl-1,3-benzothiazol-2-yl)urea Chemical compound C=1C(C=2N=CC=CC=2)=C2SC(NC(=O)NCC)=NC2=CC=1OCC1=CC=CC=C1 GWCLPHTXIBMKMS-UHFFFAOYSA-N 0.000 description 2
- HVWCNSDENPGPRD-UHFFFAOYSA-N 1-ethyl-3-(6-methoxy-1,3-benzothiazol-2-yl)urea Chemical compound C1=C(OC)C=C2SC(NC(=O)NCC)=NC2=C1 HVWCNSDENPGPRD-UHFFFAOYSA-N 0.000 description 2
- DUPZIXFRXKXGGO-UHFFFAOYSA-N 1-ethyl-3-(7-formyl-5-phenylmethoxy-1,3-benzothiazol-2-yl)urea Chemical compound C=1C(C=O)=C2SC(NC(=O)NCC)=NC2=CC=1OCC1=CC=CC=C1 DUPZIXFRXKXGGO-UHFFFAOYSA-N 0.000 description 2
- SOBVWLJAGZIYCZ-MKMNVTDBSA-N 1-ethyl-3-[5-hydroxy-7-[(e)-methoxyiminomethyl]-1,3-benzothiazol-2-yl]urea Chemical compound OC1=CC(\C=N\OC)=C2SC(NC(=O)NCC)=NC2=C1 SOBVWLJAGZIYCZ-MKMNVTDBSA-N 0.000 description 2
- GWSFSZJNHWFWEI-REZTVBANSA-N 1-ethyl-3-[5-hydroxy-7-[(e)-n-methoxy-c-methylcarbonimidoyl]-1,3-benzothiazol-2-yl]urea Chemical compound OC1=CC(\C(C)=N\OC)=C2SC(NC(=O)NCC)=NC2=C1 GWSFSZJNHWFWEI-REZTVBANSA-N 0.000 description 2
- YOQHVTUDXCCFHB-SRZZPIQSSA-N 1-ethyl-3-[7-[(e)-methoxyiminomethyl]-5-phenylmethoxy-1,3-benzothiazol-2-yl]urea Chemical compound C=1C(\C=N\OC)=C2SC(NC(=O)NCC)=NC2=CC=1OCC1=CC=CC=C1 YOQHVTUDXCCFHB-SRZZPIQSSA-N 0.000 description 2
- GVRQIMSOAHTWPB-UHFFFAOYSA-N 1-o-benzyl 4-o-methyl 4-[(2-methylpropan-2-yl)oxycarbonylamino]piperidine-1,4-dicarboxylate Chemical compound C1CC(C(=O)OC)(NC(=O)OC(C)(C)C)CCN1C(=O)OCC1=CC=CC=C1 GVRQIMSOAHTWPB-UHFFFAOYSA-N 0.000 description 2
- IDSNQTJSDFUAEV-UHFFFAOYSA-N 1-o-tert-butyl 3-o-methyl 3-methyl-4-oxopiperidine-1,3-dicarboxylate Chemical compound COC(=O)C1(C)CN(C(=O)OC(C)(C)C)CCC1=O IDSNQTJSDFUAEV-UHFFFAOYSA-N 0.000 description 2
- BTIZVAALQAGSKT-UHFFFAOYSA-N 1-o-tert-butyl 3-o-methyl 4-hydroxy-3-methylpiperidine-1,3-dicarboxylate Chemical compound COC(=O)C1(C)CN(C(=O)OC(C)(C)C)CCC1O BTIZVAALQAGSKT-UHFFFAOYSA-N 0.000 description 2
- HBWUTYLVFYVXML-UHFFFAOYSA-N 1-o-tert-butyl 3-o-methyl 4-oxopiperidine-1,3-dicarboxylate Chemical compound COC(=O)C1CN(C(=O)OC(C)(C)C)CCC1=O HBWUTYLVFYVXML-UHFFFAOYSA-N 0.000 description 2
- JYUWLRUMOZOHRW-UHFFFAOYSA-N 1-o-tert-butyl 4-o-ethyl 4-(trifluoromethyl)piperidine-1,4-dicarboxylate Chemical compound CCOC(=O)C1(C(F)(F)F)CCN(C(=O)OC(C)(C)C)CC1 JYUWLRUMOZOHRW-UHFFFAOYSA-N 0.000 description 2
- IEKGLZRZMZMUCH-UHFFFAOYSA-N 1-o-tert-butyl 4-o-ethyl 4-cyanopiperidine-1,4-dicarboxylate Chemical compound CCOC(=O)C1(C#N)CCN(C(=O)OC(C)(C)C)CC1 IEKGLZRZMZMUCH-UHFFFAOYSA-N 0.000 description 2
- ABBIQGVRIOLJNV-UHFFFAOYSA-N 1-o-tert-butyl 4-o-ethyl 4-fluoropiperidine-1,4-dicarboxylate Chemical compound CCOC(=O)C1(F)CCN(C(=O)OC(C)(C)C)CC1 ABBIQGVRIOLJNV-UHFFFAOYSA-N 0.000 description 2
- ZQZVWDXMUCTNRI-UHFFFAOYSA-N 1-o-tert-butyl 4-o-ethyl 4-methylpiperidine-1,4-dicarboxylate Chemical compound CCOC(=O)C1(C)CCN(C(=O)OC(C)(C)C)CC1 ZQZVWDXMUCTNRI-UHFFFAOYSA-N 0.000 description 2
- LRGKTXXUBMJMIC-UHFFFAOYSA-N 1-o-tert-butyl 4-o-ethyl 4-methylsulfanylpiperidine-1,4-dicarboxylate Chemical compound CCOC(=O)C1(SC)CCN(C(=O)OC(C)(C)C)CC1 LRGKTXXUBMJMIC-UHFFFAOYSA-N 0.000 description 2
- KVJRBIFIIKYCHJ-UHFFFAOYSA-N 1-o-tert-butyl 4-o-ethyl 4-methylsulfonylpiperidine-1,4-dicarboxylate Chemical compound CCOC(=O)C1(S(C)(=O)=O)CCN(C(=O)OC(C)(C)C)CC1 KVJRBIFIIKYCHJ-UHFFFAOYSA-N 0.000 description 2
- FOOVEGXEARQUBR-UHFFFAOYSA-N 1-o-tert-butyl 4-o-ethyl 4-prop-2-enylpiperidine-1,4-dicarboxylate Chemical compound CCOC(=O)C1(CC=C)CCN(C(=O)OC(C)(C)C)CC1 FOOVEGXEARQUBR-UHFFFAOYSA-N 0.000 description 2
- YOJAFCXACCYASM-UHFFFAOYSA-N 2,6-dibromo-1-oxidopyridin-1-ium Chemical compound [O-][N+]1=C(Br)C=CC=C1Br YOJAFCXACCYASM-UHFFFAOYSA-N 0.000 description 2
- MJEDSUKRJRIBKE-UHFFFAOYSA-N 2,6-dibromo-4-nitro-1-oxidopyridin-1-ium Chemical compound [O-][N+](=O)C1=CC(Br)=[N+]([O-])C(Br)=C1 MJEDSUKRJRIBKE-UHFFFAOYSA-N 0.000 description 2
- NTFZVUOMTODHRO-UHFFFAOYSA-N 2,6-dibromopyridin-4-amine Chemical compound NC1=CC(Br)=NC(Br)=C1 NTFZVUOMTODHRO-UHFFFAOYSA-N 0.000 description 2
- FEYDZHNIIMENOB-UHFFFAOYSA-N 2,6-dibromopyridine Chemical compound BrC1=CC=CC(Br)=N1 FEYDZHNIIMENOB-UHFFFAOYSA-N 0.000 description 2
- QEBYEVQKHRUYPE-UHFFFAOYSA-N 2-(2-chlorophenyl)-5-[(1-methylpyrazol-3-yl)methyl]-4-[[methyl(pyridin-3-ylmethyl)amino]methyl]-1h-pyrazolo[4,3-c]pyridine-3,6-dione Chemical compound C1=CN(C)N=C1CN1C(=O)C=C2NN(C=3C(=CC=CC=3)Cl)C(=O)C2=C1CN(C)CC1=CC=CN=C1 QEBYEVQKHRUYPE-UHFFFAOYSA-N 0.000 description 2
- WMPGJVULNTWDSF-UHFFFAOYSA-N 2-(5-bromo-4-fluoro-2-iodo-3-nitrophenyl)pyridine Chemical compound [O-][N+](=O)C1=C(F)C(Br)=CC(C=2N=CC=CC=2)=C1I WMPGJVULNTWDSF-UHFFFAOYSA-N 0.000 description 2
- PAYROHWFGZADBR-UHFFFAOYSA-N 2-[[4-amino-5-(5-iodo-4-methoxy-2-propan-2-ylphenoxy)pyrimidin-2-yl]amino]propane-1,3-diol Chemical compound C1=C(I)C(OC)=CC(C(C)C)=C1OC1=CN=C(NC(CO)CO)N=C1N PAYROHWFGZADBR-UHFFFAOYSA-N 0.000 description 2
- BQFCKIRFZPVBJL-UHFFFAOYSA-N 2-amino-3-bromo-5-nitrophenol Chemical compound NC1=C(O)C=C([N+]([O-])=O)C=C1Br BQFCKIRFZPVBJL-UHFFFAOYSA-N 0.000 description 2
- UWRIENWVWQJHNJ-UHFFFAOYSA-N 2-amino-5-methoxy-1,3-benzothiazole-7-carboxylic acid Chemical compound COC1=CC(C(O)=O)=C2SC(N)=NC2=C1 UWRIENWVWQJHNJ-UHFFFAOYSA-N 0.000 description 2
- YSUIQYOGTINQIN-UZFYAQMZSA-N 2-amino-9-[(1S,6R,8R,9S,10R,15R,17R,18R)-8-(6-aminopurin-9-yl)-9,18-difluoro-3,12-dihydroxy-3,12-bis(sulfanylidene)-2,4,7,11,13,16-hexaoxa-3lambda5,12lambda5-diphosphatricyclo[13.2.1.06,10]octadecan-17-yl]-1H-purin-6-one Chemical compound NC1=NC2=C(N=CN2[C@@H]2O[C@@H]3COP(S)(=O)O[C@@H]4[C@@H](COP(S)(=O)O[C@@H]2[C@@H]3F)O[C@H]([C@H]4F)N2C=NC3=C2N=CN=C3N)C(=O)N1 YSUIQYOGTINQIN-UZFYAQMZSA-N 0.000 description 2
- WREUCTDVXMRAJU-UHFFFAOYSA-N 2-amino-n-ethyl-5-methoxy-1,3-benzothiazole-7-carboxamide Chemical compound CCNC(=O)C1=CC(OC)=CC2=C1SC(N)=N2 WREUCTDVXMRAJU-UHFFFAOYSA-N 0.000 description 2
- KWMDHCLJYMVBNS-UHFFFAOYSA-N 2-bromo-4,6-dinitroaniline Chemical compound NC1=C(Br)C=C([N+]([O-])=O)C=C1[N+]([O-])=O KWMDHCLJYMVBNS-UHFFFAOYSA-N 0.000 description 2
- DPGSPRJLAZGUBQ-UHFFFAOYSA-N 2-ethenyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane Chemical compound CC1(C)OB(C=C)OC1(C)C DPGSPRJLAZGUBQ-UHFFFAOYSA-N 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- DRNLOOKBPHONSJ-UHFFFAOYSA-N 3,5-dibromopyridazine Chemical compound BrC1=CN=NC(Br)=C1 DRNLOOKBPHONSJ-UHFFFAOYSA-N 0.000 description 2
- FIAQAGLMZROOJY-UHFFFAOYSA-N 3-(benzoylcarbamothioylamino)-5-methoxybenzoic acid Chemical compound OC(=O)C1=CC(OC)=CC(NC(=S)NC(=O)C=2C=CC=CC=2)=C1 FIAQAGLMZROOJY-UHFFFAOYSA-N 0.000 description 2
- FAAFWHSNRKVAEU-UHFFFAOYSA-N 3-bromo-2-fluoro-6-iodo-5-pyridin-2-ylaniline Chemical compound NC1=C(F)C(Br)=CC(C=2N=CC=CC=2)=C1I FAAFWHSNRKVAEU-UHFFFAOYSA-N 0.000 description 2
- VJQGLUHOAIZTNK-UHFFFAOYSA-N 3-bromo-5-nitrophenol Chemical compound OC1=CC(Br)=CC([N+]([O-])=O)=C1 VJQGLUHOAIZTNK-UHFFFAOYSA-N 0.000 description 2
- NMQGXHUAFKKFPI-UHFFFAOYSA-N 3-bromo-5-phenylmethoxyaniline Chemical compound NC1=CC(Br)=CC(OCC=2C=CC=CC=2)=C1 NMQGXHUAFKKFPI-UHFFFAOYSA-N 0.000 description 2
- BZUSGTYFARWFPU-UHFFFAOYSA-N 4,6-dibromo-[1,3]thiazolo[5,4-c]pyridin-2-amine Chemical compound BrC1=NC(Br)=C2SC(N)=NC2=C1 BZUSGTYFARWFPU-UHFFFAOYSA-N 0.000 description 2
- HVBSAKJJOYLTQU-UHFFFAOYSA-N 4-aminobenzenesulfonic acid Chemical compound NC1=CC=C(S(O)(=O)=O)C=C1 HVBSAKJJOYLTQU-UHFFFAOYSA-N 0.000 description 2
- XXVCAXQHMVRMDB-UHFFFAOYSA-N 4-bromo-3-fluoro-2-nitro-6-pyridin-2-ylaniline Chemical compound C1=C(Br)C(F)=C([N+]([O-])=O)C(N)=C1C1=CC=CC=N1 XXVCAXQHMVRMDB-UHFFFAOYSA-N 0.000 description 2
- 229960000549 4-dimethylaminophenol Drugs 0.000 description 2
- FKKPSFIMIQSISK-UHFFFAOYSA-N 4-hydroxypiperidin-1-ium-4-carboxylate Chemical compound OC(=O)C1(O)CCNCC1 FKKPSFIMIQSISK-UHFFFAOYSA-N 0.000 description 2
- WXAKMLDDCWGCNO-UHFFFAOYSA-N 5,7-dibromo-6-methoxy-1,3-benzothiazol-2-amine Chemical compound COC1=C(Br)C=C2N=C(N)SC2=C1Br WXAKMLDDCWGCNO-UHFFFAOYSA-N 0.000 description 2
- LBSAWUJERBIKBF-UHFFFAOYSA-N 5,7-dichloro-[1,2,4]triazolo[1,5-a]pyridin-2-amine Chemical compound C1=C(Cl)C=C(Cl)N2N=C(N)N=C21 LBSAWUJERBIKBF-UHFFFAOYSA-N 0.000 description 2
- BMXJFKLSEGBBSJ-UHFFFAOYSA-N 5-bromo-2-(bromomethyl)pyrimidine Chemical compound BrCC1=NC=C(Br)C=N1 BMXJFKLSEGBBSJ-UHFFFAOYSA-N 0.000 description 2
- QRXMUCSWCMTJGU-UHFFFAOYSA-N 5-bromo-4-chloro-3-indolyl phosphate Chemical compound C1=C(Br)C(Cl)=C2C(OP(O)(=O)O)=CNC2=C1 QRXMUCSWCMTJGU-UHFFFAOYSA-N 0.000 description 2
- PYPMLIHVYVMIDD-UHFFFAOYSA-N 5-bromo-4-fluoro-7-pyridin-2-yl-1,3-benzothiazol-2-amine Chemical compound C=12SC(N)=NC2=C(F)C(Br)=CC=1C1=CC=CC=N1 PYPMLIHVYVMIDD-UHFFFAOYSA-N 0.000 description 2
- KRZIIMHWARNZMO-UHFFFAOYSA-N 7-bromo-5-iodo-1,3-benzothiazol-2-amine Chemical compound IC1=CC(Br)=C2SC(N)=NC2=C1 KRZIIMHWARNZMO-UHFFFAOYSA-N 0.000 description 2
- RLGQZKMWEFZOIZ-UHFFFAOYSA-N 7-bromo-5-phenylmethoxy-1,3-benzothiazol-2-amine Chemical compound C=1C(Br)=C2SC(N)=NC2=CC=1OCC1=CC=CC=C1 RLGQZKMWEFZOIZ-UHFFFAOYSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- OZAIFHULBGXAKX-VAWYXSNFSA-N AIBN Substances N#CC(C)(C)\N=N\C(C)(C)C#N OZAIFHULBGXAKX-VAWYXSNFSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 2
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- PKMUHQIDVVOXHQ-HXUWFJFHSA-N C[C@H](C1=CC(C2=CC=C(CNC3CCCC3)S2)=CC=C1)NC(C1=C(C)C=CC(NC2CNC2)=C1)=O Chemical compound C[C@H](C1=CC(C2=CC=C(CNC3CCCC3)S2)=CC=C1)NC(C1=C(C)C=CC(NC2CNC2)=C1)=O PKMUHQIDVVOXHQ-HXUWFJFHSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 241000283707 Capra Species 0.000 description 2
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical group NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 241000700198 Cavia Species 0.000 description 2
- 229940127007 Compound 39 Drugs 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 2
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 239000005909 Kieselgur Substances 0.000 description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 2
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 2
- POFVJRKJJBFPII-UHFFFAOYSA-N N-cyclopentyl-5-[2-[[5-[(4-ethylpiperazin-1-yl)methyl]pyridin-2-yl]amino]-5-fluoropyrimidin-4-yl]-4-methyl-1,3-thiazol-2-amine Chemical compound C1(CCCC1)NC=1SC(=C(N=1)C)C1=NC(=NC=C1F)NC1=NC=C(C=C1)CN1CCN(CC1)CC POFVJRKJJBFPII-UHFFFAOYSA-N 0.000 description 2
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- 101150003085 Pdcl gene Proteins 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 241000283984 Rodentia Species 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- 238000006619 Stille reaction Methods 0.000 description 2
- QYKIQEUNHZKYBP-UHFFFAOYSA-N Vinyl ether Chemical compound C=COC=C QYKIQEUNHZKYBP-UHFFFAOYSA-N 0.000 description 2
- VJEQAKABJGWOBP-QPSGOUHRSA-N [2-(ethylcarbamoylamino)-7-[(e)-n-methoxy-c-methylcarbonimidoyl]-1,3-benzothiazol-5-yl] trifluoromethanesulfonate Chemical compound FC(F)(F)S(=O)(=O)OC1=CC(\C(C)=N\OC)=C2SC(NC(=O)NCC)=NC2=C1 VJEQAKABJGWOBP-QPSGOUHRSA-N 0.000 description 2
- PBMZAEVQKGMCES-UHFFFAOYSA-N [2-(ethylcarbamoylamino)-7-propanoyl-1,3-benzothiazol-5-yl] trifluoromethanesulfonate Chemical compound FC(F)(F)S(=O)(=O)OC1=CC(C(=O)CC)=C2SC(NC(=O)NCC)=NC2=C1 PBMZAEVQKGMCES-UHFFFAOYSA-N 0.000 description 2
- YDKQVDADESQEMI-UHFFFAOYSA-N [5-[2-(4-ethoxycarbonyl-4-methylpiperidin-1-yl)pyrimidin-5-yl]-2-(3-ethyl-5-methyl-2-oxo-1,3,5-triazinan-1-yl)-1,3-benzothiazol-7-yl]boronic acid Chemical compound C1CC(C(=O)OCC)(C)CCN1C1=NC=C(C=2C=C3N=C(SC3=C(B(O)O)C=2)N2C(N(CC)CN(C)C2)=O)C=N1 YDKQVDADESQEMI-UHFFFAOYSA-N 0.000 description 2
- WAOAQESVEHNKDM-UHFFFAOYSA-N [7-(ethylcarbamoyl)-2-(ethylcarbamoylamino)-1,3-benzothiazol-5-yl] trifluoromethanesulfonate Chemical compound FC(F)(F)S(=O)(=O)OC1=CC(C(=O)NCC)=C2SC(NC(=O)NCC)=NC2=C1 WAOAQESVEHNKDM-UHFFFAOYSA-N 0.000 description 2
- HABVCDVEINHWTR-UHFFFAOYSA-N [B].[B].C(CO)(=O)OCC(C)(C)C Chemical compound [B].[B].C(CO)(=O)OCC(C)(C)C HABVCDVEINHWTR-UHFFFAOYSA-N 0.000 description 2
- 150000001299 aldehydes Chemical class 0.000 description 2
- 125000005210 alkyl ammonium group Chemical group 0.000 description 2
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- VZTDIZULWFCMLS-UHFFFAOYSA-N ammonium formate Chemical compound [NH4+].[O-]C=O VZTDIZULWFCMLS-UHFFFAOYSA-N 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 239000004599 antimicrobial Substances 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 150000001502 aryl halides Chemical class 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- KGNDCEVUMONOKF-UGPLYTSKSA-N benzyl n-[(2r)-1-[(2s,4r)-2-[[(2s)-6-amino-1-(1,3-benzoxazol-2-yl)-1,1-dihydroxyhexan-2-yl]carbamoyl]-4-[(4-methylphenyl)methoxy]pyrrolidin-1-yl]-1-oxo-4-phenylbutan-2-yl]carbamate Chemical compound C1=CC(C)=CC=C1CO[C@H]1CN(C(=O)[C@@H](CCC=2C=CC=CC=2)NC(=O)OCC=2C=CC=CC=2)[C@H](C(=O)N[C@@H](CCCCN)C(O)(O)C=2OC3=CC=CC=C3N=2)C1 KGNDCEVUMONOKF-UGPLYTSKSA-N 0.000 description 2
- UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 description 2
- IPWKHHSGDUIRAH-UHFFFAOYSA-N bis(pinacolato)diboron Chemical compound O1C(C)(C)C(C)(C)OB1B1OC(C)(C)C(C)(C)O1 IPWKHHSGDUIRAH-UHFFFAOYSA-N 0.000 description 2
- YNHIGQDRGKUECZ-UHFFFAOYSA-L bis(triphenylphosphine)palladium(ii) dichloride Chemical compound [Cl-].[Cl-].[Pd+2].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 YNHIGQDRGKUECZ-UHFFFAOYSA-L 0.000 description 2
- ILAHWRKJUDSMFH-UHFFFAOYSA-N boron tribromide Chemical compound BrB(Br)Br ILAHWRKJUDSMFH-UHFFFAOYSA-N 0.000 description 2
- HGXJOXHYPGNVNK-UHFFFAOYSA-N butane;ethenoxyethane;tin Chemical compound CCCC[Sn](CCCC)(CCCC)C(=C)OCC HGXJOXHYPGNVNK-UHFFFAOYSA-N 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 description 2
- 125000002843 carboxylic acid group Chemical group 0.000 description 2
- 150000001735 carboxylic acids Chemical class 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000007810 chemical reaction solvent Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 2
- 229960001231 choline Drugs 0.000 description 2
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 description 2
- LKJYEAJRWPUOGW-UHFFFAOYSA-N clerocidin Chemical compound CC1CCC(C(=CCC2)C=O)(C)C2C1(C)CC(C1(OC1)C1(O)O2)OC1OC1(O)C2OC(CC2(C)C3C(C(=CCC3)C=O)(C)CCC2C)C11CO1 LKJYEAJRWPUOGW-UHFFFAOYSA-N 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 229940125904 compound 1 Drugs 0.000 description 2
- 229940125833 compound 23 Drugs 0.000 description 2
- 229940125807 compound 37 Drugs 0.000 description 2
- 229940127573 compound 38 Drugs 0.000 description 2
- 229940126540 compound 41 Drugs 0.000 description 2
- 229940125844 compound 46 Drugs 0.000 description 2
- 229940126179 compound 72 Drugs 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- LSXDOTMGLUJQCM-UHFFFAOYSA-M copper(i) iodide Chemical compound I[Cu] LSXDOTMGLUJQCM-UHFFFAOYSA-M 0.000 description 2
- QTMDXZNDVAMKGV-UHFFFAOYSA-L copper(ii) bromide Chemical compound [Cu+2].[Br-].[Br-] QTMDXZNDVAMKGV-UHFFFAOYSA-L 0.000 description 2
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 2
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 2
- ZOCHARZZJNPSEU-UHFFFAOYSA-N diboron Chemical compound B#B ZOCHARZZJNPSEU-UHFFFAOYSA-N 0.000 description 2
- YNHIGQDRGKUECZ-UHFFFAOYSA-N dichloropalladium;triphenylphosphanium Chemical compound Cl[Pd]Cl.C1=CC=CC=C1[PH+](C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1[PH+](C=1C=CC=CC=1)C1=CC=CC=C1 YNHIGQDRGKUECZ-UHFFFAOYSA-N 0.000 description 2
- WQOXQRCZOLPYPM-UHFFFAOYSA-N dimethyl disulfide Chemical compound CSSC WQOXQRCZOLPYPM-UHFFFAOYSA-N 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- HWFGRGYTYHGKRY-UHFFFAOYSA-N ethyl 1-(3-chloro-1,2,4-thiadiazol-5-yl)-4-ethylpiperidine-4-carboxylate Chemical compound C1CC(C(=O)OCC)(CC)CCN1C1=NC(Cl)=NS1 HWFGRGYTYHGKRY-UHFFFAOYSA-N 0.000 description 2
- JTVJKPUZZYFBEN-UHFFFAOYSA-N ethyl 1-(5-bromopyrimidin-2-yl)-3,4-dimethylpiperidine-4-carboxylate Chemical compound C1C(C)C(C(=O)OCC)(C)CCN1C1=NC=C(Br)C=N1 JTVJKPUZZYFBEN-UHFFFAOYSA-N 0.000 description 2
- MRBANNMIEAVJAW-UHFFFAOYSA-N ethyl 1-(5-bromopyrimidin-2-yl)-4-cyanopiperidine-4-carboxylate Chemical compound C1CC(C(=O)OCC)(C#N)CCN1C1=NC=C(Br)C=N1 MRBANNMIEAVJAW-UHFFFAOYSA-N 0.000 description 2
- KWNVFAOEIPOIPW-UHFFFAOYSA-N ethyl 1-(5-bromopyrimidin-2-yl)-4-ethoxypiperidine-4-carboxylate Chemical compound C1CC(C(=O)OCC)(OCC)CCN1C1=NC=C(Br)C=N1 KWNVFAOEIPOIPW-UHFFFAOYSA-N 0.000 description 2
- JBLROONTPUBPMC-UHFFFAOYSA-N ethyl 1-(5-bromopyrimidin-2-yl)-4-ethylpiperidine-4-carboxylate Chemical compound C1CC(C(=O)OCC)(CC)CCN1C1=NC=C(Br)C=N1 JBLROONTPUBPMC-UHFFFAOYSA-N 0.000 description 2
- LBCFWXROIMCRLN-UHFFFAOYSA-N ethyl 1-(5-bromopyrimidin-2-yl)-4-fluoropiperidine-4-carboxylate Chemical compound C1CC(C(=O)OCC)(F)CCN1C1=NC=C(Br)C=N1 LBCFWXROIMCRLN-UHFFFAOYSA-N 0.000 description 2
- IDMRWFJHAJYZDR-UHFFFAOYSA-N ethyl 1-(5-bromopyrimidin-2-yl)-4-hydroxypiperidine-4-carboxylate Chemical compound C1CC(C(=O)OCC)(O)CCN1C1=NC=C(Br)C=N1 IDMRWFJHAJYZDR-UHFFFAOYSA-N 0.000 description 2
- NVLUIAAXEYPJKZ-UHFFFAOYSA-N ethyl 1-(5-bromopyrimidin-2-yl)-4-methylsulfanylpiperidine-4-carboxylate Chemical compound C1CC(C(=O)OCC)(SC)CCN1C1=NC=C(Br)C=N1 NVLUIAAXEYPJKZ-UHFFFAOYSA-N 0.000 description 2
- SYMHBBUUFZNONP-UHFFFAOYSA-N ethyl 1-(5-bromopyrimidin-2-yl)-4-methylsulfonylpiperidine-4-carboxylate Chemical compound C1CC(C(=O)OCC)(S(C)(=O)=O)CCN1C1=NC=C(Br)C=N1 SYMHBBUUFZNONP-UHFFFAOYSA-N 0.000 description 2
- PHEJRPJQXFMLBV-UHFFFAOYSA-N ethyl 1-(5-bromopyrimidin-2-yl)piperidine-2-carboxylate Chemical compound CCOC(=O)C1CCCCN1C1=NC=C(Br)C=N1 PHEJRPJQXFMLBV-UHFFFAOYSA-N 0.000 description 2
- UTCPYEBJBHYECT-UHFFFAOYSA-N ethyl 1-[(5-bromopyrimidin-2-yl)methyl]-4-methylpiperidine-4-carboxylate Chemical compound C1CC(C(=O)OCC)(C)CCN1CC1=NC=C(Br)C=N1 UTCPYEBJBHYECT-UHFFFAOYSA-N 0.000 description 2
- HNUCAJLBLRXDKH-UHFFFAOYSA-N ethyl 1-[5-[2-(3-ethyl-5-methyl-2-oxo-1,3,5-triazinan-1-yl)-7-(2-methoxyethoxymethyl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylate Chemical compound C1CC(C(=O)OCC)(C)CCN1C1=NC=C(C=2C=C3N=C(SC3=C(COCCOC)C=2)N2C(N(CC)CN(C)C2)=O)C=N1 HNUCAJLBLRXDKH-UHFFFAOYSA-N 0.000 description 2
- ADXAASQQKAANLE-UHFFFAOYSA-N ethyl 1-[5-[2-(3-ethyl-5-methyl-2-oxo-1,3,5-triazinan-1-yl)-7-formyl-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylate Chemical compound C1CC(C(=O)OCC)(C)CCN1C1=NC=C(C=2C=C3N=C(SC3=C(C=O)C=2)N2C(N(CC)CN(C)C2)=O)C=N1 ADXAASQQKAANLE-UHFFFAOYSA-N 0.000 description 2
- JUYWWCNMKSAZPN-UHFFFAOYSA-N ethyl 1-[5-[2-(ethylcarbamoylamino)-7-(pyridine-2-carbonylamino)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylate Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(=O)OCC)=CC=1NC(=O)C1=CC=CC=N1 JUYWWCNMKSAZPN-UHFFFAOYSA-N 0.000 description 2
- VHZIFEQSSFSDAW-UHFFFAOYSA-N ethyl 1-[5-[2-(ethylcarbamoylamino)-7-(pyrimidine-2-carbonylamino)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylate Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(=O)OCC)=CC=1NC(=O)C1=NC=CC=N1 VHZIFEQSSFSDAW-UHFFFAOYSA-N 0.000 description 2
- RDRPADFDBYVBQP-KPGMTVGESA-N ethyl 1-[5-[2-(ethylcarbamoylamino)-7-[(e)-n-methoxy-c-methylcarbonimidoyl]-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylate Chemical compound C=1C(\C(C)=N\OC)=C2SC(NC(=O)NCC)=NC2=CC=1C(C=N1)=CN=C1N1CCC(C)(C(=O)OCC)CC1 RDRPADFDBYVBQP-KPGMTVGESA-N 0.000 description 2
- FHZDQOZTPBGOME-UHFFFAOYSA-N ethyl 1-[5-[2-(ethylcarbamoylamino)-7-[2-(3-methylimidazol-4-yl)ethynyl]-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylate Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(=O)OCC)=CC=1C#CC1=CN=CN1C FHZDQOZTPBGOME-UHFFFAOYSA-N 0.000 description 2
- HDULNEUEZIPKNR-UHFFFAOYSA-N ethyl 1-[5-[2-(ethylcarbamoylamino)-7-[[methyl(pyrimidin-2-yl)amino]methyl]-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylate Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(=O)OCC)=CC=1CN(C)C1=NC=CC=N1 HDULNEUEZIPKNR-UHFFFAOYSA-N 0.000 description 2
- WLGAADGJJBTSQT-UHFFFAOYSA-N ethyl 1-[5-[2-(ethylcarbamoylamino)-7-methyl-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylate Chemical compound C=1C(C)=C2SC(NC(=O)NCC)=NC2=CC=1C(C=N1)=CN=C1N1CCC(C)(C(=O)OCC)CC1 WLGAADGJJBTSQT-UHFFFAOYSA-N 0.000 description 2
- NMCPABJGAIDNHX-UHFFFAOYSA-N ethyl 1-[5-[2-(ethylcarbamoylamino)-7-pyrazin-2-yl-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-prop-2-enylpiperidine-4-carboxylate Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(CC=C)(CC2)C(=O)OCC)=CC=1C1=CN=CC=N1 NMCPABJGAIDNHX-UHFFFAOYSA-N 0.000 description 2
- OZEJMVPPVMIPSS-UHFFFAOYSA-N ethyl 1-[5-[7-(ethylcarbamoyl)-2-(ethylcarbamoylamino)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylate Chemical compound C=1C(C(=O)NCC)=C2SC(NC(=O)NCC)=NC2=CC=1C(C=N1)=CN=C1N1CCC(C)(C(=O)OCC)CC1 OZEJMVPPVMIPSS-UHFFFAOYSA-N 0.000 description 2
- LWPRIDJHEIMKTE-UHFFFAOYSA-N ethyl 1-[5-[7-ethenyl-2-(ethylcarbamoylamino)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylate Chemical compound C=1C(C=C)=C2SC(NC(=O)NCC)=NC2=CC=1C(C=N1)=CN=C1N1CCC(C)(C(=O)OCC)CC1 LWPRIDJHEIMKTE-UHFFFAOYSA-N 0.000 description 2
- WKYFVGXGMAVNHS-UHFFFAOYSA-N ethyl 1-[5-[7-ethyl-2-(ethylcarbamoylamino)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylate Chemical compound C=1C(CC)=C2SC(NC(=O)NCC)=NC2=CC=1C(C=N1)=CN=C1N1CCC(C)(C(=O)OCC)CC1 WKYFVGXGMAVNHS-UHFFFAOYSA-N 0.000 description 2
- IWDBYBSDWPMBDZ-UHFFFAOYSA-N ethyl 2-methyl-3-oxo-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-4h-pyrido[3,2-b][1,4]oxazine-2-carboxylate Chemical compound C=1N=C2NC(=O)C(C(=O)OCC)(C)OC2=CC=1B1OC(C)(C)C(C)(C)O1 IWDBYBSDWPMBDZ-UHFFFAOYSA-N 0.000 description 2
- DBSRQLSGMFNMSQ-UHFFFAOYSA-N ethyl 3-(5-bromopyridin-2-yl)-5-methyl-4h-1,2-oxazole-5-carboxylate Chemical compound O1C(C(=O)OCC)(C)CC(C=2N=CC(Br)=CC=2)=N1 DBSRQLSGMFNMSQ-UHFFFAOYSA-N 0.000 description 2
- HNULXDMNOGMJLB-UHFFFAOYSA-N ethyl 4-(1,3-dioxoisoindol-2-yl)-1-methylcyclohexane-1-carboxylate Chemical compound C1CC(C(=O)OCC)(C)CCC1N1C(=O)C2=CC=CC=C2C1=O HNULXDMNOGMJLB-UHFFFAOYSA-N 0.000 description 2
- VCCAYWSDFKIZEF-UHFFFAOYSA-N ethyl 4-amino-1-methylcyclohexane-1-carboxylate Chemical compound CCOC(=O)C1(C)CCC(N)CC1 VCCAYWSDFKIZEF-UHFFFAOYSA-N 0.000 description 2
- WASRJUXSLHUONH-UHFFFAOYSA-N ethyl 4-aminocyclohexane-1-carboxylate Chemical compound CCOC(=O)C1CCC(N)CC1 WASRJUXSLHUONH-UHFFFAOYSA-N 0.000 description 2
- ZLMPLZLHGNPJTA-UHFFFAOYSA-N ethyl 4-cyanopiperidine-4-carboxylate;hydrochloride Chemical compound Cl.CCOC(=O)C1(C#N)CCNCC1 ZLMPLZLHGNPJTA-UHFFFAOYSA-N 0.000 description 2
- GLLIUWGRMLCKQK-UHFFFAOYSA-N ethyl 4-cyclopropylpiperidine-4-carboxylate;hydrochloride Chemical compound Cl.C1CC1C1(C(=O)OCC)CCNCC1 GLLIUWGRMLCKQK-UHFFFAOYSA-N 0.000 description 2
- YCYKNLGPLYDJJE-UHFFFAOYSA-N ethyl 4-ethyl-1-[5-[2-(ethylcarbamoylamino)-7-formyl-1,3-benzothiazol-5-yl]pyrimidin-2-yl]piperidine-4-carboxylate Chemical compound C=1C(C=O)=C2SC(NC(=O)NCC)=NC2=CC=1C(C=N1)=CN=C1N1CCC(CC)(C(=O)OCC)CC1 YCYKNLGPLYDJJE-UHFFFAOYSA-N 0.000 description 2
- WEJQDOQJHKHPNU-UHFFFAOYSA-N ethyl 4-hydroxypiperidine-4-carboxylate Chemical compound CCOC(=O)C1(O)CCNCC1 WEJQDOQJHKHPNU-UHFFFAOYSA-N 0.000 description 2
- VNHLFUMSWZCORK-UHFFFAOYSA-N ethyl 4-methylsulfanylpiperidine-4-carboxylate;hydrochloride Chemical compound Cl.CCOC(=O)C1(SC)CCNCC1 VNHLFUMSWZCORK-UHFFFAOYSA-N 0.000 description 2
- NSNZUKCRKAXQST-UHFFFAOYSA-N ethyl 4-methylsulfonylpiperidine-4-carboxylate;hydrochloride Chemical compound Cl.CCOC(=O)C1(S(C)(=O)=O)CCNCC1 NSNZUKCRKAXQST-UHFFFAOYSA-N 0.000 description 2
- REMKTWLYWWGNEV-UHFFFAOYSA-N ethyl 4-prop-2-enylpiperidine-4-carboxylate;hydrochloride Chemical compound Cl.CCOC(=O)C1(CC=C)CCNCC1 REMKTWLYWWGNEV-UHFFFAOYSA-N 0.000 description 2
- IUYVWBHQRUQKER-UHFFFAOYSA-N ethyl 7-[2-(ethylcarbamoylamino)-7-pyridin-2-yl-1,3-benzothiazol-5-yl]-2-methyl-3-oxo-4h-pyrido[3,2-b][1,4]oxazine-2-carboxylate Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=C3OC(C)(C(=O)NC3=NC=2)C(=O)OCC)=CC=1C1=CC=CC=N1 IUYVWBHQRUQKER-UHFFFAOYSA-N 0.000 description 2
- YGPAXFFZCMHLTK-UHFFFAOYSA-N ethyl 7-bromo-2-methyl-3-oxo-4h-pyrido[3,2-b][1,4]oxazine-2-carboxylate Chemical compound BrC1=CN=C2NC(=O)C(C(=O)OCC)(C)OC2=C1 YGPAXFFZCMHLTK-UHFFFAOYSA-N 0.000 description 2
- LWGLDXOPXMASKJ-UHFFFAOYSA-N ethyl 7-bromo-5-chloroimidazo[1,2-a]pyridine-2-carboxylate Chemical compound ClC1=CC(Br)=CC2=NC(C(=O)OCC)=CN21 LWGLDXOPXMASKJ-UHFFFAOYSA-N 0.000 description 2
- BDTDECDAHYOJRO-UHFFFAOYSA-N ethyl n-(sulfanylidenemethylidene)carbamate Chemical compound CCOC(=O)N=C=S BDTDECDAHYOJRO-UHFFFAOYSA-N 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 229940124307 fluoroquinolone Drugs 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 229940102223 injectable solution Drugs 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- 125000000842 isoxazolyl group Chemical group 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000012263 liquid product Substances 0.000 description 2
- 229910052744 lithium Inorganic materials 0.000 description 2
- RENRQMCACQEWFC-UGKGYDQZSA-N lnp023 Chemical compound C1([C@H]2N(CC=3C=4C=CNC=4C(C)=CC=3OC)CC[C@@H](C2)OCC)=CC=C(C(O)=O)C=C1 RENRQMCACQEWFC-UGKGYDQZSA-N 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 238000004949 mass spectrometry Methods 0.000 description 2
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 2
- YFMQGYOIFRMLMJ-UHFFFAOYSA-N methyl 1-(5-bromopyrimidin-2-yl)-3-(trifluoromethyl)pyrrolidine-3-carboxylate Chemical compound C1C(C(=O)OC)(C(F)(F)F)CCN1C1=NC=C(Br)C=N1 YFMQGYOIFRMLMJ-UHFFFAOYSA-N 0.000 description 2
- SIMZEKAJFZJWCP-UHFFFAOYSA-N methyl 1-(5-bromopyrimidin-2-yl)-4-[(2-methylpropan-2-yl)oxycarbonylamino]piperidine-4-carboxylate Chemical compound C1CC(C(=O)OC)(NC(=O)OC(C)(C)C)CCN1C1=NC=C(Br)C=N1 SIMZEKAJFZJWCP-UHFFFAOYSA-N 0.000 description 2
- WDSKESLDQBMPLD-UHFFFAOYSA-N methyl 1-(5-bromopyrimidin-2-yl)-4-hydroxy-3-methylpiperidine-3-carboxylate Chemical compound C1CC(O)C(C(=O)OC)(C)CN1C1=NC=C(Br)C=N1 WDSKESLDQBMPLD-UHFFFAOYSA-N 0.000 description 2
- HFQYLMMYIGSJBU-UHFFFAOYSA-N methyl 2,3,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrole-3a-carboxylate Chemical compound C1CCC2CNCC21C(=O)OC HFQYLMMYIGSJBU-UHFFFAOYSA-N 0.000 description 2
- WTBMTSLTOFBBET-UHFFFAOYSA-N methyl 2-(5-bromopyrimidin-2-yl)-1,3,4,5,6,6a-hexahydrocyclopenta[c]pyrrole-3a-carboxylate Chemical compound C1C2(C(=O)OC)CCCC2CN1C1=NC=C(Br)C=N1 WTBMTSLTOFBBET-UHFFFAOYSA-N 0.000 description 2
- DFKYQTUJTMSPII-UHFFFAOYSA-N methyl 2-benzyl-1,3,4,5,6,6a-hexahydrocyclopenta[c]pyrrole-3a-carboxylate Chemical compound C1C2(C(=O)OC)CCCC2CN1CC1=CC=CC=C1 DFKYQTUJTMSPII-UHFFFAOYSA-N 0.000 description 2
- VBMHFZJINCOCDH-UHFFFAOYSA-N methyl 3-(trifluoromethyl)pyrrolidine-3-carboxylate;hydrochloride Chemical compound Cl.COC(=O)C1(C(F)(F)F)CCNC1 VBMHFZJINCOCDH-UHFFFAOYSA-N 0.000 description 2
- XWBFIPVPQLAHMA-UHFFFAOYSA-N methyl 4-[(2-methylpropan-2-yl)oxycarbonylamino]piperidine-4-carboxylate Chemical compound CC(C)(C)OC(=O)NC1(C(=O)OC)CCNCC1 XWBFIPVPQLAHMA-UHFFFAOYSA-N 0.000 description 2
- MCIOJLAJBZGHGI-UHFFFAOYSA-N methyl 4-hydroxy-3-methylpiperidine-3-carboxylate;hydrochloride Chemical compound Cl.COC(=O)C1(C)CNCCC1O MCIOJLAJBZGHGI-UHFFFAOYSA-N 0.000 description 2
- 125000006533 methyl amino methyl group Chemical group [H]N(C([H])([H])[H])C([H])([H])* 0.000 description 2
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 2
- BQNSIPJDOWWKNQ-UHFFFAOYSA-N n-(4-bromo-3-fluoro-2-nitro-6-pyridin-2-ylphenyl)-2,2-dimethylpropanamide Chemical compound C1=C(Br)C(F)=C([N+]([O-])=O)C(NC(=O)C(C)(C)C)=C1C1=CC=CC=N1 BQNSIPJDOWWKNQ-UHFFFAOYSA-N 0.000 description 2
- IYYHGHQCLDLPHB-UHFFFAOYSA-N n-(4-bromo-5-fluoro-2-pyridin-2-ylphenyl)-2,2-dimethylpropanamide Chemical compound CC(C)(C)C(=O)NC1=CC(F)=C(Br)C=C1C1=CC=CC=N1 IYYHGHQCLDLPHB-UHFFFAOYSA-N 0.000 description 2
- JDMOBPVQUSTBRF-UHFFFAOYSA-N n-(5-fluoro-2-pyridin-2-ylphenyl)-2,2-dimethylpropanamide Chemical compound CC(C)(C)C(=O)NC1=CC(F)=CC=C1C1=CC=CC=N1 JDMOBPVQUSTBRF-UHFFFAOYSA-N 0.000 description 2
- PUHSWGKSQUHSDT-UHFFFAOYSA-N n-[(2,6-dibromopyridin-4-yl)carbamothioyl]benzamide Chemical compound BrC1=NC(Br)=CC(NC(=S)NC(=O)C=2C=CC=CC=2)=C1 PUHSWGKSQUHSDT-UHFFFAOYSA-N 0.000 description 2
- WQLPHGABHNNMTL-UHFFFAOYSA-N n-[(3-bromo-5-phenylmethoxyphenyl)carbamothioyl]benzamide Chemical compound C=1C(OCC=2C=CC=CC=2)=CC(Br)=CC=1NC(=S)NC(=O)C1=CC=CC=C1 WQLPHGABHNNMTL-UHFFFAOYSA-N 0.000 description 2
- VHDOMZSBOGQSMO-UHFFFAOYSA-N n-[5-fluoro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-2,2-dimethylpropanamide Chemical compound CC(C)(C)C(=O)NC1=CC(F)=CC=C1B1OC(C)(C)C(C)(C)O1 VHDOMZSBOGQSMO-UHFFFAOYSA-N 0.000 description 2
- GEHDCVXPBUTGAR-UHFFFAOYSA-N n-ethyl-2-(ethylcarbamoylamino)-5-hydroxy-1,3-benzothiazole-7-carboxamide Chemical compound OC1=CC(C(=O)NCC)=C2SC(NC(=O)NCC)=NC2=C1 GEHDCVXPBUTGAR-UHFFFAOYSA-N 0.000 description 2
- QNLZQGYGAFQUAF-UHFFFAOYSA-N n-ethyl-2-(ethylcarbamoylamino)-5-methoxy-1,3-benzothiazole-7-carboxamide Chemical compound COC1=CC(C(=O)NCC)=C2SC(NC(=O)NCC)=NC2=C1 QNLZQGYGAFQUAF-UHFFFAOYSA-N 0.000 description 2
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 2
- IOMMMLWIABWRKL-WUTDNEBXSA-N nazartinib Chemical compound C1N(C(=O)/C=C/CN(C)C)CCCC[C@H]1N1C2=C(Cl)C=CC=C2N=C1NC(=O)C1=CC=NC(C)=C1 IOMMMLWIABWRKL-WUTDNEBXSA-N 0.000 description 2
- 229910017604 nitric acid Inorganic materials 0.000 description 2
- 239000000346 nonvolatile oil Substances 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 229960002969 oleic acid Drugs 0.000 description 2
- PIDFDZJZLOTZTM-KHVQSSSXSA-N ombitasvir Chemical compound COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)NC1=CC=C([C@H]2N([C@@H](CC2)C=2C=CC(NC(=O)[C@H]3N(CCC3)C(=O)[C@@H](NC(=O)OC)C(C)C)=CC=2)C=2C=CC(=CC=2)C(C)(C)C)C=C1 PIDFDZJZLOTZTM-KHVQSSSXSA-N 0.000 description 2
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 2
- 125000003544 oxime group Chemical group 0.000 description 2
- LXNAVEXFUKBNMK-UHFFFAOYSA-N palladium(II) acetate Substances [Pd].CC(O)=O.CC(O)=O LXNAVEXFUKBNMK-UHFFFAOYSA-N 0.000 description 2
- 235000003270 potassium fluoride Nutrition 0.000 description 2
- TVDSBUOJIPERQY-UHFFFAOYSA-N prop-2-yn-1-ol Chemical compound OCC#C TVDSBUOJIPERQY-UHFFFAOYSA-N 0.000 description 2
- 125000002098 pyridazinyl group Chemical group 0.000 description 2
- 125000004527 pyrimidin-4-yl group Chemical group N1=CN=C(C=C1)* 0.000 description 2
- 125000000168 pyrrolyl group Chemical group 0.000 description 2
- 150000007660 quinolones Chemical class 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 238000004366 reverse phase liquid chromatography Methods 0.000 description 2
- 238000004007 reversed phase HPLC Methods 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 239000012047 saturated solution Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 235000010378 sodium ascorbate Nutrition 0.000 description 2
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 description 2
- 229960005055 sodium ascorbate Drugs 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 2
- 239000012265 solid product Substances 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 239000013077 target material Substances 0.000 description 2
- DYHSDKLCOJIUFX-UHFFFAOYSA-N tert-butoxycarbonyl anhydride Chemical compound CC(C)(C)OC(=O)OC(=O)OC(C)(C)C DYHSDKLCOJIUFX-UHFFFAOYSA-N 0.000 description 2
- 239000012414 tert-butyl nitrite Substances 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- PBIMIGNDTBRRPI-UHFFFAOYSA-N trifluoro borate Chemical compound FOB(OF)OF PBIMIGNDTBRRPI-UHFFFAOYSA-N 0.000 description 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 2
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 2
- 239000003981 vehicle Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 1
- XPYLJGVHPLMDHY-UHFFFAOYSA-N (2,3,5-tribromo-4-methoxyphenyl)thiourea Chemical compound COC1=C(Br)C=C(NC(N)=S)C(Br)=C1Br XPYLJGVHPLMDHY-UHFFFAOYSA-N 0.000 description 1
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 1
- 125000006583 (C1-C3) haloalkyl group Chemical group 0.000 description 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 description 1
- 125000000171 (C1-C6) haloalkyl group Chemical group 0.000 description 1
- FZENGILVLUJGJX-NSCUHMNNSA-N (E)-acetaldehyde oxime Chemical compound C\C=N\O FZENGILVLUJGJX-NSCUHMNNSA-N 0.000 description 1
- XUBOMFCQGDBHNK-JTQLQIEISA-N (S)-gatifloxacin Chemical compound FC1=CC(C(C(C(O)=O)=CN2C3CC3)=O)=C2C(OC)=C1N1CCN[C@@H](C)C1 XUBOMFCQGDBHNK-JTQLQIEISA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- UWYVPFMHMJIBHE-OWOJBTEDSA-N (e)-2-hydroxybut-2-enedioic acid Chemical compound OC(=O)\C=C(\O)C(O)=O UWYVPFMHMJIBHE-OWOJBTEDSA-N 0.000 description 1
- SRKGZXIJDGWVAI-GVAVTCRGSA-M (e,3r)-7-[6-tert-butyl-4-(4-fluorophenyl)-2-propan-2-ylpyridin-3-yl]-3,5-dihydroxyhept-6-enoate Chemical compound CC(C)C1=NC(C(C)(C)C)=CC(C=2C=CC(F)=CC=2)=C1\C=C\C(O)C[C@@H](O)CC([O-])=O SRKGZXIJDGWVAI-GVAVTCRGSA-M 0.000 description 1
- UKAUYVFTDYCKQA-UHFFFAOYSA-N -2-Amino-4-hydroxybutanoic acid Natural products OC(=O)C(N)CCO UKAUYVFTDYCKQA-UHFFFAOYSA-N 0.000 description 1
- ZXMGHDIOOHOAAE-UHFFFAOYSA-N 1,1,1-trifluoro-n-(trifluoromethylsulfonyl)methanesulfonamide Chemical compound FC(F)(F)S(=O)(=O)NS(=O)(=O)C(F)(F)F ZXMGHDIOOHOAAE-UHFFFAOYSA-N 0.000 description 1
- APQIUTYORBAGEZ-UHFFFAOYSA-N 1,1-dibromoethane Chemical compound CC(Br)Br APQIUTYORBAGEZ-UHFFFAOYSA-N 0.000 description 1
- 125000001399 1,2,3-triazolyl group Chemical group N1N=NC(=C1)* 0.000 description 1
- 125000001376 1,2,4-triazolyl group Chemical group N1N=C(N=C1)* 0.000 description 1
- HGSZQBRMZNHXJZ-UHFFFAOYSA-N 1,3-benzothiazole-2,5-diamine Chemical compound NC1=CC=C2SC(N)=NC2=C1 HGSZQBRMZNHXJZ-UHFFFAOYSA-N 0.000 description 1
- RAIPHJJURHTUIC-UHFFFAOYSA-N 1,3-thiazol-2-amine Chemical compound NC1=NC=CS1 RAIPHJJURHTUIC-UHFFFAOYSA-N 0.000 description 1
- VMSULLWOZGMHHT-UHFFFAOYSA-N 1-(5,7-dibromo-1,3-benzoxazol-2-yl)-3-ethylurea Chemical compound BrC1=CC(Br)=C2OC(NC(=O)NCC)=NC2=C1 VMSULLWOZGMHHT-UHFFFAOYSA-N 0.000 description 1
- RFKRDPYHZJVHEY-UHFFFAOYSA-N 1-(5-bromopyrimidin-2-yl)-4-hydroxypiperidine-4-carboxylic acid Chemical compound C1CC(C(=O)O)(O)CCN1C1=NC=C(Br)C=N1 RFKRDPYHZJVHEY-UHFFFAOYSA-N 0.000 description 1
- DCGXHMAFIVXRDZ-UHFFFAOYSA-N 1-(7-acetyl-5-phenylmethoxy-1,3-benzothiazol-2-yl)-3-ethylurea Chemical compound C=1C(C(C)=O)=C2SC(NC(=O)NCC)=NC2=CC=1OCC1=CC=CC=C1 DCGXHMAFIVXRDZ-UHFFFAOYSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- FOLUJVXYMKGLHI-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-7-pyridin-2-yl-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-[(2-methylpropan-2-yl)oxycarbonylamino]piperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(CC2)(NC(=O)OC(C)(C)C)C(O)=O)=CC=1C1=CC=CC=N1 FOLUJVXYMKGLHI-UHFFFAOYSA-N 0.000 description 1
- CYYKTHUFSMHJEP-UHFFFAOYSA-N 1-[5-[7-borono-2-(ethylcarbamoylamino)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-ethylpiperidine-4-carboxylic acid Chemical compound C=1C(B(O)O)=C2SC(NC(=O)NCC)=NC2=CC=1C(C=N1)=CN=C1N1CCC(CC)(C(O)=O)CC1 CYYKTHUFSMHJEP-UHFFFAOYSA-N 0.000 description 1
- OVQAJYCAXPHYNV-UHFFFAOYSA-N 1-benzyl-3-methylpiperidin-4-one Chemical compound C1CC(=O)C(C)CN1CC1=CC=CC=C1 OVQAJYCAXPHYNV-UHFFFAOYSA-N 0.000 description 1
- SQZXLXJCTKIWBA-UHFFFAOYSA-N 1-benzyl-3-methylpiperidine-4-carbonitrile Chemical compound C1CC(C#N)C(C)CN1CC1=CC=CC=C1 SQZXLXJCTKIWBA-UHFFFAOYSA-N 0.000 description 1
- WHSFFWOFTHUWPA-UHFFFAOYSA-N 1-benzyl-3-methylpiperidine-4-carboxylic acid Chemical compound C1CC(C(O)=O)C(C)CN1CC1=CC=CC=C1 WHSFFWOFTHUWPA-UHFFFAOYSA-N 0.000 description 1
- VFWCMGCRMGJXDK-UHFFFAOYSA-N 1-chlorobutane Chemical compound CCCCCl VFWCMGCRMGJXDK-UHFFFAOYSA-N 0.000 description 1
- NKSHEPVIIYJIIJ-UHFFFAOYSA-N 1-ethyl-3-(5-hydroxy-7-pyridin-2-yl-1,3-benzothiazol-2-yl)urea Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(O)=CC=1C1=CC=CC=N1 NKSHEPVIIYJIIJ-UHFFFAOYSA-N 0.000 description 1
- POSKTELTRWAJSU-ZMOGYAJESA-N 1-ethyl-3-[7-[(e)-n-methoxy-c-methylcarbonimidoyl]-5-phenylmethoxy-1,3-benzothiazol-2-yl]urea Chemical compound C=1C(\C(C)=N\OC)=C2SC(NC(=O)NCC)=NC2=CC=1OCC1=CC=CC=C1 POSKTELTRWAJSU-ZMOGYAJESA-N 0.000 description 1
- YMFJXYNWLGUMEW-UHFFFAOYSA-N 1-o-tert-butyl 4-o-ethyl 4-cyclopropylpiperidine-1,4-dicarboxylate Chemical compound C1CC1C1(C(=O)OCC)CCN(C(=O)OC(C)(C)C)CC1 YMFJXYNWLGUMEW-UHFFFAOYSA-N 0.000 description 1
- JVSFQJZRHXAUGT-UHFFFAOYSA-N 2,2-dimethylpropanoyl chloride Chemical compound CC(C)(C)C(Cl)=O JVSFQJZRHXAUGT-UHFFFAOYSA-N 0.000 description 1
- OFFVYRQUDQVBNC-UHFFFAOYSA-N 2,3,5,6-tetrabromo-4-methoxyaniline Chemical compound COC1=C(Br)C(Br)=C(N)C(Br)=C1Br OFFVYRQUDQVBNC-UHFFFAOYSA-N 0.000 description 1
- GBBSAMQTQCPOBF-UHFFFAOYSA-N 2,4,6-trimethyl-1,3,5,2,4,6-trioxatriborinane Chemical compound CB1OB(C)OB(C)O1 GBBSAMQTQCPOBF-UHFFFAOYSA-N 0.000 description 1
- MKEJZKKVVUZXIS-UHFFFAOYSA-N 2,4-dibromo-1,3-thiazole Chemical compound BrC1=CSC(Br)=N1 MKEJZKKVVUZXIS-UHFFFAOYSA-N 0.000 description 1
- LXQOQPGNCGEELI-UHFFFAOYSA-N 2,4-dinitroaniline Chemical compound NC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O LXQOQPGNCGEELI-UHFFFAOYSA-N 0.000 description 1
- XIBIQFJKUZZLLX-UHFFFAOYSA-N 2,5-dibromo-1,3-thiazole Chemical compound BrC1=CN=C(Br)S1 XIBIQFJKUZZLLX-UHFFFAOYSA-N 0.000 description 1
- DOPJTDJKZNWLRB-UHFFFAOYSA-N 2-Amino-5-nitrophenol Chemical compound NC1=CC=C([N+]([O-])=O)C=C1O DOPJTDJKZNWLRB-UHFFFAOYSA-N 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- LBLYYCQCTBFVLH-UHFFFAOYSA-N 2-Methylbenzenesulfonic acid Chemical compound CC1=CC=CC=C1S(O)(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-N 0.000 description 1
- FLVDBDRWWRSJDX-UHFFFAOYSA-N 2-[(5-bromopyrimidin-2-yl)amino]propane-1,3-diol Chemical compound OCC(CO)NC1=NC=C(Br)C=N1 FLVDBDRWWRSJDX-UHFFFAOYSA-N 0.000 description 1
- YQADLKDQAXAIKW-UHFFFAOYSA-N 2-amino-5-bromopyridin-3-ol Chemical compound NC1=NC=C(Br)C=C1O YQADLKDQAXAIKW-UHFFFAOYSA-N 0.000 description 1
- KJJPLEZQSCZCKE-UHFFFAOYSA-N 2-aminopropane-1,3-diol Chemical compound OCC(N)CO KJJPLEZQSCZCKE-UHFFFAOYSA-N 0.000 description 1
- FWTXFEKVHSFTDQ-UHFFFAOYSA-N 2-bromo-5-fluoroaniline Chemical compound NC1=CC(F)=CC=C1Br FWTXFEKVHSFTDQ-UHFFFAOYSA-N 0.000 description 1
- KMODISUYWZPVGV-UHFFFAOYSA-N 2-bromo-6-methoxypyridine Chemical compound COC1=CC=CC(Br)=N1 KMODISUYWZPVGV-UHFFFAOYSA-N 0.000 description 1
- IMRWILPUOVGIMU-UHFFFAOYSA-N 2-bromopyridine Chemical compound BrC1=CC=CC=N1 IMRWILPUOVGIMU-UHFFFAOYSA-N 0.000 description 1
- MZVSTDHRRYQFGI-UHFFFAOYSA-N 2-chloro-4-methylpyridine Chemical compound CC1=CC=NC(Cl)=C1 MZVSTDHRRYQFGI-UHFFFAOYSA-N 0.000 description 1
- GELVZYOEQVJIRR-UHFFFAOYSA-N 2-chloropyrazine Chemical compound ClC1=CN=CC=N1 GELVZYOEQVJIRR-UHFFFAOYSA-N 0.000 description 1
- UNCQVRBWJWWJBF-UHFFFAOYSA-N 2-chloropyrimidine Chemical compound ClC1=NC=CC=N1 UNCQVRBWJWWJBF-UHFFFAOYSA-N 0.000 description 1
- 125000006176 2-ethylbutyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(C([H])([H])*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- CFMZSMGAMPBRBE-UHFFFAOYSA-N 2-hydroxyisoindole-1,3-dione Chemical compound C1=CC=C2C(=O)N(O)C(=O)C2=C1 CFMZSMGAMPBRBE-UHFFFAOYSA-N 0.000 description 1
- 125000004493 2-methylbut-1-yl group Chemical group CC(C*)CC 0.000 description 1
- 125000005916 2-methylpentyl group Chemical group 0.000 description 1
- WLJVXDMOQOGPHL-PPJXEINESA-N 2-phenylacetic acid Chemical compound O[14C](=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-PPJXEINESA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- SOSPMXMEOFGPIM-UHFFFAOYSA-N 3,5-dibromopyridine Chemical compound BrC1=CN=CC(Br)=C1 SOSPMXMEOFGPIM-UHFFFAOYSA-N 0.000 description 1
- CEUHPOVLEQUFCC-UHFFFAOYSA-N 3,5-dichloro-1,2,4-thiadiazole Chemical compound ClC1=NSC(Cl)=N1 CEUHPOVLEQUFCC-UHFFFAOYSA-N 0.000 description 1
- JHUUPUMBZGWODW-UHFFFAOYSA-N 3,6-dihydro-1,2-dioxine Chemical compound C1OOCC=C1 JHUUPUMBZGWODW-UHFFFAOYSA-N 0.000 description 1
- KFQQSQRBEGPQEA-UHFFFAOYSA-N 3-(carbamothioylamino)-5-methoxybenzoic acid Chemical compound COC1=CC(NC(N)=S)=CC(C(O)=O)=C1 KFQQSQRBEGPQEA-UHFFFAOYSA-N 0.000 description 1
- VEUBBZBEISLEIY-UHFFFAOYSA-N 3-(trifluoromethyl)pyrrolidine-3-carboxylic acid Chemical compound OC(=O)C1(C(F)(F)F)CCNC1 VEUBBZBEISLEIY-UHFFFAOYSA-N 0.000 description 1
- BRMWTNUJHUMWMS-UHFFFAOYSA-N 3-Methylhistidine Natural products CN1C=NC(CC(N)C(O)=O)=C1 BRMWTNUJHUMWMS-UHFFFAOYSA-N 0.000 description 1
- DBEMTZANGFGKMX-UHFFFAOYSA-N 3-amino-5-methoxybenzoic acid Chemical compound COC1=CC(N)=CC(C(O)=O)=C1 DBEMTZANGFGKMX-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- 125000005917 3-methylpentyl group Chemical group 0.000 description 1
- 125000001963 4 membered heterocyclic group Chemical group 0.000 description 1
- AGJMDETXSYICGZ-UHFFFAOYSA-N 4,6-dichloropyridin-2-amine Chemical compound NC1=CC(Cl)=CC(Cl)=N1 AGJMDETXSYICGZ-UHFFFAOYSA-N 0.000 description 1
- BGRHKAAVXJAPGP-UHFFFAOYSA-N 4-[(2-methylpropan-2-yl)oxycarbonylamino]-1-phenylmethoxycarbonylpiperidine-4-carboxylic acid Chemical compound C1CC(NC(=O)OC(C)(C)C)(C(O)=O)CCN1C(=O)OCC1=CC=CC=C1 BGRHKAAVXJAPGP-UHFFFAOYSA-N 0.000 description 1
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 1
- CZMDWZPSXYKKPY-UHFFFAOYSA-N 4-amino-1-[5-[2-(ethylcarbamoylamino)-7-pyridin-2-yl-1,3-benzothiazol-5-yl]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(N)(CC2)C(O)=O)=CC=1C1=CC=CC=N1 CZMDWZPSXYKKPY-UHFFFAOYSA-N 0.000 description 1
- HTKGGRAYKFMAGW-UHFFFAOYSA-N 4-amino-1-[5-[2-(ethylcarbamoylamino)-7-pyridin-2-yl-1,3-benzothiazol-5-yl]pyrimidin-2-yl]piperidine-4-carboxylic acid;hydrochloride Chemical compound Cl.C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(N)(CC2)C(O)=O)=CC=1C1=CC=CC=N1 HTKGGRAYKFMAGW-UHFFFAOYSA-N 0.000 description 1
- HFYPXERYZGFDBD-UHFFFAOYSA-N 4-amino-2,6-dibromophenol Chemical compound NC1=CC(Br)=C(O)C(Br)=C1 HFYPXERYZGFDBD-UHFFFAOYSA-N 0.000 description 1
- DRNGLYHKYPNTEA-UHFFFAOYSA-N 4-azaniumylcyclohexane-1-carboxylate Chemical compound NC1CCC(C(O)=O)CC1 DRNGLYHKYPNTEA-UHFFFAOYSA-N 0.000 description 1
- PTPTZLXZHPPVKG-UHFFFAOYSA-N 4-bromo-2-fluoropyridine Chemical compound FC1=CC(Br)=CC=N1 PTPTZLXZHPPVKG-UHFFFAOYSA-N 0.000 description 1
- IVBVKTPDEWDNRW-UHFFFAOYSA-N 4-bromooxane Chemical compound BrC1CCOCC1 IVBVKTPDEWDNRW-UHFFFAOYSA-N 0.000 description 1
- KXHPZYVKCDTIHE-UHFFFAOYSA-N 4-bromopyridine-2,6-diamine Chemical compound NC1=CC(Br)=CC(N)=N1 KXHPZYVKCDTIHE-UHFFFAOYSA-N 0.000 description 1
- NHMLZGFOEYLZEN-UHFFFAOYSA-N 4-chloro-1h-pyridazin-6-one Chemical compound ClC=1C=NNC(=O)C=1 NHMLZGFOEYLZEN-UHFFFAOYSA-N 0.000 description 1
- LCNYQNVPJCXVMP-UHFFFAOYSA-N 4-fluoropiperidine-4-carboxylic acid;hydrochloride Chemical compound Cl.OC(=O)C1(F)CCNCC1 LCNYQNVPJCXVMP-UHFFFAOYSA-N 0.000 description 1
- 125000004203 4-hydroxyphenyl group Chemical group [H]OC1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- YORPCQSBLZIBKP-UHFFFAOYSA-N 4-methylpiperidin-1-ium-4-carboxylate Chemical compound OC(=O)C1(C)CCNCC1 YORPCQSBLZIBKP-UHFFFAOYSA-N 0.000 description 1
- GGMOJYOORZQAFB-UHFFFAOYSA-N 4-methylpiperidine-4-carboxylic acid;hydrochloride Chemical compound Cl.OC(=O)C1(C)CCNCC1 GGMOJYOORZQAFB-UHFFFAOYSA-N 0.000 description 1
- DMCVVFIWYIKAEJ-UHFFFAOYSA-N 4-phenylpiperidine-4-carbonitrile Chemical compound C=1C=CC=CC=1C1(C#N)CCNCC1 DMCVVFIWYIKAEJ-UHFFFAOYSA-N 0.000 description 1
- FXYIDUGIODSYAI-UHFFFAOYSA-N 5,7-dibromo-1,3-benzoxazol-2-amine Chemical compound BrC1=CC(Br)=C2OC(N)=NC2=C1 FXYIDUGIODSYAI-UHFFFAOYSA-N 0.000 description 1
- OEKXUEWGXWCENG-UHFFFAOYSA-N 5-bromo-2-chloro-3-fluoropyridine Chemical compound FC1=CC(Br)=CN=C1Cl OEKXUEWGXWCENG-UHFFFAOYSA-N 0.000 description 1
- NEDJTEXNSTUKHW-UHFFFAOYSA-N 5-bromo-2-methylpyrimidine Chemical compound CC1=NC=C(Br)C=N1 NEDJTEXNSTUKHW-UHFFFAOYSA-N 0.000 description 1
- IDDNIGSLIWGZNV-UHFFFAOYSA-N 5-bromo-N-hydroxypyridine-2-carboximidoyl chloride Chemical compound ON=C(Cl)C1=CC=C(Br)C=N1 IDDNIGSLIWGZNV-UHFFFAOYSA-N 0.000 description 1
- ZQVLPMNLLKGGIU-UHFFFAOYSA-N 5-bromopyridine-2-carbaldehyde Chemical compound BrC1=CC=C(C=O)N=C1 ZQVLPMNLLKGGIU-UHFFFAOYSA-N 0.000 description 1
- XGPTXUYKEDPXCO-UHFFFAOYSA-N 5-bromopyrimidine-2-carboxylic acid Chemical compound OC(=O)C1=NC=C(Br)C=N1 XGPTXUYKEDPXCO-UHFFFAOYSA-N 0.000 description 1
- JFOSWQQRTHDTGG-UHFFFAOYSA-N 5-ethynyl-1-methylimidazole Chemical compound CN1C=NC=C1C#C JFOSWQQRTHDTGG-UHFFFAOYSA-N 0.000 description 1
- IJRKLHTZAIFUTB-UHFFFAOYSA-N 5-nitro-2-(2-phenylethylamino)benzoic acid Chemical compound OC(=O)C1=CC([N+]([O-])=O)=CC=C1NCCC1=CC=CC=C1 IJRKLHTZAIFUTB-UHFFFAOYSA-N 0.000 description 1
- KZHGPDSVHSDCMX-UHFFFAOYSA-N 6-methoxy-1,3-benzothiazol-2-amine Chemical compound COC1=CC=C2N=C(N)SC2=C1 KZHGPDSVHSDCMX-UHFFFAOYSA-N 0.000 description 1
- 125000003341 7 membered heterocyclic group Chemical group 0.000 description 1
- YPRXXWWNYKXJRI-UHFFFAOYSA-N 7-bromo-1,3-benzothiazole-2,5-diamine Chemical compound NC1=CC(Br)=C2SC(N)=NC2=C1 YPRXXWWNYKXJRI-UHFFFAOYSA-N 0.000 description 1
- 108091006112 ATPases Proteins 0.000 description 1
- 102000057290 Adenosine Triphosphatases Human genes 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- PUNWRBDLVUREHU-UHFFFAOYSA-N BrC1=C(C=C(C=C1)F)C=1C(=C(C=CC=1)NC(C(C)(C)C)=O)F Chemical compound BrC1=C(C=C(C=C1)F)C=1C(=C(C=CC=1)NC(C(C)(C)C)=O)F PUNWRBDLVUREHU-UHFFFAOYSA-N 0.000 description 1
- LSUUXPUZPKFURR-UHFFFAOYSA-N BrC1=CC(=CC=2N=C(SC21)NC(=O)NCC)C=2C=NC(=NC2)N2CCC(CC2)C Chemical compound BrC1=CC(=CC=2N=C(SC21)NC(=O)NCC)C=2C=NC(=NC2)N2CCC(CC2)C LSUUXPUZPKFURR-UHFFFAOYSA-N 0.000 description 1
- PLSCKZJJWHCRQR-UHFFFAOYSA-M Br[Zn]C1CCOCC1 Chemical compound Br[Zn]C1CCOCC1 PLSCKZJJWHCRQR-UHFFFAOYSA-M 0.000 description 1
- LMUWNCPJGVMEPH-UHFFFAOYSA-N C(C)(C)(C)OC(=O)NC1CCN(CC1)C1=NC=C(C=N1)C=1C=C(C2=C(N=C(S2)NC(=O)NCC)C1)C1=NC=CC=C1 Chemical compound C(C)(C)(C)OC(=O)NC1CCN(CC1)C1=NC=C(C=N1)C=1C=C(C2=C(N=C(S2)NC(=O)NCC)C1)C1=NC=CC=C1 LMUWNCPJGVMEPH-UHFFFAOYSA-N 0.000 description 1
- LWBFALFBXNHOCA-UHFFFAOYSA-N C(C)C1(CCN(CC1)C(=O)OC(C)(C)C)C(=O)O.C1(CC1)C1(CCN(CC1)C(=O)OC(C)(C)C)C(=O)OCC Chemical compound C(C)C1(CCN(CC1)C(=O)OC(C)(C)C)C(=O)O.C1(CC1)C1(CCN(CC1)C(=O)OC(C)(C)C)C(=O)OCC LWBFALFBXNHOCA-UHFFFAOYSA-N 0.000 description 1
- DQQWRSKZZGPSQL-UHFFFAOYSA-N C(C)C1N(CCC(C1)C)C1=NC=C(C=N1)C1=CC2=C(C(=N1)C1=NC=CC=C1)SC(=N2)NC(=O)NCC Chemical compound C(C)C1N(CCC(C1)C)C1=NC=C(C=N1)C1=CC2=C(C(=N1)C1=NC=CC=C1)SC(=N2)NC(=O)NCC DQQWRSKZZGPSQL-UHFFFAOYSA-N 0.000 description 1
- LRAZNWANMDJJKH-UHFFFAOYSA-N C(C)C1N(CCC(C1)C)C1=NC=C(C=N1)C=1C=C(C2=C(N=C(S2)NC(NCC)=O)C1)Br Chemical compound C(C)C1N(CCC(C1)C)C1=NC=C(C=N1)C=1C=C(C2=C(N=C(S2)NC(NCC)=O)C1)Br LRAZNWANMDJJKH-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical group [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 229910021590 Copper(II) bromide Inorganic materials 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000495778 Escherichia faecalis Species 0.000 description 1
- XXRCUYVCPSWGCC-UHFFFAOYSA-N Ethyl pyruvate Chemical compound CCOC(=O)C(C)=O XXRCUYVCPSWGCC-UHFFFAOYSA-N 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 102000020897 Formins Human genes 0.000 description 1
- 108091022623 Formins Proteins 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 229940127266 GyrB and ParE Drugs 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- LCWXJXMHJVIJFK-UHFFFAOYSA-N Hydroxylysine Natural products NCC(O)CC(N)CC(O)=O LCWXJXMHJVIJFK-UHFFFAOYSA-N 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- 108090000769 Isomerases Proteins 0.000 description 1
- 102000004195 Isomerases Human genes 0.000 description 1
- SNDPXSYFESPGGJ-BYPYZUCNSA-N L-2-aminopentanoic acid Chemical compound CCC[C@H](N)C(O)=O SNDPXSYFESPGGJ-BYPYZUCNSA-N 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- FFFHZYDWPBMWHY-VKHMYHEASA-N L-homocysteine Chemical compound OC(=O)[C@@H](N)CCS FFFHZYDWPBMWHY-VKHMYHEASA-N 0.000 description 1
- UKAUYVFTDYCKQA-VKHMYHEASA-N L-homoserine Chemical compound OC(=O)[C@@H](N)CCO UKAUYVFTDYCKQA-VKHMYHEASA-N 0.000 description 1
- UCUNFLYVYCGDHP-BYPYZUCNSA-N L-methionine sulfone Chemical compound CS(=O)(=O)CC[C@H](N)C(O)=O UCUNFLYVYCGDHP-BYPYZUCNSA-N 0.000 description 1
- SNDPXSYFESPGGJ-UHFFFAOYSA-N L-norVal-OH Natural products CCCC(N)C(O)=O SNDPXSYFESPGGJ-UHFFFAOYSA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- JDHILDINMRGULE-LURJTMIESA-N N(pros)-methyl-L-histidine Chemical compound CN1C=NC=C1C[C@H](N)C(O)=O JDHILDINMRGULE-LURJTMIESA-N 0.000 description 1
- YWDDJRVQIHUDGK-UHFFFAOYSA-N NC1=CC(Br)=CC2=NC(C(O)=O)=CN12 Chemical compound NC1=CC(Br)=CC2=NC(C(O)=O)=CN12 YWDDJRVQIHUDGK-UHFFFAOYSA-N 0.000 description 1
- RHGKLRLOHDJJDR-UHFFFAOYSA-N Ndelta-carbamoyl-DL-ornithine Natural products OC(=O)C(N)CCCNC(N)=O RHGKLRLOHDJJDR-UHFFFAOYSA-N 0.000 description 1
- YJQPYGGHQPGBLI-UHFFFAOYSA-N Novobiocin Natural products O1C(C)(C)C(OC)C(OC(N)=O)C(O)C1OC1=CC=C(C(O)=C(NC(=O)C=2C=C(CC=C(C)C)C(O)=CC=2)C(=O)O2)C2=C1C YJQPYGGHQPGBLI-UHFFFAOYSA-N 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- LGRFSURHDFAFJT-UHFFFAOYSA-N Phthalic anhydride Natural products C1=CC=C2C(=O)OC(=O)C2=C1 LGRFSURHDFAFJT-UHFFFAOYSA-N 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 241000288906 Primates Species 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical class [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 241000295644 Staphylococcaceae Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- OKJPEAGHQZHRQV-UHFFFAOYSA-N Triiodomethane Natural products IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 description 1
- VNDYJBBGRKZCSX-UHFFFAOYSA-L Zinc bromide Inorganic materials Br[Zn]Br VNDYJBBGRKZCSX-UHFFFAOYSA-L 0.000 description 1
- LJOOWESTVASNOG-UFJKPHDISA-N [(1s,3r,4ar,7s,8s,8as)-3-hydroxy-8-[2-[(4r)-4-hydroxy-6-oxooxan-2-yl]ethyl]-7-methyl-1,2,3,4,4a,7,8,8a-octahydronaphthalen-1-yl] (2s)-2-methylbutanoate Chemical compound C([C@H]1[C@@H](C)C=C[C@H]2C[C@@H](O)C[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)CC1C[C@@H](O)CC(=O)O1 LJOOWESTVASNOG-UFJKPHDISA-N 0.000 description 1
- WTIJXIZOODAMJT-WBACWINTSA-N [(3r,4s,5r,6s)-5-hydroxy-6-[4-hydroxy-3-[[5-[[4-hydroxy-7-[(2s,3r,4s,5r)-3-hydroxy-5-methoxy-6,6-dimethyl-4-(5-methyl-1h-pyrrole-2-carbonyl)oxyoxan-2-yl]oxy-8-methyl-2-oxochromen-3-yl]carbamoyl]-4-methyl-1h-pyrrole-3-carbonyl]amino]-8-methyl-2-oxochromen- Chemical compound O([C@@H]1[C@H](C(O[C@H](OC=2C(=C3OC(=O)C(NC(=O)C=4C(=C(C(=O)NC=5C(OC6=C(C)C(O[C@@H]7[C@@H]([C@H](OC(=O)C=8NC(C)=CC=8)[C@@H](OC)C(C)(C)O7)O)=CC=C6C=5O)=O)NC=4)C)=C(O)C3=CC=2)C)[C@@H]1O)(C)C)OC)C(=O)C1=CC=C(C)N1 WTIJXIZOODAMJT-WBACWINTSA-N 0.000 description 1
- JAKDZHBBTWYAKG-UHFFFAOYSA-N [5-[2-(4-ethoxycarbonyl-4-methylpiperidin-1-yl)pyrimidin-5-yl]-2-(ethylcarbamoylamino)-1,3-benzothiazol-7-yl]boronic acid Chemical compound C=1C(B(O)O)=C2SC(NC(=O)NCC)=NC2=CC=1C(C=N1)=CN=C1N1CCC(C)(C(=O)OCC)CC1 JAKDZHBBTWYAKG-UHFFFAOYSA-N 0.000 description 1
- QFYKHWFHKLUGAV-UHFFFAOYSA-N [Mg]C1CCCCC1 Chemical compound [Mg]C1CCCCC1 QFYKHWFHKLUGAV-UHFFFAOYSA-N 0.000 description 1
- MNZMECMQTYGSOI-UHFFFAOYSA-N acetic acid;hydron;bromide Chemical compound Br.CC(O)=O MNZMECMQTYGSOI-UHFFFAOYSA-N 0.000 description 1
- ZOIORXHNWRGPMV-UHFFFAOYSA-N acetic acid;zinc Chemical compound [Zn].CC(O)=O.CC(O)=O ZOIORXHNWRGPMV-UHFFFAOYSA-N 0.000 description 1
- WDJHALXBUFZDSR-UHFFFAOYSA-N acetoacetic acid Chemical compound CC(=O)CC(O)=O WDJHALXBUFZDSR-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000003570 air Substances 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- BHELZAPQIKSEDF-UHFFFAOYSA-N allyl bromide Chemical compound BrCC=C BHELZAPQIKSEDF-UHFFFAOYSA-N 0.000 description 1
- TWKVUTXHANJYGH-UHFFFAOYSA-L allyl palladium chloride Chemical class Cl[Pd]CC=C.Cl[Pd]CC=C TWKVUTXHANJYGH-UHFFFAOYSA-L 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 239000012080 ambient air Substances 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 125000002029 aromatic hydrocarbon group Chemical group 0.000 description 1
- 150000001499 aryl bromides Chemical class 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005261 aspartic acid Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 238000011914 asymmetric synthesis Methods 0.000 description 1
- HONIICLYMWZJFZ-UHFFFAOYSA-N azetidine Chemical compound C1CNC1 HONIICLYMWZJFZ-UHFFFAOYSA-N 0.000 description 1
- RFRXIWQYSOIBDI-UHFFFAOYSA-N benzarone Chemical compound CCC=1OC2=CC=CC=C2C=1C(=O)C1=CC=C(O)C=C1 RFRXIWQYSOIBDI-UHFFFAOYSA-N 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 229940092714 benzenesulfonic acid Drugs 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- 125000004540 benzothiazol-5-yl group Chemical group S1C=NC2=C1C=CC(=C2)* 0.000 description 1
- FFBHFFJDDLITSX-UHFFFAOYSA-N benzyl N-[2-hydroxy-4-(3-oxomorpholin-4-yl)phenyl]carbamate Chemical compound OC1=C(NC(=O)OCC2=CC=CC=C2)C=CC(=C1)N1CCOCC1=O FFBHFFJDDLITSX-UHFFFAOYSA-N 0.000 description 1
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 229940000635 beta-alanine Drugs 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 150000001642 boronic acid derivatives Chemical class 0.000 description 1
- 125000005620 boronic acid group Chemical group 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 125000004369 butenyl group Chemical group C(=CCC)* 0.000 description 1
- JHIWVOJDXOSYLW-UHFFFAOYSA-N butyl 2,2-difluorocyclopropane-1-carboxylate Chemical compound CCCCOC(=O)C1CC1(F)F JHIWVOJDXOSYLW-UHFFFAOYSA-N 0.000 description 1
- 125000000480 butynyl group Chemical group [*]C#CC([H])([H])C([H])([H])[H] 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 150000001733 carboxylic acid esters Chemical class 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000013330 chicken meat Nutrition 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- IJOOHPMOJXWVHK-UHFFFAOYSA-N chlorotrimethylsilane Chemical compound C[Si](C)(C)Cl IJOOHPMOJXWVHK-UHFFFAOYSA-N 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 229960003405 ciprofloxacin Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 229960002173 citrulline Drugs 0.000 description 1
- 235000013477 citrulline Nutrition 0.000 description 1
- 229940127204 compound 29 Drugs 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 150000001879 copper Chemical class 0.000 description 1
- 229910000365 copper sulfate Inorganic materials 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- OPQARKPSCNTWTJ-UHFFFAOYSA-L copper(ii) acetate Chemical compound [Cu+2].CC([O-])=O.CC([O-])=O OPQARKPSCNTWTJ-UHFFFAOYSA-L 0.000 description 1
- 229950001513 coumamycin Drugs 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 150000004775 coumarins Chemical class 0.000 description 1
- 239000010779 crude oil Substances 0.000 description 1
- GCUVBACNBHGZRS-UHFFFAOYSA-N cyclopenta-1,3-diene cyclopenta-2,4-dien-1-yl(diphenyl)phosphane iron(2+) Chemical compound [Fe++].c1cc[cH-]c1.c1cc[c-](c1)P(c1ccccc1)c1ccccc1 GCUVBACNBHGZRS-UHFFFAOYSA-N 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- YSMODUONRAFBET-UHFFFAOYSA-N delta-DL-hydroxylysine Natural products NCC(O)CCC(N)C(O)=O YSMODUONRAFBET-UHFFFAOYSA-N 0.000 description 1
- 238000010511 deprotection reaction Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 150000008050 dialkyl sulfates Chemical class 0.000 description 1
- HKBUFTCADGLKAS-UHFFFAOYSA-N diazonio(trimethylsilylmethyl)azanide Chemical compound C[Si](C)(C)C[N-][N+]#N HKBUFTCADGLKAS-UHFFFAOYSA-N 0.000 description 1
- AYOHIQLKSOJJQH-UHFFFAOYSA-N dibutyltin Chemical compound CCCC[Sn]CCCC AYOHIQLKSOJJQH-UHFFFAOYSA-N 0.000 description 1
- VILAVOFMIJHSJA-UHFFFAOYSA-N dicarbon monoxide Chemical compound [C]=C=O VILAVOFMIJHSJA-UHFFFAOYSA-N 0.000 description 1
- CVKBMWWNKUWISK-UHFFFAOYSA-L dichloromethane;dichloropalladium Chemical compound ClCCl.Cl[Pd]Cl CVKBMWWNKUWISK-UHFFFAOYSA-L 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- CSLQAXTUGPUBCW-UHFFFAOYSA-N diethyl 2-bromo-2-methylpropanedioate Chemical compound CCOC(=O)C(C)(Br)C(=O)OCC CSLQAXTUGPUBCW-UHFFFAOYSA-N 0.000 description 1
- DENRZWYUOJLTMF-UHFFFAOYSA-N diethyl sulfate Chemical compound CCOS(=O)(=O)OCC DENRZWYUOJLTMF-UHFFFAOYSA-N 0.000 description 1
- 229940008406 diethyl sulfate Drugs 0.000 description 1
- 125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 description 1
- 125000005048 dihydroisoxazolyl group Chemical group O1N(CC=C1)* 0.000 description 1
- IJKVHSBPTUYDLN-UHFFFAOYSA-N dihydroxy(oxo)silane Chemical compound O[Si](O)=O IJKVHSBPTUYDLN-UHFFFAOYSA-N 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 125000000532 dioxanyl group Chemical group 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 229960001484 edetic acid Drugs 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 238000000132 electrospray ionisation Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- YSMODUONRAFBET-UHNVWZDZSA-N erythro-5-hydroxy-L-lysine Chemical compound NC[C@H](O)CC[C@H](N)C(O)=O YSMODUONRAFBET-UHNVWZDZSA-N 0.000 description 1
- PSLIMVZEAPALCD-UHFFFAOYSA-N ethanol;ethoxyethane Chemical compound CCO.CCOCC PSLIMVZEAPALCD-UHFFFAOYSA-N 0.000 description 1
- ZKQFHRVKCYFVCN-UHFFFAOYSA-N ethoxyethane;hexane Chemical compound CCOCC.CCCCCC ZKQFHRVKCYFVCN-UHFFFAOYSA-N 0.000 description 1
- XDQNYAJLSMQCIW-UHFFFAOYSA-N ethyl 1-(4-bromo-1,3-thiazol-2-yl)-4-ethylpiperidine-4-carboxylate Chemical compound C1CC(C(=O)OCC)(CC)CCN1C1=NC(Br)=CS1 XDQNYAJLSMQCIW-UHFFFAOYSA-N 0.000 description 1
- MBUBKDGRAXXYME-UHFFFAOYSA-N ethyl 1-(4-bromopyridin-2-yl)-4-methylpiperidine-4-carboxylate Chemical compound C1CC(C(=O)OCC)(C)CCN1C1=CC(Br)=CC=N1 MBUBKDGRAXXYME-UHFFFAOYSA-N 0.000 description 1
- BDQYMUXSLLYYFF-UHFFFAOYSA-N ethyl 1-(5-bromo-1,3-thiazol-2-yl)-4-ethylpiperidine-4-carboxylate Chemical compound C1CC(C(=O)OCC)(CC)CCN1C1=NC=C(Br)S1 BDQYMUXSLLYYFF-UHFFFAOYSA-N 0.000 description 1
- DIISFVIUHBFMLD-UHFFFAOYSA-N ethyl 1-(5-bromopyridin-3-yl)-4-methylpiperidine-4-carboxylate Chemical compound C1CC(C(=O)OCC)(C)CCN1C1=CN=CC(Br)=C1 DIISFVIUHBFMLD-UHFFFAOYSA-N 0.000 description 1
- OCRLZABSXCDFHW-UHFFFAOYSA-N ethyl 1-(5-bromopyrimidine-2-carbonyl)-4-methylpiperidine-4-carboxylate Chemical compound C1CC(C(=O)OCC)(C)CCN1C(=O)C1=NC=C(Br)C=N1 OCRLZABSXCDFHW-UHFFFAOYSA-N 0.000 description 1
- NOJYIHASRCBTBX-UHFFFAOYSA-N ethyl 1-[5-[2-(3-ethyl-5-methyl-2-oxo-1,3,5-triazinan-1-yl)-7-(hydroxymethyl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylate Chemical compound C1CC(C(=O)OCC)(C)CCN1C1=NC=C(C=2C=C3N=C(SC3=C(CO)C=2)N2C(N(CC)CN(C)C2)=O)C=N1 NOJYIHASRCBTBX-UHFFFAOYSA-N 0.000 description 1
- YDKYCJORKJUGCA-UHFFFAOYSA-N ethyl 1-[5-[2-(3-ethyl-5-methyl-2-oxo-1,3,5-triazinan-1-yl)-7-(iodomethyl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylate Chemical compound C1CC(C(=O)OCC)(C)CCN1C1=NC=C(C=2C=C3N=C(SC3=C(CI)C=2)N2C(N(CC)CN(C)C2)=O)C=N1 YDKYCJORKJUGCA-UHFFFAOYSA-N 0.000 description 1
- ATXSGVFJJGSVCR-UHFFFAOYSA-N ethyl 1-[5-[2-(ethylcarbamoylamino)-4-pyridin-2-yl-[1,3]thiazolo[5,4-c]pyridin-6-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylate Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(=O)OCC)=NC=1C1=CC=CC=N1 ATXSGVFJJGSVCR-UHFFFAOYSA-N 0.000 description 1
- HTCSZBUCAVAHCX-UHFFFAOYSA-N ethyl 1-[5-[2-(ethylcarbamoylamino)-7-(1-methyltriazol-4-yl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylate Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(=O)OCC)=CC=1C1=CN(C)N=N1 HTCSZBUCAVAHCX-UHFFFAOYSA-N 0.000 description 1
- LYPYNCKARCZOBZ-UHFFFAOYSA-N ethyl 1-[5-[2-(ethylcarbamoylamino)-7-(1-phenyltriazol-4-yl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylate Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(=O)OCC)=CC=1C(N=N1)=CN1C1=CC=CC=C1 LYPYNCKARCZOBZ-UHFFFAOYSA-N 0.000 description 1
- HOJPOJRAYSGURI-UHFFFAOYSA-N ethyl 1-[5-[2-(ethylcarbamoylamino)-7-(2-trimethylsilylethynyl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylate Chemical compound C=1C(C#C[Si](C)(C)C)=C2SC(NC(=O)NCC)=NC2=CC=1C(C=N1)=CN=C1N1CCC(C)(C(=O)OCC)CC1 HOJPOJRAYSGURI-UHFFFAOYSA-N 0.000 description 1
- FZWUEYWUGDOKGO-UHFFFAOYSA-N ethyl 1-[5-[2-(ethylcarbamoylamino)-7-(4-methylpyridin-2-yl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylate Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(=O)OCC)=CC=1C1=CC(C)=CC=N1 FZWUEYWUGDOKGO-UHFFFAOYSA-N 0.000 description 1
- CLXOGXXNPUWTGI-UHFFFAOYSA-N ethyl 1-[5-[2-(ethylcarbamoylamino)-7-[1-(trimethylsilylmethyl)triazol-4-yl]-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylate Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(=O)OCC)=CC=1C1=CN(C[Si](C)(C)C)N=N1 CLXOGXXNPUWTGI-UHFFFAOYSA-N 0.000 description 1
- XDJRQLPJARTBIG-UHFFFAOYSA-N ethyl 1-[5-[2-(ethylcarbamoylamino)-7-formyl-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylate Chemical compound C=1C(C=O)=C2SC(NC(=O)NCC)=NC2=CC=1C(C=N1)=CN=C1N1CCC(C)(C(=O)OCC)CC1 XDJRQLPJARTBIG-UHFFFAOYSA-N 0.000 description 1
- XMSSBALEOXEDDX-UHFFFAOYSA-N ethyl 1-[5-[2-(ethylcarbamoylamino)-7-pyridin-2-yl-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-(trifluoromethyl)piperidine-4-carboxylate Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(CC2)(C(=O)OCC)C(F)(F)F)=CC=1C1=CC=CC=N1 XMSSBALEOXEDDX-UHFFFAOYSA-N 0.000 description 1
- HYLAZACPTHMXHD-UHFFFAOYSA-N ethyl 1-[5-[7-(1-ethoxyethenyl)-2-(ethylcarbamoylamino)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylate Chemical compound C=1C(C(=C)OCC)=C2SC(NC(=O)NCC)=NC2=CC=1C(C=N1)=CN=C1N1CCC(C)(C(=O)OCC)CC1 HYLAZACPTHMXHD-UHFFFAOYSA-N 0.000 description 1
- SAOYDBVIYCQBGN-UHFFFAOYSA-N ethyl 1-[5-[7-(4,5-dihydro-1,3-thiazol-2-ylcarbamoyl)-2-(ethylcarbamoylamino)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylate Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(=O)OCC)=CC=1C(=O)NC1=NCCS1 SAOYDBVIYCQBGN-UHFFFAOYSA-N 0.000 description 1
- ZKHZALBCNHGJPW-UHFFFAOYSA-N ethyl 1-[5-[7-[3-(1,3-dioxoisoindol-2-yl)oxyprop-1-ynyl]-2-(3-ethyl-5-methyl-2-oxo-1,3,5-triazinan-1-yl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-ethylpiperidine-4-carboxylate Chemical compound C1CC(C(=O)OCC)(CC)CCN1C1=NC=C(C=2C=C3N=C(SC3=C(C#CCON3C(C4=CC=CC=C4C3=O)=O)C=2)N2C(N(CC)CN(C)C2)=O)C=N1 ZKHZALBCNHGJPW-UHFFFAOYSA-N 0.000 description 1
- BLNDYICHICBTNJ-UHFFFAOYSA-N ethyl 1-[5-[7-acetyl-2-(ethylcarbamoylamino)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylate Chemical compound C=1C(C(C)=O)=C2SC(NC(=O)NCC)=NC2=CC=1C(C=N1)=CN=C1N1CCC(C)(C(=O)OCC)CC1 BLNDYICHICBTNJ-UHFFFAOYSA-N 0.000 description 1
- YYJKGWIOPAFYMR-UHFFFAOYSA-N ethyl 1-[5-[7-bromo-2-(3-ethyl-5-methyl-2-oxo-1,3,5-triazinan-1-yl)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-ethylpiperidine-4-carboxylate Chemical compound C1CC(C(=O)OCC)(CC)CCN1C1=NC=C(C=2C=C3N=C(SC3=C(Br)C=2)N2C(N(CC)CN(C)C2)=O)C=N1 YYJKGWIOPAFYMR-UHFFFAOYSA-N 0.000 description 1
- QXWPKJONVDGFMF-UHFFFAOYSA-N ethyl 1-[5-[7-bromo-2-(ethylcarbamoylamino)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-prop-2-enylpiperidine-4-carboxylate Chemical compound C=1C(Br)=C2SC(NC(=O)NCC)=NC2=CC=1C(C=N1)=CN=C1N1CCC(CC=C)(C(=O)OCC)CC1 QXWPKJONVDGFMF-UHFFFAOYSA-N 0.000 description 1
- QCMXVVUAXJLYPC-UHFFFAOYSA-N ethyl 1-[5-[7-cyclohexyl-2-(ethylcarbamoylamino)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methylpiperidine-4-carboxylate Chemical compound C=12SC(NC(=O)NCC)=NC2=CC(C=2C=NC(=NC=2)N2CCC(C)(CC2)C(=O)OCC)=CC=1C1CCCCC1 QCMXVVUAXJLYPC-UHFFFAOYSA-N 0.000 description 1
- FLUKEWNALZFURC-UHFFFAOYSA-N ethyl 1-benzyl-3,4-dimethylpiperidine-4-carboxylate Chemical compound C1C(C)C(C(=O)OCC)(C)CCN1CC1=CC=CC=C1 FLUKEWNALZFURC-UHFFFAOYSA-N 0.000 description 1
- SUPCQIBBMFXVTL-UHFFFAOYSA-N ethyl 2-methylprop-2-enoate Chemical compound CCOC(=O)C(C)=C SUPCQIBBMFXVTL-UHFFFAOYSA-N 0.000 description 1
- LZMHMDGOQOZBNM-UHFFFAOYSA-N ethyl 3,4-dimethylpiperidine-4-carboxylate Chemical compound CCOC(=O)C1(C)CCNCC1C LZMHMDGOQOZBNM-UHFFFAOYSA-N 0.000 description 1
- VICYTAYPKBLQFB-UHFFFAOYSA-N ethyl 3-bromo-2-oxopropanoate Chemical compound CCOC(=O)C(=O)CBr VICYTAYPKBLQFB-UHFFFAOYSA-N 0.000 description 1
- YYNJXQIQHNPOSH-UHFFFAOYSA-N ethyl 4-[(5-bromopyrimidin-2-yl)-methylamino]-1-methylcyclohexane-1-carboxylate Chemical compound C1CC(C(=O)OCC)(C)CCC1N(C)C1=NC=C(Br)C=N1 YYNJXQIQHNPOSH-UHFFFAOYSA-N 0.000 description 1
- XGFRNAHHYBGXIZ-UHFFFAOYSA-N ethyl 4-benzyl-1-(5-bromopyrimidin-2-yl)piperidine-4-carboxylate Chemical compound C1CN(C=2N=CC(Br)=CN=2)CCC1(C(=O)OCC)CC1=CC=CC=C1 XGFRNAHHYBGXIZ-UHFFFAOYSA-N 0.000 description 1
- CAPDUHXHHVMIOJ-UHFFFAOYSA-N ethyl 4-benzylpiperidine-4-carboxylate Chemical compound C=1C=CC=CC=1CC1(C(=O)OCC)CCNCC1 CAPDUHXHHVMIOJ-UHFFFAOYSA-N 0.000 description 1
- WKFHWILNBMRPON-OKCVXOCRSA-N ethyl 4-ethyl-1-[5-[2-(ethylcarbamoylamino)-7-[(e)-methoxyiminomethyl]-1,3-benzothiazol-5-yl]pyrimidin-2-yl]piperidine-4-carboxylate Chemical compound C=1C(\C=N\OC)=C2SC(NC(=O)NCC)=NC2=CC=1C(C=N1)=CN=C1N1CCC(CC)(C(=O)OCC)CC1 WKFHWILNBMRPON-OKCVXOCRSA-N 0.000 description 1
- YXDJXSLUZFBZIQ-ATZGPIRCSA-N ethyl 4-ethyl-1-[5-[2-(ethylcarbamoylamino)-7-[(e)-n-methoxy-c-methylcarbonimidoyl]-1,3-benzothiazol-5-yl]pyrimidin-2-yl]piperidine-4-carboxylate Chemical compound C=1C(\C(C)=N\OC)=C2SC(NC(=O)NCC)=NC2=CC=1C(C=N1)=CN=C1N1CCC(CC)(C(=O)OCC)CC1 YXDJXSLUZFBZIQ-ATZGPIRCSA-N 0.000 description 1
- LMOYJYURBYZOPT-UHFFFAOYSA-N ethyl 4-fluoropiperidin-1-ium-4-carboxylate;chloride Chemical compound Cl.CCOC(=O)C1(F)CCNCC1 LMOYJYURBYZOPT-UHFFFAOYSA-N 0.000 description 1
- SBYNEUJOCHDCOL-UHFFFAOYSA-N ethyl 4-methyl-1-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-yl]piperidine-4-carboxylate Chemical compound C1CC(C(=O)OCC)(C)CCN1C1=NC=C(B2OC(C)(C)C(C)(C)O2)C=N1 SBYNEUJOCHDCOL-UHFFFAOYSA-N 0.000 description 1
- INWHPEOLADZATF-UHFFFAOYSA-N ethyl 4-prop-2-enyl-1-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-yl]piperidine-4-carboxylate Chemical compound C1CC(C(=O)OCC)(CC=C)CCN1C1=NC=C(B2OC(C)(C)C(C)(C)O2)C=N1 INWHPEOLADZATF-UHFFFAOYSA-N 0.000 description 1
- UBXLGRCSCOVRMZ-UHFFFAOYSA-N ethyl 5-amino-7-bromoimidazo[1,2-a]pyridine-2-carboxylate Chemical compound NC1=CC(Br)=CC2=NC(C(=O)OCC)=CN21 UBXLGRCSCOVRMZ-UHFFFAOYSA-N 0.000 description 1
- RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 description 1
- TUXCQKQMKGATPB-UHFFFAOYSA-N ethyl n-[(4,6-dichloropyridin-2-yl)carbamothioyl]carbamate Chemical compound CCOC(=O)NC(=S)NC1=CC(Cl)=CC(Cl)=N1 TUXCQKQMKGATPB-UHFFFAOYSA-N 0.000 description 1
- KGAWPIXNSIYQPC-UHFFFAOYSA-N ethyl piperidine-2-carboxylate;hydrochloride Chemical compound Cl.CCOC(=O)C1CCCCN1 KGAWPIXNSIYQPC-UHFFFAOYSA-N 0.000 description 1
- 229940117360 ethyl pyruvate Drugs 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000000105 evaporative light scattering detection Methods 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- LRBQNJMCXXYXIU-QWKBTXIPSA-N gallotannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@H]2[C@@H]([C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-QWKBTXIPSA-N 0.000 description 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 1
- 229960003923 gatifloxacin Drugs 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 229950006191 gluconic acid Drugs 0.000 description 1
- 229960002989 glutamic acid Drugs 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000008241 heterogeneous mixture Substances 0.000 description 1
- KDCIHNCMPUBDKT-UHFFFAOYSA-N hexane;propan-2-one Chemical compound CC(C)=O.CCCCCC KDCIHNCMPUBDKT-UHFFFAOYSA-N 0.000 description 1
- 125000006038 hexenyl group Chemical group 0.000 description 1
- 125000005980 hexynyl group Chemical group 0.000 description 1
- 239000000710 homodimer Substances 0.000 description 1
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- NMAACQILAGCQPR-UHFFFAOYSA-N hydron;methyl 4-oxopiperidine-3-carboxylate;chloride Chemical compound Cl.COC(=O)C1CNCCC1=O NMAACQILAGCQPR-UHFFFAOYSA-N 0.000 description 1
- VIPHVHVAGBKHGR-UHFFFAOYSA-N hydron;pyridine-2-carbonyl chloride;chloride Chemical compound Cl.ClC(=O)C1=CC=CC=N1 VIPHVHVAGBKHGR-UHFFFAOYSA-N 0.000 description 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 1
- QJHBJHUKURJDLG-UHFFFAOYSA-N hydroxy-L-lysine Natural products NCCCCC(NO)C(O)=O QJHBJHUKURJDLG-UHFFFAOYSA-N 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229940102213 injectable suspension Drugs 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 125000002346 iodo group Chemical group I* 0.000 description 1
- HVTICUPFWKNHNG-UHFFFAOYSA-N iodoethane Chemical compound CCI HVTICUPFWKNHNG-UHFFFAOYSA-N 0.000 description 1
- 125000004491 isohexyl group Chemical group C(CCC(C)C)* 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000000555 isopropenyl group Chemical group [H]\C([H])=C(\*)C([H])([H])[H] 0.000 description 1
- 125000003253 isopropoxy group Chemical group [H]C([H])([H])C([H])(O*)C([H])([H])[H] 0.000 description 1
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 description 1
- QHDRKFYEGYYIIK-UHFFFAOYSA-N isovaleronitrile Chemical compound CC(C)CC#N QHDRKFYEGYYIIK-UHFFFAOYSA-N 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 229940033355 lauric acid Drugs 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- FRIJBUGBVQZNTB-UHFFFAOYSA-M magnesium;ethane;bromide Chemical compound [Mg+2].[Br-].[CH2-]C FRIJBUGBVQZNTB-UHFFFAOYSA-M 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- ZPMYIAUKLBTNRG-UHFFFAOYSA-N methyl 1-(5-bromo-3-fluoropyridin-2-yl)-4-methylpiperidine-4-carboxylate Chemical compound C1CC(C(=O)OC)(C)CCN1C1=NC=C(Br)C=C1F ZPMYIAUKLBTNRG-UHFFFAOYSA-N 0.000 description 1
- QWDGTEHBLUGZAL-UHFFFAOYSA-N methyl 1-benzyl-3-methylpiperidine-4-carboxylate Chemical compound C1C(C)C(C(=O)OC)CCN1CC1=CC=CC=C1 QWDGTEHBLUGZAL-UHFFFAOYSA-N 0.000 description 1
- VTYCAXIAUKEGBQ-UHFFFAOYSA-N methyl cyclopentene-1-carboxylate Chemical compound COC(=O)C1=CCCC1 VTYCAXIAUKEGBQ-UHFFFAOYSA-N 0.000 description 1
- RZVWBASHHLFBJF-UHFFFAOYSA-N methyl piperidine-4-carboxylate Chemical compound COC(=O)C1CCNCC1 RZVWBASHHLFBJF-UHFFFAOYSA-N 0.000 description 1
- PGXWDLGWMQIXDT-UHFFFAOYSA-N methylsulfinylmethane;hydrate Chemical compound O.CS(C)=O PGXWDLGWMQIXDT-UHFFFAOYSA-N 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 1
- FABPRXSRWADJSP-MEDUHNTESA-N moxifloxacin Chemical compound COC1=C(N2C[C@H]3NCCC[C@H]3C2)C(F)=CC(C(C(C(O)=O)=C2)=O)=C1N2C1CC1 FABPRXSRWADJSP-MEDUHNTESA-N 0.000 description 1
- 229960003702 moxifloxacin Drugs 0.000 description 1
- LNOPIUAQISRISI-UHFFFAOYSA-N n'-hydroxy-2-propan-2-ylsulfonylethanimidamide Chemical compound CC(C)S(=O)(=O)CC(N)=NO LNOPIUAQISRISI-UHFFFAOYSA-N 0.000 description 1
- DYCRFHKDWNMPEG-UHFFFAOYSA-N n-(2-bromo-5-fluorophenyl)-2,2-dimethylpropanamide Chemical compound CC(C)(C)C(=O)NC1=CC(F)=CC=C1Br DYCRFHKDWNMPEG-UHFFFAOYSA-N 0.000 description 1
- RLKHFSNWQCZBDC-UHFFFAOYSA-N n-(benzenesulfonyl)-n-fluorobenzenesulfonamide Chemical compound C=1C=CC=CC=1S(=O)(=O)N(F)S(=O)(=O)C1=CC=CC=C1 RLKHFSNWQCZBDC-UHFFFAOYSA-N 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 210000004897 n-terminal region Anatomy 0.000 description 1
- MHWLWQUZZRMNGJ-UHFFFAOYSA-N nalidixic acid Chemical compound C1=C(C)N=C2N(CC)C=C(C(O)=O)C(=O)C2=C1 MHWLWQUZZRMNGJ-UHFFFAOYSA-N 0.000 description 1
- 229960000210 nalidixic acid Drugs 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000012457 nonaqueous media Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 229960001180 norfloxacin Drugs 0.000 description 1
- OGJPXUAPXNRGGI-UHFFFAOYSA-N norfloxacin Chemical compound C1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCNCC1 OGJPXUAPXNRGGI-UHFFFAOYSA-N 0.000 description 1
- YJQPYGGHQPGBLI-KGSXXDOSSA-N novobiocin Chemical compound O1C(C)(C)[C@H](OC)[C@@H](OC(N)=O)[C@@H](O)[C@@H]1OC1=CC=C(C(O)=C(NC(=O)C=2C=C(CC=C(C)C)C(O)=CC=2)C(=O)O2)C2=C1C YJQPYGGHQPGBLI-KGSXXDOSSA-N 0.000 description 1
- 229960002950 novobiocin Drugs 0.000 description 1
- 238000012587 nuclear overhauser effect experiment Methods 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 229960003104 ornithine Drugs 0.000 description 1
- 125000001715 oxadiazolyl group Chemical group 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 229940116315 oxalic acid Drugs 0.000 description 1
- BSCHIACBONPEOB-UHFFFAOYSA-N oxolane;hydrate Chemical compound O.C1CCOC1 BSCHIACBONPEOB-UHFFFAOYSA-N 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- QJPQVXSHYBGQGM-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 QJPQVXSHYBGQGM-UHFFFAOYSA-N 0.000 description 1
- 229940098695 palmitic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 125000002255 pentenyl group Chemical group C(=CCCC)* 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 125000005981 pentynyl group Chemical group 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 125000004193 piperazinyl group Chemical group 0.000 description 1
- 125000005936 piperidyl group Chemical group 0.000 description 1
- IUGYQRQAERSCNH-UHFFFAOYSA-N pivalic acid Chemical compound CC(C)(C)C(O)=O IUGYQRQAERSCNH-UHFFFAOYSA-N 0.000 description 1
- 230000036470 plasma concentration Effects 0.000 description 1
- 125000003367 polycyclic group Chemical group 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920001184 polypeptide Chemical group 0.000 description 1
- ZNNZYHKDIALBAK-UHFFFAOYSA-M potassium thiocyanate Chemical compound [K+].[S-]C#N ZNNZYHKDIALBAK-UHFFFAOYSA-M 0.000 description 1
- 229940116357 potassium thiocyanate Drugs 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 108090000765 processed proteins & peptides Chemical group 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 125000004368 propenyl group Chemical group C(=CC)* 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 125000002568 propynyl group Chemical group [*]C#CC([H])([H])[H] 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- 125000004307 pyrazin-2-yl group Chemical group [H]C1=C([H])N=C(*)C([H])=N1 0.000 description 1
- SSRHUSRCYKOCMA-UHFFFAOYSA-N pyridin-2-ylstannane Chemical compound [SnH3]C1=CC=CC=N1 SSRHUSRCYKOCMA-UHFFFAOYSA-N 0.000 description 1
- 125000004528 pyrimidin-5-yl group Chemical group N1=CN=CC(=C1)* 0.000 description 1
- ZFCHNZDUMIOWFV-UHFFFAOYSA-N pyrimidine-2-carboxylic acid Chemical compound OC(=O)C1=NC=CC=N1 ZFCHNZDUMIOWFV-UHFFFAOYSA-N 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- LISFMEBWQUVKPJ-UHFFFAOYSA-N quinolin-2-ol Chemical compound C1=CC=C2NC(=O)C=CC2=C1 LISFMEBWQUVKPJ-UHFFFAOYSA-N 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 239000013557 residual solvent Substances 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 125000006413 ring segment Chemical group 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 229960004274 stearic acid Drugs 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000000547 substituted alkyl group Chemical group 0.000 description 1
- 125000003107 substituted aryl group Chemical group 0.000 description 1
- 229950000244 sulfanilic acid Drugs 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- UQADQTBQNVARAP-UHFFFAOYSA-N tert-butyl 4-cyanopiperidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCC(C#N)CC1 UQADQTBQNVARAP-UHFFFAOYSA-N 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 description 1
- 125000001412 tetrahydropyranyl group Chemical group 0.000 description 1
- 125000003554 tetrahydropyrrolyl group Chemical group 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 125000001544 thienyl group Chemical group 0.000 description 1
- 125000005505 thiomorpholino group Chemical group 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- CFOAUYCPAUGDFF-UHFFFAOYSA-N tosmic Chemical compound CC1=CC=C(S(=O)(=O)C[N+]#[C-])C=C1 CFOAUYCPAUGDFF-UHFFFAOYSA-N 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- GYUURHMITDQTRU-UHFFFAOYSA-N tributyl(pyridin-2-yl)stannane Chemical compound CCCC[Sn](CCCC)(CCCC)C1=CC=CC=N1 GYUURHMITDQTRU-UHFFFAOYSA-N 0.000 description 1
- JCZRGWAGRPABLT-UHFFFAOYSA-N tributyl-(2-methoxy-1,3-thiazol-4-yl)stannane Chemical compound CCCC[Sn](CCCC)(CCCC)C1=CSC(OC)=N1 JCZRGWAGRPABLT-UHFFFAOYSA-N 0.000 description 1
- ITMCEJHCFYSIIV-UHFFFAOYSA-M triflate Chemical compound [O-]S(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-M 0.000 description 1
- QXXHXTRTGZBOGD-UHFFFAOYSA-M trifluoromethanesulfonate;5-(trifluoromethyl)dibenzothiophen-5-ium Chemical compound [O-]S(=O)(=O)C(F)(F)F.C1=CC=C2[S+](C(F)(F)F)C3=CC=CC=C3C2=C1 QXXHXTRTGZBOGD-UHFFFAOYSA-M 0.000 description 1
- SEDZOYHHAIAQIW-UHFFFAOYSA-N trimethylsilyl azide Chemical compound C[Si](C)(C)N=[N+]=[N-] SEDZOYHHAIAQIW-UHFFFAOYSA-N 0.000 description 1
- CWMFRHBXRUITQE-UHFFFAOYSA-N trimethylsilylacetylene Chemical group C[Si](C)(C)C#C CWMFRHBXRUITQE-UHFFFAOYSA-N 0.000 description 1
- 238000001665 trituration Methods 0.000 description 1
- 238000003828 vacuum filtration Methods 0.000 description 1
- 229940005605 valeric acid Drugs 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
- 239000004246 zinc acetate Substances 0.000 description 1
- 229940102001 zinc bromide Drugs 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
- GTLDTDOJJJZVBW-UHFFFAOYSA-N zinc cyanide Chemical compound [Zn+2].N#[C-].N#[C-] GTLDTDOJJJZVBW-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N47/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
- A01N47/08—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having one or more single bonds to nitrogen atoms
- A01N47/28—Ureas or thioureas containing the groups >N—CO—N< or >N—CS—N<
- A01N47/36—Ureas or thioureas containing the groups >N—CO—N< or >N—CS—N< containing the group >N—CO—N< directly attached to at least one heterocyclic ring; Thio analogues thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Dentistry (AREA)
- Engineering & Computer Science (AREA)
- Plant Pathology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Pest Control & Pesticides (AREA)
- Agronomy & Crop Science (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39116310P | 2010-10-08 | 2010-10-08 | |
| US61/391,163 | 2010-10-08 | ||
| PCT/AU2011/001284 WO2012045124A1 (en) | 2010-10-08 | 2011-10-07 | Bacteria topoisomerase ii inhibiting 2-ethylcarbamoylamino-1, 3-benzothiazol-5-yls |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013542204A JP2013542204A (ja) | 2013-11-21 |
| JP2013542204A5 JP2013542204A5 (enExample) | 2014-11-27 |
| JP5864589B2 true JP5864589B2 (ja) | 2016-02-17 |
Family
ID=45925612
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013532015A Expired - Fee Related JP5864589B2 (ja) | 2010-10-08 | 2011-10-07 | 細菌トポイソメラーゼii阻害性2−エチルカルバモイルアミノ−1,3−ベンゾチアゾール−5−イル類 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US9181234B2 (enExample) |
| EP (1) | EP2625178A4 (enExample) |
| JP (1) | JP5864589B2 (enExample) |
| CN (1) | CN103249732B (enExample) |
| AU (1) | AU2011313820A1 (enExample) |
| WO (1) | WO2012045124A1 (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2015514063A (ja) * | 2012-03-22 | 2015-05-18 | ビオタ ヨーロッパ リミテッドBiota Europe Ltd | 抗菌化合物 |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2663558A1 (en) | 2011-01-14 | 2013-11-20 | Vertex Pharmaceuticals Incorporated | Solid forms of gyrase inhibitor (r)-1-ethyl-3-[5-[2-{1-hydroxy-1-methyl-ethyl}pyrimidin-5-yl]-7-(tetrahydrofuran-2-yl}-1h-benzimidazol-2-yl]urea |
| ES2705923T3 (es) | 2011-01-14 | 2019-03-27 | Spero Trinem Inc | Formas sólidas de inhibidor de girasa (R)-1-etil-3-[6-fluoro-5-[2-(1-hidroxi-1-metil-etil)pirimidin-5-il]-7-(tetrahidrofuran-2-il)-1H-bencimidazol-2-il]urea |
| EP2663556B1 (en) | 2011-01-14 | 2014-10-15 | Vertex Pharmaceuticals Incorporated | Process of making gyrase and topoisomerase iv inhibitors |
| SG191946A1 (en) | 2011-01-14 | 2013-08-30 | Vertex Pharma | Pyrimidine gyrase and topoisomerase iv inhibitors |
| CN103702994B (zh) | 2011-06-20 | 2016-03-23 | 沃泰克斯药物股份有限公司 | 旋转酶和拓扑异构酶抑制剂的磷酸酯 |
| WO2014015105A1 (en) | 2012-07-18 | 2014-01-23 | Vertex Pharmaceuticals Incorporated | Solid forms of (r)-2-(5-(2-(3-ethylureido)-6-fluoro-7-(tetrahydrofuran-2-yl)-1h-benzo[d]imidazol-5-yl)pyrimidin-2-yl)propan-2-yl dihydrogen phosphate and salts thereof |
| US9572809B2 (en) | 2012-07-18 | 2017-02-21 | Spero Trinem, Inc. | Combination therapy to treat Mycobacterium diseases |
| BR112016018048A2 (pt) | 2014-02-03 | 2017-08-08 | Spero Gyrase Inc | Método para o tratamento ou prevenção de uma infecção bacteriana, uso de um inibidor de topoisomerase tipo ii bacteriana em combinação com uma polimixina ou derivado de polimixina no tratamento ou prevenção de uma infecção bacteriana, uso de um inibidor de topoisomerase tipo ii bacteriana em combinação com uma polimixina ou derivado de polimixina na preparação de um medicamento para o tratamento ou prevenção de uma infecção bacteriana, método para melhorar a atividade antibacteriana de um inibidor de topoisomerase tipo ii bacteriana, método para melhorar a eficácia bactericida de um inibidor de topoisomerase tipo ii bacteriana, composição, agente antibacteriano, processo, e, composto |
| CN104230991A (zh) * | 2014-08-25 | 2014-12-24 | 亿腾药业(泰州)有限公司 | 一种控制福沙吡坦二甲葡胺中钯残留的方法 |
| WO2016119700A1 (en) | 2015-01-28 | 2016-08-04 | Jn Therapeutics | Substituted imidazo [1, 2-a] pyridin-2-ylamine compounds, and pharmaceutical compositions and methods of use thereof |
| CN106167486B (zh) * | 2015-05-22 | 2019-06-14 | 北京四环制药有限公司 | 单环类回旋酶和拓扑异构酶iv抑制剂 |
| PT3436461T (pt) | 2016-03-28 | 2024-01-23 | Incyte Corp | Compostos de pirrolotriazina como inibidores de tam |
| ES2948194T3 (es) * | 2017-01-18 | 2023-09-01 | Array Biopharma Inc | Compuestos de pirazolo[1,5-a]pirazina sustituida como inhibidores de la cinasa RET |
| RU2019133662A (ru) | 2017-03-24 | 2021-04-26 | Тайсо Фармасьютикал Ко., Лтд. | Производное 2(1h)-хинолинона |
| WO2019057946A1 (en) | 2017-09-25 | 2019-03-28 | F. Hoffmann-La Roche Ag | MULTI-CYCLIC AROMATIC COMPOUNDS AS D-FACTOR INHIBITORS |
| JP7569688B2 (ja) | 2017-12-22 | 2024-10-18 | ハイバーセル,インコーポレイテッド | ホスファチジルイノシトールリン酸キナーゼ阻害剤としてのアミノピリジン誘導体 |
| TW202112767A (zh) | 2019-06-17 | 2021-04-01 | 美商佩特拉製藥公司 | 作為磷脂酸肌醇磷酸激酶抑制劑之胺基吡啶衍生物 |
| EP4013744A1 (de) * | 2019-08-15 | 2022-06-22 | Bayer Aktiengesellschaft | Verfahren zur herstellung von 2-(phenylimino)-3-alkyl-1,3-thiazolidin-4-onen |
| CN115315425B (zh) * | 2020-08-14 | 2025-03-28 | 上海复旦张江生物医药股份有限公司 | 一种取代的咪唑并[1,2-a]吡啶-2-基酰胺化合物的制备方法及其中间体 |
| CN115073358B (zh) * | 2022-07-21 | 2023-09-26 | 安徽德诺医药股份有限公司 | 一种n-苄基-4-哌啶甲酸乙酯的制备方法 |
| CN118955404A (zh) * | 2024-07-30 | 2024-11-15 | 凯美克(上海)医药科技有限公司 | 一种化合物3,5-二溴哒嗪的合成方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT100905A (pt) * | 1991-09-30 | 1994-02-28 | Eisai Co Ltd | Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem |
| SI1341769T1 (sl) | 2000-12-15 | 2008-02-29 | Vertex Pharma | Inhibitorji bakterijske giraze in njihove uporabe |
| US7569591B2 (en) * | 2003-01-31 | 2009-08-04 | Vertex Pharmaceuticals Incorporated | Gyrase inhibitors and uses thereof |
| US7618974B2 (en) * | 2003-01-31 | 2009-11-17 | Vertex Pharmaceuticals Incorporated | Gyrase inhibitors and uses thereof |
| US8404852B2 (en) * | 2003-01-31 | 2013-03-26 | Vertex Pharmaceuticals Incorporated | Gyrase inhibitors and uses thereof |
| JPWO2007119833A1 (ja) * | 2006-04-14 | 2009-08-27 | 武田薬品工業株式会社 | 含窒素複素環化合物 |
| GB0724342D0 (en) * | 2007-12-13 | 2008-01-30 | Prolysis Ltd | Anitbacterial compositions |
| US20110166088A1 (en) * | 2008-06-25 | 2011-07-07 | Ranbaxy Laboratories Limited | Benzothiazoles and aza-analogues thereof use as antibacterial agents |
| WO2010100144A1 (en) * | 2009-03-04 | 2010-09-10 | Merck Serono S.A. | Fused bicyclic compounds as inhibitors for pi3 kinase |
-
2011
- 2011-10-07 AU AU2011313820A patent/AU2011313820A1/en not_active Abandoned
- 2011-10-07 US US13/268,154 patent/US9181234B2/en not_active Expired - Fee Related
- 2011-10-07 EP EP11830125.8A patent/EP2625178A4/en not_active Withdrawn
- 2011-10-07 WO PCT/AU2011/001284 patent/WO2012045124A1/en not_active Ceased
- 2011-10-07 JP JP2013532015A patent/JP5864589B2/ja not_active Expired - Fee Related
- 2011-10-07 CN CN201180059188.1A patent/CN103249732B/zh not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2015514063A (ja) * | 2012-03-22 | 2015-05-18 | ビオタ ヨーロッパ リミテッドBiota Europe Ltd | 抗菌化合物 |
Also Published As
| Publication number | Publication date |
|---|---|
| US20120088750A1 (en) | 2012-04-12 |
| EP2625178A1 (en) | 2013-08-14 |
| JP2013542204A (ja) | 2013-11-21 |
| CN103249732A (zh) | 2013-08-14 |
| EP2625178A4 (en) | 2014-04-30 |
| CN103249732B (zh) | 2016-08-10 |
| US9181234B2 (en) | 2015-11-10 |
| WO2012045124A1 (en) | 2012-04-12 |
| AU2011313820A1 (en) | 2013-04-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5864589B2 (ja) | 細菌トポイソメラーゼii阻害性2−エチルカルバモイルアミノ−1,3−ベンゾチアゾール−5−イル類 | |
| TWI863945B (zh) | 2-側氧基喹唑啉衍生物作為甲硫胺酸腺苷基轉移酶2a抑制劑 | |
| EP3630770B1 (en) | Pyrazolo[3,4-b]pyrazine derivatives as shp2 phosphatase inhibitors | |
| AU2015323572B2 (en) | Novel compounds | |
| KR101443795B1 (ko) | 항균성 조성물 | |
| DE602004009089T2 (de) | Pyrrolderivate mit antibakterieller wirkung | |
| KR102007056B1 (ko) | 과증식성 질환 치료시 Bub1 키나제 저해제로 사용하기 위한 치환된 벤질인다졸 | |
| JP5561702B2 (ja) | Pi3キナーゼ調節剤および使用方法 | |
| US11420966B2 (en) | Substituted pyrrolopyridines as JAK inhibitors | |
| ES2784655T3 (es) | 1H-pirazolo[4,3-b]piridinas como inhibidores de PDE1 | |
| US20120101100A1 (en) | Heterocyclic urea derivatives and methods of use thereof-211 | |
| JP2021514359A (ja) | キナーゼ阻害剤としての複素環式化合物 | |
| KR20170040300A (ko) | 2-(모르폴린-4-일)-l,7-나프티리딘 | |
| CA3061392A1 (en) | Azalactam compounds as hpk1 inhibitors | |
| AU2022349569A1 (en) | Pyridine derivative and use thereof | |
| KR20140117651A (ko) | 이소퀴놀린 및 나프티리딘 유도체 | |
| KR20230112605A (ko) | 키나아제 억제제 및 그의 용도 | |
| TW201111380A (en) | Heterocyclic urea derivatives and methods of use thereof | |
| ES2899868T3 (es) | Tratamientos de combinación que comprenden la administración de 1H-pirazolo[4,3-b]piridinas | |
| AU2015212495A1 (en) | Antibacterial combinations comprising polymyxin | |
| US20230365551A1 (en) | Inhibitors of human respiratory syncytial virus and metapneumovirus | |
| AU2012203026B2 (en) | Novel heterocyclic compounds and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20141003 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20141003 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20150519 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20150521 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20150817 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20151013 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20151029 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20151208 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20151224 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 5864589 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| LAPS | Cancellation because of no payment of annual fees |